{"pdf": "docs/real/0-6914-3_p125.pdf", "category": "real", "id": "0-6914-3_p125", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" = ∗ ∗ ∗ ∗ ℎℎ: = 2.4\\n √ '\\n\\nwhere:\\n\\n = ℎ ( . )\\n\\n =\\n\\n=\\n\\n= 5.4.2.8\\n\\n =\\n\\n = .\\n\\n= ℎ ( )\\n\\n' = ℎ ( )\\n\\n = ( . )\\n\\nModification factors shall be applied to the basic development length to account for the various\\neffects specified herein. They shall be taken equal to 1.0 unless they are specified to increase in\\nArticle 5.11.2.1.2, or to decrease in Article 5.11.2.1.3.\\n\\n5.11.2.1.2 - Modification factors which increase\\n\\nThe basic development length, , shall be multiplied by the following factor or factors, as\\napplicable:\\n\\n • For horizontal reinforcement, placed such that more than 12.0 in of fresh concrete is cast\\n below the reinforcement, = ⋯ … … … … … … … … … … … … … . 1.3\\n • For horizontal reinforcement, placed such that no more than 12.0 in of fresh concrete is\\n cast below the reinforcement and ' is greater than 10.0 ksi, = ⋯ … … … … . 1.3\\n • For lightweight concrete, use as specified in Article 5.4.2.8\\n • For epoxy-coated bars with cover less than 3 or with clear spacing between bars less\\n than 6, = ⋯ … … … … … . . 1.5\\n • For epoxy-coated bars not covered above, = ⋯ … … … … … … … … … … 1.2\\n\\nThe product of need not be taken as greater than 1.7.\\n\\n\\n 114\", \"page_fill_runs\": [40, 13, 17, 30], \"page_lines\": 28}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:ellipsis"]} {"pdf": "docs/real/0000930661-99-000626_p48.pdf", "category": "real", "id": "0000930661-99-000626_p48", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" Reserves attributable to certain oil and gas discoveries were not\\n considered proved as of year-end 1998 due to geological, technological or\\n economic uncertainties and therefore are not included in the tabulation.\\n\\n Crude oil and natural gas liquids and natural gas production quantities\\n shown are the net volumes withdrawn from Exxon's oil and gas reserves. The\\n natural gas quantities differ from the quantities of gas delivered for sale by\\n the producing function as reported on page F31 due to volumes consumed or flared\\n and inventory changes. Such quantities amounted to approximately 236 billion\\n cubic feet in 1996, 268 billion cubic feet in 1997 and 242 billion cubic feet in\\n 1998.\\n\\n \\n
\\n\\n Consolidated Subsidiaries\\n ----------------------------------------------------------------\\nNon-\\n United Consolidated\\n Total\\n Natural Gas States Canada Europe Asia-Pacific Other Interests Total\\n Worldwide\\n - - -------------------------------------------------------------------------------------------------------------------------\\n ---------\\n (billions of cubic feet)\\n \\n Net proved developed and undeveloped reserves\\n January 1, 1996 9,947 2,118 7,553 5,764 102 25,484 16,552\\n 42,036\\n Revisions 422 (118) 101 107 13 525 196\\n 721\\n Purchases 4 11 -- -- 13 28 11\\n 39\\n Sales (36) (76) -- -- (1) (113) (3)\\n (116)\\n Improved recovery 39 18 5 -- -- 62 --\\n 62\\n Extensions and discoveries 615 61 506 53 -- 1,235 166\\n 1,401\\n Production (841) (142) (525) (380) (8) (1,896) (747)\\n (2,643)\\n --------------------------------------------------------------------------------------\\n ---\\n December 31, 1996 10,150 1,872 7,640 5,544 119 25,325 16,175\\n 41,500\\n Revisions (53) (43) (1) 433 -- 336 107\\n 443\\n Purchases 2 -- -- -- -- 2 --\\n 2\\n Sales (27) (122) (6) -- -- (155) --\\n (155)\\n Improved recovery (2) 19 17 -- -- 34 --\\n 34\\n Extensions and discoveries 450 24 363 1,687 -- 2,524 363\\n 2,887\\n Production (831) (138) (531) (441) (8) (1,949) (633)\\n (2,582)\\n --------------------------------------------------------------------------------------\\n ---\\n December 31, 1997 9,689 1,612 7,482 7,223 111 26,117 16,012\\n 42,129\\n Revisions 922 65 161 386 2 1,536 176\\n 1,712\\n Purchases -- 2 -- -- -- 2 --\\n 2\\n Sales (23) (23) (10) -- -- (56) --\\n (56)\\n Improved recovery 1 13 6 -- -- 20 --\\n 20\\n Extensions and discoveries 160 221 113 362 111 967 69\\n 1,036\\n Production (832) (138) (565) (420) (7) (1,962) (587)\\n (2,549)\\n --------------------------------------------------------------------------------------\\n ---\\n December 31, 1998 9,917 1,752 7,187 7,551 217 26,624 15,670\\n 42,294\\n\\n Developed reserves, included above\\n At December 31, 1996 8,216 1,392 4,872 3,995 83 18,558 6,754\\n 25,312\\n At December 31, 1997 7,625 1,236 5,334 5,191 76 19,462 6,463\\n 25,925\\n At December 31, 1998 7,812 1,231 5,034 5,424 75 19,576 6,740\\n 26,316\\n =================================================================================================================================\\n =\\n
\\n\\n\\n F29\", \"page_fill_runs\": [], \"page_lines\": 85}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:equals"]} {"pdf": "docs/real/03-26-01_p80.pdf", "category": "real", "id": "03-26-01_p80", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" HANDBOOK ON INTELLECTUAL PROPERTY\\n INFORMATION AND DOCUMENTATION\\n\\nRef.: Standards - ST.26 page: 3.26.i.54\\n\\n\\n 9 - Echinoderm and Flatworm Mitochondrial Code\\n AAs = F F L L S S S S Y Y * * C C W W L L L L P P P P H H Q Q R R R R I I I M T T T T N N N K S S S S V V V V A A A A D D E E G G G G\\nStarts = - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - M - - - - - - - - - - - - - - - M- - - - - - - - - - - -\\nBase1 = t t t t t t t t t t t t t t t t c c c c c c c c c c c c c c c c a a a a a a a a a a a a a a a a g g g g g g g g g g g g g g g g\\nBase2 = t t t t c c c c a a a a g g g g t t t t c c c c a a a a g g g g t t t t c c c c a a a a g g g g t t t t c c c c a a a a g g g g\\nBase3 = t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g\\n\\n 10 - Euplotid Nuclear Code\\n AAs = F F L L S S S S Y Y * * C C C W L L L L P P P P H H Q Q R R R R I I I M T T T T N N K K S S R R V V V V A A A A D D E E G G G G\\nStarts = - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - M - - - - - - - - - - - - - - - - - - - - - - - - - - - -\\nBase1 = t t t t t t t t t t t t t t t t c c c c c c c c c c c c c c c c a a a a a a a a a a a a a a a a g g g g g g g g g g g g g g g g\\nBase2 = t t t t c c c c a a a a g g g g t t t t c c c c a a a a g g g g t t t t c c c c a a a a g g g g t t t t c c c c a a a a g g g g\\nBase3 = t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g\\n\\n 11 - Bacterial, Archaeal, and Plant Plastid Code\\n AAs = F F L L S S S S Y Y * * C C * W L L L L P P P P H H Q Q R R R R I I I M T T T T N N K K S S R R V V V V A A A A D D E E G G G G\\nStarts = - - -M - - - - - - - - - - - - - - - M - - - - - - - - - - - - M M M M - - - - - - - - - - - - - - - M- - - - - - - - - - - -\\nBase1 = t t t t t t t t t t t t t t t t c c c c c c c c c c c c c c c c a a a a a a a a a a a a a a a a g g g g g g g g g g g g g g g g\\nBase2 = t t t t c c c c a a a a g g g g t t t t c c c c a a a a g g g g t t t t c c c c a a a a g g g g t t t t c c c c a a a a g g g g\\nBase3 = t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g\\n\\n 12 - Alternative Yeast Nuclear Code\\n AAs = F F L L S S S S Y Y * * C C * W L L L S P P P P H H Q Q R R R R I I I M T T T T N N K K S S R R V V V V A A A A D D E E G G G G\\nStarts = - - - - - - - - - - - - - - - - - - - M - - - - - - - - - - - - - - - M - - - - - - - - - - - - - - - - - - - - - - - - - - - -\\nBase1 = t t t t t t t t t t t t t t t t c c c c c c c c c c c c c c c c a a a a a a a a a a a a a a a a g g g g g g g g g g g g g g g g\\nBase2 = t t t t c c c c a a a a g g g g t t t t c c c c a a a a g g g g t t t t c c c c a a a a g g g g t t t t c c c c a a a a g g g g\\nBase3 = t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g\\n\\n 13 - Ascidian Mitochondrial Code\\n AAs = F F L L S S S S Y Y * * C C W W L L L L P P P P H H Q Q R R R R I I M M T T T T N N K K S S G G V V V V A A A A D D E E G G G G\\nStarts = - - -M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - MM - - - - - - - - - - - - - - - M- - - - - - - - - - - -\\nBase1 = t t t t t t t t t t t t t t t t c c c c c c c c c c c c c c c c a a a a a a a a a a a a a a a a g g g g g g g g g g g g g g g g\\nBase2 = t t t t c c c c a a a a g g g g t t t t c c c c a a a a g g g g t t t t c c c c a a a a g g g g t t t t c c c c a a a a g g g g\\nBase3 = t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g\\n\\n\\n 14 - Alternative Flatworm Mitochondrial Code\\n AAs = F F L L S S S S Y Y Y * C C W W L L L L P P P P H H Q Q R R R R I I I M T T T T N N N K S S S S V V V V A A A A D D E E G G G G\\nStarts = - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - M - - - - - - - - - - - - - - - - - - - - - - - - - - - -\\nBase1 = t t t t t t t t t t t t t t t t c c c c c c c c c c c c c c c c a a a a a a a a a a a a a a a a g g g g g g g g g g g g g g g g\\nBase2 = t t t t c c c c a a a a g g g g t t t t c c c c a a a a g g g g t t t t c c c c a a a a g g g g t t t t c c c c a a a a g g g g\\nBase3 = t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g\\n\\n\\n 16 - Chlorophycean Mitochondrial Code\\n AAs = F F L L S S S S Y Y * L C C * W L L L L P P P P H H Q Q R R R R I I I M T T T T N N K K S S R R V V V V A A A A D D E E G G G G\\nStarts = - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - M - - - - - - - - - - - - - - - - - - - - - - - - - - - -\\nBase1 = t t t t t t t t t t t t t t t t c c c c c c c c c c c c c c c c a a a a a a a a a a a a a a a a g g g g g g g g g g g g g g g g\\nBase2 = t t t t c c c c a a a a g g g g t t t t c c c c a a a a g g g g t t t t c c c c a a a a g g g g t t t t c c c c a a a a g g g g\\nBase3 = t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g t c a g\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nen / 03-26-i Date: January 2024\", \"page_fill_runs\": [36, 15, 12, 36, 28, 15, 12, 15, 12, 20, 15, 28, 30, 15, 12, 36, 28, 36, 28], \"page_lines\": 46}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:dash"]} {"pdf": "docs/real/0fe7d4a254d2864f9643e80aeea188a28e81_p22.pdf", "category": "real", "id": "0fe7d4a254d2864f9643e80aeea188a28e81_p22", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"Annu. Rev. Linguist.2018.4:151-171. Downloaded from www.annualreviews.org\\n by alessandro.lenci@unipi.it on 01/25/18. For personal use only.\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n Annual Review\\n of Linguistics\\n Volume 4, 2018\\n\\n Contents\\n\\n\\n Words in Edgewise\\n Laurence R. Horn ♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣ 1\\n Phonological Knowledge and Speech Comprehension\\n Philip J. Monahan ♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣21\\n The Minimalist Program After 25 Years\\n Norbert Hornstein ♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣49\\n Minimizing Syntactic Dependency Lengths:\\n Typological/Cognitive Universal?\\n David Temperley and Daniel Gildea ♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣67\\n Reflexives and Reflexivity\\n Eric Reuland ♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣81\\n Semantic Typology and Efficient Communication\\n Charles Kemp, Yang Xu, and Terry Regier ♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣ 109\\n An Inquisitive Perspective on Modals and Quantifiers\\n Ivano Ciardelli and Floris Roelofsen ♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣ 129\\n Distributional Models of Word Meaning\\n Alessandro Lenci ♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣ 151\\n Game-Theoretic Approaches to Pragmatics\\n Anton Benz and Jon Stevens ♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣ 173\\n Creole Tense-Mood-Aspect Systems\\n Donald Winford ♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣ 193\\n Creolization in Context: Historical and Typological Perspectives\\n Silvia Kouwenberg and John Victor Singler ♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣ 213\\n The Relationship Between Parsing and Generation\\n Shota Momma and Colin Phillips ♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣ 233\\n The Biology and Evolution of Speech: A Comparative Analysis\\n W. Tecumseh Fitch ♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣ 255\", \"page_fill_runs\": [78, 76, 77, 57, 83, 48, 56, 77, 64, 77, 47, 58, 74], \"page_lines\": 33}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:symbol"]} {"pdf": "docs/real/140692_p1.pdf", "category": "real", "id": "140692_p1", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" IN THE SUPREME COURT OF TEXAS\\n\\n 444444444444\\n NO. 14-0692\\n 444444444444\\n\\n THE STATE OF TEXAS, PETITIONER,\\n\\n v.\\n\\nONE (1) 2004 LINCOLN NAVIGATOR, VIN # 5LMFU27RX4LJ28242,\\n RESPONDENT\\n\\n 4444444444444444444444444444444444444444444444444444\\n ON PETITION FOR REVIEW FROM THE\\n COURT OF APPEALS FOR THE THIRTEENTH DISTRICT OF TEXAS\\n 4444444444444444444444444444444444444444444444444444\\n\\n\\n Argued November 4, 2015\\n\\n\\n JUSTICE BROWN delivered the opinion of the Court, in which JUSTICE GREEN, JUSTICE\\n WILLETT,JUSTICE GUZMAN, and JUSTICEBOYD joined, and in which CHIEF JUSTICEHECHT,JUSTICE\\n JOHNSON, and JUSTICE LEHRMANN joined in all but Part IV.\\n\\n JUSTICE WILLETT filed a concurring opinion.\\n\\n JUSTICE DEVINE filed a concurring opinion, in which CHIEF JUSTICE HECHT, JUSTICE\\n JOHNSON, and JUSTICE LEHRMANN joined.\\n\\n\\n In this civil-forfeiture case, police officers arrested Miguel Herrera and seized his Lincoln\\n\\nNavigator. After finding drugs during an inventory search of the vehicle, the state filed a notice of\\n\\nseizure and intended forfeiture under Chapter 59 of the Code of Criminal Procedure, claiming that\", \"page_fill_runs\": [], \"page_lines\": 22}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:digit"]} {"pdf": "docs/real/148027981_p68.pdf", "category": "real", "id": "148027981_p68", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"I at least l t11ch\\n i 3\\n STATEMENT DY THE PRESIDENT\\n lines\\n 6 sf>aces -1 have today approved leglalation enacted by the Congreu which\\n authorh:ea the Preaident to determine Cuba's eugar quota for the bal-\\n\\n ance of calendar year 1960 and for the thTee-month period ending\\n\\n March 31, 1961. In confor~ty with thio legialation I have al11ned a\\n proclamation which, ln the national interest, eatabliahea the Cuban\\n l-l/2 tnc:hes l Inch\\n 1-1 1--------•ugar quota for the balance of 1960 at 39, 75l ahort tons, phuthe augar ♦---..-u\\n certified !or entry prior to July 3, 1960. Thia repreaenta a reduction\\n\\n of 700,000 short ton• from the original 1960 Cuban quota of 3,119,655\\n\\n ahort ton•.\\n\\n Thia deficit will be !illeC: by purchase~ from other free world\\n\\n •uppller•.\\n The Importance of the United State• Government'• action relaUn1\\n\\n to augar quota leglllation makes it deairable, I believe, to et forth\\n the reaaona which led the Congreu to authorize and the Executive to\\n\\n take this actioft in the national intereat.\\n\\n Normally about one-third of our total au1ar aupply come• from\\n\\n Cuba • •..••. ·•••• ••· ••.. ••• •• ••· •·••• ••· •· • •·• •· ·· •• · ·• · ·• · •••• •\\n ························································\\n ········\\n\\n The American people will alway• maintain their fri endly feelina•\\n for the people of Cuba. We look forward to the day when the Cuban\\n\\n Oovernment wilt once &gain allow thi1 friendahip to be (ul,y expreued\\n\\n In the relations between our two countr!ee.\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n l Inch\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n 113\", \"page_fill_runs\": [59, 56], \"page_lines\": 30}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:middot"]} {"pdf": "docs/real/155459_p328.pdf", "category": "real", "id": "155459_p328", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" 314\\n\\n\\n\\n\\ne (TESSOR(S X íUNC~O CE (~fE~PílL~CAO). MStST5?l\\ne · MS1!,T52,.\\n1 = , MS t~Vi~5\\n)fJZlOJ:::t,13 MS IS T526\\nfJ.::J(J) MS I Sí527\\nílú2))l=1 .. '1SIST52S\\nt = ( • MS1ST529\\nIN (l): TN (1) • TJ • ~N (L,. NPl) MSIST530\\n'ºº CO'irINUE MS(Sf5H\\n!:)Nfl.'HJE 1'1SIST5'J2\\n220 :Ot-TINU[ MS 1Sl5Jl\\nGO fJ 2\\\"50 MS l s rs H\\ne MS1Sf515\\nc---------- INfEGR.lC.a.O EXHA.. HS(Sf'il&\\nc· MS(SJ537\\n210 C OH ( NUE MS 1SJ5l3\\ne HS 1Sf5l9\\ne DADOS GEOMEfRICOS DO ELE~E~JO CfRlANGULOJ. MSI Sf54G-\\ne A2 \\\" - MS1Sf541\\n'12 Xll !'IS 1ST542\\n.. - X21 t 1SISI543\\n\\\" .. '\\\"\\nX3 2 - MS[SfSU\\n., \\\" 2 • ,!,2••2t-AJH2 MStST545\\n(X 11 - Xl 31 • • 2· t- ( X 21 .. X 2 3) u 2 t1SI Sf51i&\\n•• + 03 1 XB) • • 2 MS[ST547\\n( Jt1 2 '(13) •• 2 + CX22 - X23) •• 2 MSI~l548\\n• CXJ 2 03) .. 2 l'IS 1Sí51+ 9\\n!)12'. SQ!H (AI(,) 111 PREC1S~O S[~PLES ?X%1!1%ItZT.t11~S!ST55J\\ne :>12- DS Q::I. r CH) III PRECISAO DUPLA t 1 1 1 1 1 1 1 1 1 1 1 1 1~Si5í55 1\\nSQ:f.J CA.5) 111 PREC[SAO SlHPLES ttt1 1 1I 1%1 1t1ZMS 1Sf552\\ne D 1' DSQ!H CA5) 1%1 PRECISAO DUPLA !I 1 1 1l?1 1 1 1 1 1 1MS[ST55J\\n\\\"' S Q ~T ( A. f.) 1?? PREClSAJ Sl~PLES ?1 1 1Ill 1t 1 1 1 1 1MS[Sf55,\\ne \\\"' ilSQRT C ,H>l 1 1 1 P~(CISA.iJ OUPU 1111t111111tt11\\\";SIST555\\n02 3 t- ll2l ' KS1ST55&\\nH! JAC03 I 02! 11SIST551\\ne l1S1ST558\\nc--- ------- CALCULO DA Ml\\\\íRIZ OE RD r ACAO MSIST559\\ne :-!SIST5SJ\\nEl 1 · AI I 012 MSIST5~l\\n.. I Dl2 1'4S1Sf5S2\\n[ll Al I 012 MS1ST5':.3\\n~ Z 1 , [13 ,- VN 3 [12 l1S1ST5ft4\\nEZ'?: 'i~l3 • [l l - v·n El' MSI5f5S5\\nE2~ V\\\"1 [12 - 'IN2 E 11 l1S1Sí5S&\\nEll VNl MSIST5::>7\\n[jÇ '\\\" V/iZ Jo11S[Sf5S8\\n\\\"~ 3 \\\"stsr5S9\\ne l 1S[Sl5TJ\\ne C0\\\"45íANíES O[ 1N fC::iR-'CAO. 11S1Sf57 l\\ne HS1ST572\\n:uu e1 Hl .. P1.SIST573\\n..\\n1'!10 Hl HI HS 1Sf57'\\n, .. MS1ST575\\nli 1: H l - • , ( A7 12 > P1SIST57&\\n5[~ l - A> f IJ\\nS[ .~ J ( '5 • ,H,> f •Woio;~:,'.'.:'.,~!~:~::!:~ .~&y~~~t ~!: w~~:..\\n Speakini:-, Dancing, Flirting, Cooking; also. Rules o.f:Etiquette, The\\n Art of YPntriloquism, Gy 1nnastic 1'~xercise, aml The Science and\\n Art of Self-Defens•._\\n How to Behave READ 'l'llE FOLLOWING LIST: Price 10 c.. nts\\n How to Dress Price 10 Cents\\n How to Play Gan1es • Price 10 Cents\\n i How to l{eep Birds Price 10 Ct'nt.s\\n How to Keep House • Price 10 Cents\\n How to l\\\\Iake Love Price 10 Cents\\n Hon to 'Yrite Love Letter\\\" Price lOCe 1••,\\n How to Explain Dream.• Price 10 Cen1 s\\n How to Tell Fortunes j Price 10 Cents\\n How to Row, Sail au1l Build a Uoat Price 10 Cenh\\n How to J{eep and l\\\\Ianage Pets • 'j' Price 10 Cenh\\n How to Become a :Magician Price 10 Cents\\n Ho'v to lJo It. . ~~ Price 10 Cent<\\n How to Do Tricks Price 10 Cent~\\n How to \\\"'rite Lf'tters Price 10 Cents\\n How to Cook Price 10 Cents\\n How to Entertain an l<:veniug l'artJ Price 10 Cents\\n How to Beeo1n1> Ueautiful Price 10 Cents\\n How to Flirt Price 10 Cents\\n How to Beconw a Yf'ntriloquist Pric<' 10 Cent!!\\n Jlow to llef'on1e lU<'h Price 10 Cent.\\n How to Box Price 10 Cent•\\ni Ho\\\\v 1o Da11<'e • Price 10 ('en, I\\n How to Become an A.thlt'lt• Price 10 C<-uts\\n How to Jlpcorne a S 1waker Price 10 Cents\\n\\\\ How to Play Cards Price 10 Cents\\n How to Hunt and Fi~h Price 10 Ccnh\\n How to Become a S<'ientist Price 10 Cents\\n How to Become an Inventor Price 10 Cents\\n The Boys of New York l\\\\Iiustrel Gnis Distance Tables,\\n Pocket Co 1npaniou and Guide Price 10 Cents\\n lr~land's Struggles for Liberty and Lancl • Price 10 Cents\\n All the above books are tor \\\"ale by newsdeal ~rs throughout the T:'nited\\n I States and Canada; or they will be sent, postage paid, to your address, on\\n receipt oflo cents each. &\\n Frank Tousey, Publisher, 34 36 N. Moore St., N. Y.\\n --------1 -- ---- - - ---- - -- ~\", \"page_fill_runs\": [16], \"page_lines\": 48}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:digit"]} {"pdf": "docs/real/1987.A.6_p4.pdf", "category": "real", "id": "1987.A.6_p4", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" Unemployment somewhat lower. - In April the number of\\nGRAPH 5 : Money supply (EUR 12) and nominal GDP (EUR 4) registered unemployed, seasonally adjusted, in the Community\\n (EUR12) fell by 16 000 to 16,3 million (11,8 % of the civilian\\n labour force) but was still nearly a quarter of a million higher\\n than a year earlier. Numbers unemployed (s.a.) fell in five\\n Member States in April (Germany, France, the Netherlands,\\n Portugal and the United Kingdom) but only in the latter two\\n Money supply (M 2/3) countries has the downward movement been in evidence for\\n Nominal GDP' Change over 12 months more than one month. On a year-to-year basis, Community\\n unemployment was 1,4 % higher than in April last, with de-\\n creases being recorded in Germany (-0,6%), Belgium\\n (-1,7%), the Netherlands (-4,3%), the United Kingdom\\n (-6,6 %) and Portugal (-8,4 %), while other Member States\\n registered increases ranging from 0,6 % in Greece to 17,4 % in\\n Luxembourg.\\n\\n Consumer price increases remain low. - The index of consumer\\n prices in the Community in April increased by 0,5 % on a month\\n Monthly change (s.a.) earlier after increases of 0,3 % in the previous two months.\\n '''' I Μ I I M\\n 83 84 85 86 87 However, on a seasonally adjusted basis, the month-to-month\\n rise in April (0,3 %) was only marginally higher than the 0,2 %\\n Change over the same quarter of previous year. recorded in February and March. The sharp rise in the United\\n Kingdom monthly increase in April was principally due to the\\n annual increase in local authority rates and rents; with the\\n seasonally adjusted figure registering a much smaller rise of\\n 0,2 %. The absence of budgetary adjustments to indirect taxes\\n did have a moderating effect on the April figure. Elsewhere,\\nGRAPH 6 : Short-term interest rates apart from Greece where the monthly rise was 2,3 %, April\\n% increases were 0,5 % or below and in Luxembourg prices fell\\n - the seasonally adjusted rate of change over six months at an\\n16 by 0,2 %. The underlying trend rate of inflation, measured as\\n15 annual rate, for the Community as a whole, after dropping in\\n14 March to 2,8 %, moved back to its earlier level in April (3,2 %),\\n while divergence in price trends between Member States has\\n13 EUR 1 ! continued to narrow since October 1986.\\n12\\n\\n11 Trade surplus temporarily higher in March. - The Community's\\n10 trade surplus (EUR 12) in March, at 1 391 million ECU, returned\\n 9 \\\"us i^^ to the level of the beginning of the year after a February result\\n - when surpluses were recorded only in Germany and Ireland. In\\n 8 - March, the fall in the German trade surplus and the higher\\n 7 . _ French deficit was more than counterbalanced by improvements\\n in the Benelux countries, Denmark, Italy and the United\\n 6 * \\\\-,/~~v^/x_. \\\\ v~ ; Kingdom. On the basis of preliminary information for April, a\\n 5 lower German surplus and increases in deficits in Italy and the\\n United Kingdom are likely to result in a reduced Community\\n 4 k w surplus.\\n 3 ; .1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 ,,ι,,ι..;, ,\\n 83 84 85 86 87\\n Money supply continues to grow rapidly. - In March the rate\\n of increase in the money supply for the Community as a whole\\n (s.a.) was 1,2 % with rates of growth picking up in all countries\\n except Germany, Italy and Ireland. After compensating for\\nGRAPH 7: Long-term interest rates declines in the previous two months, money supply grew by\\n % 0,5 % in Denmark in April, while in Germany a similar increase\\n16 was recorded after lower rises in February and March. The\\n acceleration in German money supply in April was mainly a\\n15 - result of the pick-up in bank lending to firms and individuals,\\n14 ■ although public sector cash transactions also had an expansion-\\n EUR 10 ary influence and monetary capital formation tailed off. Central\\n - and, in May, the seasonally adjusted annual growth rate of\\n13 bank money stock in Germany also continued to grow rapidly\\n12 - - nearly 8 % compared to the fourth quarter of 1986 was above\\n11 ■MJS - the target range of 3 to 6 % for 1987. High rates of growth in\\n10 - liquid assets held by the public (ALP) in Spain, meant that the\\n accumulated growth until April in annualised terms was nearly\\n 9 - 14 % and this led the Bank of Spain to tighten monetary policy\\n to bring rates of growth back within the target band set for\\n 8 •\\\"ÍT\\\"\\\"' 1987. In France the acceleration of the broad aggregates, which\\n 7 Ν _ - began in March, continued in April, taking the growth of M3\\n slightly above the upper end of the target range. The sharp rise\\n 6 --^ in broad money in Ireland in April was principally due to a\\n 5 . substantial increase in Irish pound deposits. In the United\\n - longer a monetary policy target variable, slowed down to 1,8 %\\n 4 Kingdom the monthly rate of increase of M3, which is now no\\n 3 ,. I..I..I. , ι Ι Ι Ι ι in April but the annual rate of change was over 20 %. The\\n 83 84 85 86 87 principal narrow measure of money M0 was in the upper half\\n of its 2 - 6 % target range.\", \"page_fill_runs\": [], \"page_lines\": 78}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:digit"]} {"pdf": "docs/real/1987_Commencement_Program_001-compressed_p68.pdf", "category": "real", "id": "1987_Commencement_Program_001-compressed_p68", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" Venard Paul Dean •••Richard Mark O'Barr e, Hueytown .. , . .\\n***Jeffrey Curtis Harris Destin, Horida Carey Lee Oliver Shr<=veport, Louisiana\\n James Allen Hunt Montgomery Marc Todd Pettit \\\"\\\" b\\n Paul Peter Urbanowski Concord, Ohio ••Timothy L. Phillips Montgomery\\n Kenneth Warren Pruitt untsville\\n Bachelor of Electrical Engineering Donald Ralph Pugh Cullman\\n •Keith Patrick Queeney Br*Wt°n\\n Mark Daniel Acker Merritt Island, Florida Todd Edwin Revels ... Hu \\\"tSV,lle\\n Benjamin William Addison Pensacola, Florida Marcus Lee Schick i Lr \\\" \\\"\\n Read Lowery Ballew David DuaneSchnuelle LaGrange, Georgia Memphis, Tennessee\\n Paul Matthew Beard Lizella, Georgia\\n •Karen Anne Bishop Huntsville\\n Julie Ellen Bodenheimer Hattiesburg, Mississippi Anita Gwen Shoopman Albany, Georgia\\n Paul Winston Brannon Dothan Brian Russell Sproles Birmingham\\n Dale Wesley Callahan Montgomery ••Robert Wayne Stevens ^ Hunstville\\n John Paul Cimino Mobile Arthur Lee Storey, Jr i!! i!!' Montgomery\\n Mitchell Floyd Cohen Abbeville, Georgia Robert Martin Thompson .... • ^ver d •\\n •Jimmy Dwayne Compton Pell City Sherri Lynn Thurman Birmingham\\n Michael Doyle Darnell Grand Bay Peter Torres H\\\",le\\n Michael Joseph Dendy Huntsville •'David William Turnage M°blle\\n Robert Michael Eison Hunstville c\\n Noel Conrad Engelman Albertville •••Todd Eric Turnquist IT'6\\n Steven Jerome Faulk Tallahassee, Florida ***Douglas Alan Vechinski t \\\" Um\\n Joel Brian Flatt Riceville, Tennessee Mark Elliot Waldrip . . . . Hixson, Tennessee\\n •Kenneth Clark Frame Birmingham Zane Vincent Wingard V.\\\" V.'.V.'.'.'.'.'.'.'.'.'.'.'.'.'.'.' Birmingham\\n Cadwallader Franklin Montgomery Bachelor of Industrial Engineering\\n Teresita Maria Gagnon Fort Walton Beach, Florida\\n Danny Wayne Gilliam Kennedy Kimberly Gayle Alise » orrQfl\\\" r\\n •Thomas Christopher Glassock Clanton Alice Marie Blackburn ^Grange Georgia\\n ••Stuart Charles Haden Ocean Springs, Mississippi Carolyn Ann Channon Virginia Rparh \\\\r V' 6\\n Gregory David Halen Little Rock, Arkansas Patncia Dee Chapman .... Virginia Beach, Virginia\\n Robert Bruce Hall Auburn Todd Michael Fuller\\n Curtis James Head Albertville Donna Mary Havrisik 7.7.7.7.7.7.'' r,\\n ••Beverly JoAnne Dees Hooker Dothan Thomas Allen Henthorne J?Bton\\n ••Frank Scott Johnson Douglas, Georgia James Franklin Hester p V ' r 0ney\\n Robert Wayne Jordan, Jr Albany, Georgia Scott Adam Hofacker\\n Kenneth James Knight Sandy, Utah Renee Alene Ingersoli r\\n Scott Anthony Littrell Rogersville Richard Milton Larkin\\n •David Wayne Long Piedmont Sara Liston Long L.lburn, Georgia\\n Benjamin Philip Lowers Huntsville Patrick Brian McDuffee 'Mnn^°rence\\n •Robert Lee Luna Montgomery Belinda Gail Mitchell 7.7.7.7\\n Ben Horace Martin, Jr Oakwood, Georgia •Paula Antoinette Chung MitcheU Hudson, Iowa\\n Richard Franklin May Saint Petersburg, Florida John Barry Mores m.-w™ o ^\\n Norman Otis McCommon, Jr Warner Robins, Georgia ••Melanie Lynn Morgan Mnntor,0\\\" 3\\n Michael David McLain Fort Walton Beach, Florida Kimberly Denise Dennison Ruple Flmnre\\n Sandra Lee Mims Headland **Stuart Chris Shirley , r\\n ••Mark Thomas Montgomery Indialantic, Florida Paula Diane Smith Gr^!Ie\\n Kenneth Howell Murphy Anniston 222222222221212V o°i\\n\\n\\n • WITH HONOR * WITH HONOR\\n •• WITH HIGH HONOR ** WITH HIGH HONOR\\n ••* WITH HIGHEST HONOR ** WITH HIGHEST HONOR\\n\\n [32] [33]\", \"page_fill_runs\": [30], \"page_lines\": 52}", "page": null, "expected_markdown": null, "tags": ["real", "kind:unit"]} {"pdf": "docs/real/199238-young-learners-movers-word-list-picture-book_p15.pdf", "category": "real", "id": "199238-young-learners-movers-word-list-picture-book_p15", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"Monkey goes swimming! Movers A-Z\\nMonkey is at the swimming pool. Read the sentences. Find the missing pairs of words.\\n\\n Word List\\n\\n Grammatical key\\n adj adjective excl exclamation pron pronoun\\n adv adverb int interrogative v verb\\n conj conjunction n noun\\n det determiner poss possessive\\n dis discourse marker prep preposition\\n\\n\\n A\\n above prep all adj + adv + another det +\\n address n det + pron pron\\n Choose from: afraid adj all right adj + any det + pron\\n after prep adv at prep of time\\n above/below round/square before/after age n always adv aunt n\\n awake adj\\n on/off get undressed/ up/down\\n get dressed B\\n back adj + adv bat n better adj + adv break n\\n Example: Monkey is o u t s i d e the swimming pool, then he's i n s i d e . + n be called v blanket n bring v\\n bad adj bear n blond(e) adj bus station n\\n 1. Monkey has to _ _ _ _ _ _ _ _ _ _ _ _ , then later he has to _ _ _ badly adv beard n boring adj bus stop n\\n balcony n because conj both det + pron busy adj\\n _ _ _ _ _ _ _ . band (music) n before prep bottle n buy v\\n bank n below prep bottom adj + n by prep\\n 2. Monkey climbs _ _ , then he climbs _ _ _ _ . basement n best adj + adv bowl n\\n 3. This is better. Monkey is _ _ the diving board and then he's _ _ _ the C\\n diving board! café n CD n city n coat n\\n cage n CD player n city/town coffee n\\n 4. Monkey has fun ______ his dive and then _ _ ___ his dive! call v centre n centre n cold adj + n\\n careful adj change v clever adj come on! excl\\n 5. Monkey loves swimming _____ the water, then _ _ _ _ _ the water. carefully adv Charlie n climb v comic n\\n carry v cheese n cloud n comic book n\\n 6. Monkey likes to hide in the small _____ pool, then swim in the big catch v (e.g. a cinema n cloudy adj cook v\\n ______ pool. bus) circle n clown n cough n\\n\\n24 25\", \"page_fill_runs\": [12], \"page_lines\": 36}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:underscore"]} {"pdf": "docs/real/2002_finstatreport_p41.pdf", "category": "real", "id": "2002_finstatreport_p41", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" Edison Capital Financial Information\\n\\n Inmillions Year Ended December 31, 2002 2001 2000 1999 1998 1997\\n ____________________________________________________________________________________________________\\n Condensed Consolidated Statements of Income\\n Lease revenue $ 6 $ 154 $ 192 $ 218 $ 213 $ 86\\n Other 1 71 78 47 22 52\\n ________________________________________________________________________________________________________________________________________________________________________________________\\n Total operating revenue 7 225 270 265 235 138\\n Operating expenses 48 73 81 96 71 78\\n ________________________________________________________________________________________________________________________________________________________________________________________\\n (Loss) income from operations (41) 152 189 169 164 60\\n Equity in (losses) from unconsolidated entities (34) (32) (17) (28) (30) (20)\\n Interest expense 35 64 57 41 48 29\\n Other (expense) income (3) 4 10 4 4 6\\n ________________________________________________________________________________________________________________________________________________________________________________________\\n (Loss) income before income taxes (113) 60 125 104 90 17\\n Income tax benefit 146 24 10 25 15 44\\n ________________________________________________________________________________________________________________________________________________________________________________________\\n Net income $ 33 $ 84 $ 135 $ 129 $ 105 $ 61\\n ________________________________________________________________________________________________________________________________________________________________________________________\\n Condensed Consolidated Balance Sheets\\n Current assets $ 627 $ 904 $ 500 $ 236 $ 148 $ 169\\n Investments 2,674 2,788 3,153 2,440 2,065 1,450\\n Property, plant, and equipment - net and other 178 44 60 36 63 164\\n ________________________________________________________________________________________________________________________________________________________________________________________\\n Total assets $3,479 $3,736 $3,713 $2,712 $2,276 $1,783\\n ________________________________________________________________________________________________________________________________________________________________________________________\\n Current liabilities $ 46 $ 382 $ 530 $ 475 $ 436 $ 345\\n Long-term liabilities 2,652 2,601 2,504 1,701 1,432 1,136\\n ________________________________________________________________________________________________________________________________________________________________________________________\\n Total liabilities 2,697 2,983 3,034 2,176 1,869 1,481\\n Shareholder's equity 781 753 679 536 408 302\\n ________________________________________________________________________________________________________________________________________________________________________________________\\n Total liabilities and shareholder's equity $3,479 $3,736 $3,713 $2,712 $2,276 $1,783\\n ________________________________________________________________________________________________________________________________________________________________________________________\\n Condensed Consolidated Statements of Cash Flows\\n Cash flows from operating activities:\\n Net income $ 33 $ 84 $ 135 $ 129 $ 105 $ 61\\n Adjustment for non-cash income statement items 172 210 247 178 184 48\\n Changes in working capital components 444 (341) (148) (13) (42) 13\\n ________________________________________________________________________________________________________________________________________________________________________________________\\n Net cash provided (used) by operating activities 649 234 294 247 122 (47)\\n ________________________________________________________________________________________________________________________________________________________________________________________\\n Cash flows from financing activities:\\n Issuances of debt - net of discount 12 131 941 384 195 180\\n Other (332) (380) (478) (483) - -\\n ________________________________________________________________________________________________________________________________________________________________________________________\\n Net cash (used) provided by financing activities (320) (249) 463 195 180 (99)\\n ________________________________________________________________________________________________________________________________________________________________________________________\\n Cash flows from investing activities:\\n Investments 9 (45) (634) (233) (499) (465)\\n Other 2 319 35 73 (3) 94\\n ________________________________________________________________________________________________________________________________________________________________________________________\\n Net cash provided (used) by investing activities 11 274 (599) (160) (502) (371)\\n ________________________________________________________________________________________________________________________________________________________________________________________\\n Net increase (decrease) in cash and equivalents 340 (22) 98 35 (60) (69)\\n Cash and equivalents, beginning of period 148 153 55 20 80 149\\n ________________________________________________________________________________________________________________________________________________________________________________________\\n Cash and equivalents, end of period $ 488 $ 131 $ 153 $ 55 $ 20 $ 80\\n ________________________________________________________________________________________________________________________________________________________________________________________\\n\\n\\n\\n NET INCOME RETURN ON COMMON EQUITY TOTAL ASSETS\\nMillions 35 % Millions 3,713 3,736\\n $150 129 135 30.2 $4000 3,479\\n 30 27.0 3500\\n 120 105 25 22.4 3000 2,712\\n 90 84 20 2500 2,276\\n 15 11.9 2000\\n 60 33 10 1500\\n 30 5 4.1 1000\\n 500\\n 0 1998 1999 2000 2001 2002 0 1998 1999 2000 2001 2002 0 1998 1999 2000 2001 2002\\n\\n\\n 39\", \"page_fill_runs\": [], \"page_lines\": 72}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:underscore"]} {"pdf": "docs/real/2020.12.15-Dkt.-No.-1-Complaint_p1.pdf", "category": "real", "id": "2020.12.15-Dkt.-No.-1-Complaint_p1", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"FILED: NEW YORK COUNTY CLERK 12/15/2020 12:52 PM INDEX NO. 160890/2020\\nNYSCEF DOC. NO. 1 RECEIVED NYSCEF: 12/15/2020\\n\\n .SUPREME COURT OF THE STATE OF NEW YORK\\n COUNTY OF NEW YORK\\n - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - X\\n :\\n INFORMATION SERVICES GROUP, INC., :\\n :\\n :\\n Plaintiff, :\\n : Index No.\\n - against - :\\n : SUMMONS\\n PENTON LEARNING SYSTEMS, L.L.C. d/b/a :\\n INTERNATIONAL QUALITY AND PRODUCTIVITY : Venue is based on CPLR § 501, 503(a)\\n CENTER, :\\n :\\n Defendant. :\\n - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - X\\n\\n TO: Penton Learning Systems, L.L.C. d/b/a International Quality and Productivity Center\\n 535 Fifth Avenue Floor 8\\n New York, NY 10017\\n\\n YOU ARE HEREBY SUMMONED to answer the complaint in this action and to serve a copy\\n of your answer, or, if the complaint is not served with this summons, to serve a notice of appearance, on\\n the Plaintiff's Attorney(s) within 20 days after the service of this summons, exclusive of the day of\\n service (or within 30 days after the service is complete if this summons is not personally delivered to\\n you within the State of New York); and in case of your failure to appear or answer, judgment will be\\n taken against you by default for the relief demanded in the complaint. This is an action for breach of\\n contract.\\n\\n Dated: New York, New York\\n December 15, 2020\\n HUNTON ANDREWS KURTH LLP\\n\\n\\n By: ___________________________\\n Joseph J. Saltarelli\\n 200 Park Avenue\\n New York, New York 10166\\n Telephone: (212) 309-1047\\n E-Mail: jsaltarelli@HuntonAK.com\\n\\n and\\n\\n John Shely (Pro Hac Vice Pending)\\n Brian Pidcock (Pro Hac Vice Pending)\\n 600 Travis Street, Suite 4200\\n Houston, Texas 77002\\n Telephone: (713) 220-4200\\n\\n\\n\\n 1 of 10\", \"page_fill_runs\": [32, 32, 27], \"page_lines\": 45}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:dash"]} {"pdf": "docs/real/2021.01.28-Answer-and-Counterclaims_p1.pdf", "category": "real", "id": "2021.01.28-Answer-and-Counterclaims_p1", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"FILED: NEW YORK COUNTY CLERK 01/28/2021 08:37 PM INDEX NO. 150164/2021\\nNYSCEF DOC. NO. 32 RECEIVED NYSCEF: 01/28/2021\\n\\n\\n\\n SUPREME COURT OF THE STATE OF NEW YORK\\n COUNTY OF NEW YORK\\n - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - X\\n LITTLE FISH CORP. a/k/a LITTLE FISH INC., :\\n : Index No. 150164/21\\n Plaintiff, :\\n : VERIFIED ANSWER\\n -against- : WITH COUNTERCLAIMS\\n :\\n PARAMOUNT LEASEHOLD LP, :\\n :\\n Defendant. :\\n - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - X\\n Defendant Paramount Leasehold LP (\\\"Landlord\\\"), by its attorneys, Rosenberg & Estis P.C.,\\n\\n as and for its verified answer and counterclaims in response to the verified complaint herein (the\\n\\n \\\"Complaint\\\"), alleges as follows:\\n\\n 1. Denies knowledge or information sufficient to form a belief as to the truth of the\\n\\n allegations set forth in Paragraphs \\\"2,\\\" \\\"6,\\\" \\\"8,\\\" \\\"18,\\\" \\\"19,\\\" \\\"20,\\\" \\\"26,\\\" \\\"27,\\\" \\\"29,\\\" \\\"30,\\\" \\\"31,\\\" \\\"35,\\\"\\n \\\"38,\\\" \\\"39,\\\" \\\"40,\\\" \\\"70,\\\" \\\"71,\\\" \\\"72\\\" and \\\"75\\\" of the Complaint.\\n 2. Denies the allegations set forth in Paragraphs \\\"1,\\\" \\\"34,\\\" \\\"41,\\\" \\\"42,\\\" \\\"43,\\\" \\\"45,\\\" \\\"46,\\\"\\n \\\"50,\\\" \\\"51,\\\" \\\"53,\\\" \\\"60,\\\" \\\"61,\\\" \\\"65,\\\" \\\"66,\\\" \\\"67,\\\" \\\"68,\\\" \\\"73\\\" and \\\"74\\\" of the Complaint.\\n 3. Denies the allegations set forth in Paragraph \\\"3\\\" of the Complaint and respectfully\\n\\n refers the Court to the lease between the parties and the various amendments thereto (hereinafter,\\n\\n collectively, the \\\"Lease\\\").\\n 4. Denies the allegation set forth in Paragraph \\\"4\\\" of the Complaint, except admits\\n serving a Thirty (30) Day Notice of Default dated December 9, 2020 (the \\\"Default Notice\\\") on\\n\\n plaintiff, and respectfully refers the Court to the Default Notice for its content.\\n\\n 5. Denies the allegation set forth in Paragraph \\\"5\\\" of the Complaint and specifically\\n\\n denies that plaintiff is entitled to any of the relief sought in this action.\\n\\n\\n\\n\\n RE\\\\61748\\\\0026\\\\3310340v1\\n\\n 1 of 17\", \"page_fill_runs\": [30, 30], \"page_lines\": 33}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:dash"]} {"pdf": "docs/real/2024-annual-report_10_p5.pdf", "category": "real", "id": "2024-annual-report_10_p5", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" INSIDE THIS FY 2024 ANNUAL REPORT\\nMission Statement…………………………………………………………………………………………………………………….1\\nOrganizational Chart…………………………………………………………..……………………………………………………..2\\nDivision Primary Function………………………………………………………..…………………………………………….….3\\n2024 Summary of Taxes Administered…………………………………………………..…………………………..….….5\\nLegislative Session In Review FY 2024………………….…………………………………………………………………..13\\nDRA Highlights FY 2024.…………………………………………………………….…………………………………………….17\\nOffice of Revenue Counsel..……………………………………………………….………………………………………….…18\\nHearings Bureau….…………………………………………………………………………………………………………………..21\\nCollections Division…………………………………………….……………………………………………………..…………….23\\nTaxpayer Services..…………………………………………………………………………………………………………………..25\\nForms Calendar………………………………………………………………………………………………………………………..26\\nMunicipal and Property Division.…………………………………………..………………………………………………..27\\nAudit Division……………………………………………………………………..……………………………………………………30\\nTechnology Developments….………………………………….……………………………………………………………….32\\nRevenue Information Management System (RIMS)………………………………….……………………………..33\\nTransparency Reports and Statistics.……………………………………………………………………………………….34\\nLegislative History.……………………………………………………………………………………………………….………….51\\n2023 Tables by County per RSA 21-J:3, XII….……………………………………………………………………….…..91\\nNew Hampshire Property Tax Summary ………………………………………………………………………………..126\\n2023 Equalization Survey Including Utility and Railroad………………………………………….……………..132\\n2023 Equalization Survey Not Including Utility and Railroad …………………………………………….…..149\\n2023 Base Valuation for Debt Limits………………………………………………………………….………………..…171\\n2023 Comparison of Full Value Tax Rates………………………………………………………………………………178\", \"page_fill_runs\": [133, 130, 121, 99, 99, 123, 118, 135, 130, 133, 137, 107, 140, 117, 75, 101, 132, 91, 92, 66, 57, 99, 90], \"page_lines\": 24}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:ellipsis"]} {"pdf": "docs/real/202601151456353479_p22.pdf", "category": "real", "id": "202601151456353479_p22", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" çek.k&i= la[;k& 6\\n mRrj izn s'k l s ckgj ds vu qlwfpr tkfr vFkok vu qlwfpr tutkfr ds izoklh mEehnokj }kjk is'k fd;s\\n tkus okys tkfr izek.k&i= dk izk:i\\n\\n izekf.kr fd;k tkrk gS fd Jh@Jherh@d qekjh-----------------------------------------------------------iq=@iq=h---------------------\\n --------------------------fuoklh xkao@'kgj-------------------------------------------ftyk@e.My---------------------------------jkT;@la?k 'kkflr\\n {ks=---------------------------dh-----------------------tkfr@ tutkfr dk@dh gS] tks lafo/kku d s vkns'k d s v/khu vuqlwfpr\\n tkfr@vuqlwfpr tutkfr ?kksf\\\"kr dh xbZ gS A\\n ;g izek.k&i= Jh@Jherh@d qekjh------------------------------------dks mld s firk@ekrk Jh@Jherh-------------------\\n fuoklh--------------------------- xkao@'kgj-------------------------------------ftyk@e.My--------------------------------jkT;@la?k 'kkflr\\n {ks=----------------------------fn;s x;s vu qlwfpr tkfr @vu qlwfpr tutkfr izek.k&i= ds vk/kkj ij tkjh fd;k gS\\n vkSj-------------------------tkfr@tutkfr ds gSa ftl s-------------------------------jkT;@la?k 'kkflr {ks= esa vu qlwfpr\\n tkfr@vuqlwfpr tutkfr ?kksf\\\"kr fd;k x;k gS A\\n ¼fu/kkZfjr inkf/kdkjh dk uke½----------------------------------------------------}kjk vkids i= ;k------------------------------------------\\n fnukad----------------ds vUrxZr tkjh fd;k x;k gS A\\n\\n LFkku % gLrk{kj %\\n jkT;@la?k 'kkflr {ks= % in\\n fnukad % eqgj\\n d `i;k jk\\\"Vªifr ds lEcfU/kr vkns'k dk mYys[k dj sa A\\n\\n çek.k&i= la[;k& 7\\ndk;kZy; ftykf/kdkjh@l{ke vf/kdkjh ------------------------------------------ tuin -----------------------\\n lkekU; fuokl izek.k&i=\\n ¼d soy lsok;k stu@f'k{k.k laLFkku iz;kstukFkZ½\\n dk;kZy; miftykf/kdkjh --------------------------------------------------------------------------------------- tuin ----------------------------------------------\\n rglhynkj Jh ----------------------------------------------------------------------------------------------------- dh vk[;k fnukad -----------------------------\\n d s ,rn~}kjk ;g izekf.kr fd;k tkrk gS fd %&\\n Jh@Jherh@d qekjh ----------------------------------------------------------------------------------------------------------------------------------\\n iq=@iq=h@ifr Jh -----------------------------------------------------------------------------------------------------------------------------------\\n fuoklh edku uEcj ----------------------------------------------------------------------------------------------------------------------------------\\n xzke@eksgYyk ---------------------------------------------------------------------------------------------------------------------------------------------\\n Fkkuk ----------------------------------------------------------------------- tuin ----------------------------------------------------------\\n mRrj izns'k dk@dh fuoklh gS A\\n o mudk orZeku irk ---------------------------------------------------------------------------------------------------------------------------------\\n ---------------------------------------------------------------------------------------------------------------------------------------------------------------- gS A\\n mi;q ZDr dh iqf\\\"V izk:i&1 esa vkosnd ,oa lR;kiudrkZ }kjk djkbZ xbZ lwpuk rFkk buls l arq\\\"V\\n gks tkus d s mijkUr v/kksgLrk{kjh }kjk mRrj izns'k d s bl tuin dk lkekU; fuoklh gksus fo\\\"k;d\\n izek.k&i= fuxZr fd;k tk jgk gS A\\n uksV %& mi;q ZDr izek.k&i= fdlh 'kS{kf.kd laLFkk es a izos'k vFkok fdlh lsok;kstu gsr q vkosnu djus d s\\n fy, gh d soy tkjh fd;k x;k gS rFkk blls ukxfjdrk izkIr djus dk dksbZ lEcU/k ugha gS A mYys[kuh;\\n gS fd ukxfjdrk dk fo\\\"k; fn flVhtuf'ki ,DV&1955 esa Li\\\"V :i ls izko/kkfur gS rFkk ;g Hkkjr\\n ljdkj ds fopkj {ks= dk fo\\\"k; gS] ;fn fdlh O;fDr dh ukxfjdrk ij iz'u fpUg gks vFkok bu ij\\n fopkj fd;k tkuk gks rks izdj.k ftyk eftLVªsV ds ek/;e ls 'kklu dks izLr qr gksxk] ftl s varr% Hkkjr\\n ljdkj dks fopjkFkZ izsf\\\"kr dj fn;k tk;sxk A\\n fnukad % gLrk{kj\\n\\n miftykf/kdkjh\\n --------------------------------------------\\n 20\", \"page_fill_runs\": [59, 21, 26, 43, 33, 28, 23, 36, 19, 27, 37, 32, 29, 25, 31, 52, 42, 16, 42, 23, 87, 46, 101, 29, 130, 131, 130, 141, 71, 58, 129, 160], \"page_lines\": 46}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:dash"]} {"pdf": "docs/real/2026_Edelman_Trust_Barometer_Global_Report_01.21.26_0_p46.pdf", "category": "real", "id": "2026_Edelman_Trust_Barometer_Global_Report_01.21.26_0_p46", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"P. 46\\n\\n\\nDespite Declines, Most Industry Sectors Remain Trusted\\n\\nPercent trust\\n\\n\\n\\n\\n\\n\\nGLOBAL 28 Significant change\\n Distrust Neutral Trust\\n (1-49) (50-59) (60-100)\\n Social media\\n no longer distrusted\\n\\n 73 73 71 71 70 69 68 67 67 66 65 65 65 64 63 63\\n\\n 50\\n\\n\\n\\n\\n\\n Change, ⚫ ⚫ ⚫ ⚫ ⚫ ⚫ ⚫ ⚫ ⚫ ⚫ ⚫ ⚫ ⚫ ⚫ ⚫ ⚫ ⚫\\n2025 to 2026 -2 -3 -2 -2 -3 -2 -1 -1 -1 0 -1 -2 -2 -1 0 -1 +2\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n2026 Edelman Trust Barometer. TRU_IND. Please indicate how much you trust businesses in each of the following industries to do what is right. 9-point scale; top 4 box, trust. Question asked to partial sample. General population, 28-mkt\\navg. Year-over-year changes were tested for significance using a t-test set at the 99%+ confidence level.\", \"page_fill_runs\": [17], \"page_lines\": 14}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:symbol"]} {"pdf": "docs/real/25.5131.02000presentation1300_p2.pdf", "category": "real", "id": "25.5131.02000presentation1300_p2", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"PRESENTATION OVERVIEW\\n\\nPROJECT OVERVIEW & UPDATE\\n••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••\\n2023-2025 APPROPRIATIONS & WORK PLAN\\n••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••\\nUSER OUTREACH\\n••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••\\nCONSTRUCTION STATUS\\n••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••\\n2025-2027 BIENNIUM OUTLOOK\\n\\n RED RIVER VALLEY WATER SUPPLY PROJECT | 2\", \"page_fill_runs\": [116, 116, 116, 116], \"page_lines\": 11}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:symbol"]} {"pdf": "docs/real/396159-yle-movers-word-list-picture-book-2018_p25.pdf", "category": "real", "id": "396159-yle-movers-word-list-picture-book-2018_p25", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"Monkey goes swimming!\\nMonkey is at the swimming pool. Read the sentences. Find the missing pairs of words.\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n Choose from:\\n above/below get undressed/ before/after\\n round/square get dressed up/down\\n\\n Example: Monkey is o u t s i d e the swimming pool, then he's i n s i d e .\\n 1. Monkey has to _ _ _ _ _ _ _ _ _ _ _ _ , then later he has to _ _ _\\n _ _ _ _ _ _ _ .\\n 2. Monkey climbs _ _ , then he climbs _ _ _ _ .\\n 3. Monkey has fun _ _ _ _ _ _ his swim and then _ _ _ _ _ his dive.\\n 4. Monkey loves swimming _ _ _ _ _ the water, then _ _ _ _ _ the water.\\n 5. Monkey likes to hide in the small _ _ _ _ _ pool, then swim in the big\\n _ _ _ _ _ _ pool.\\n\\n That's the end of the games. Thank you for taking part. Check the answers on page 30.\\n\\n24\", \"page_fill_runs\": [12], \"page_lines\": 15}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:underscore"]} {"pdf": "docs/real/3a8626fe-4bf4-4bdc-a251-aaa067b812ed_p14.pdf", "category": "real", "id": "3a8626fe-4bf4-4bdc-a251-aaa067b812ed_p14", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"Question 9 continued\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n_____________________________________________________________________________________\\n\\n 20 *S54258A02021*\\n 72 Pearson Edexcel Level 3 Advanced GCE in Mathematics - Sample Assessment Materials\\n Issue 1 - June 2017 © Pearson Education Limited 2017\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n DO NOT WRITE IN TH IS ARE A\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n D O NOT WRITE IN TH IS ARE A\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n DO NOT WRITE IN TH IS AREA\", \"page_fill_runs\": [], \"page_lines\": 42}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:underscore"]} {"pdf": "docs/real/5d36a8f8abe9a_1_p70.pdf", "category": "real", "id": "5d36a8f8abe9a_1_p70", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" 59\\n\\n\\n\\n\\n\\n\\nI am grateful to you for spending your time in commenting on the following questions:\\n\\nQ1-Are the questions of the current study related to its topic?\\n\\n……………………………………………………………………………………………\\n\\n……………………………………………………………………………………………\\n\\n……………………………………………………………………………………………\\n\\n…………………………………………………………………………………………..\\n\\nQ2-Does the test measure the goals that it is supposed to measure?\\n\\n……………………………………………………………………………………………\\n\\n……………………………………………………………………………………………\\n\\n……………………………………………………………………………………………\\n\\n……………………………………………………………………………………………\\n\\nQ3- Is the language clear and does not have grammatical mistakes?\\n\\n……………………………………………………………………………………………\\n\\n……………………………………………………………………………………………\\n\\n……………………………………………………………………………………………\\n\\n………………………………………………………………………………………….\\n\\nQ4- Are the items in the test appropriate for all students` levels?\\n\\n……………………………………………………………………………………………\\n\\n……………………………………………………………………………………………\\n\\n……………………………………………………………………………………………\\n\\n……………………………………………………………………………………………\", \"page_fill_runs\": [105, 105, 105, 104, 105, 105, 105, 105, 105, 105, 105, 103, 105, 105, 105, 105], \"page_lines\": 22}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:ellipsis"]} {"pdf": "docs/real/683e4766c02710030b20de0d_GECC-133902368_p566.pdf", "category": "real", "id": "683e4766c02710030b20de0d_GECC-133902368_p566", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" Exhibit 4\\n Sheet19\\n\\n\\n\\n\\n\\n\\n\\n GEICO Corporation\\n\\n Voluntary Private Passenger Automobile Insurance\\n Maryland\\nIncurred Loss + ALAE Development by Accident Quarter\\n as of 6/30/2023\\n Emergency Road Service\\n\\n\\n Acc Qtr Age of Accident Quarter in Months\\n ERS Ending 6 9 12 15 18 21 24 27 30 33 36 39 42 45 48 51 54 57 60 63 66 69 72 75 78 81 84 87 90 93 96 99\\n 9/30/2012 1,661,745 1,663,128 1,663,931 1,664,167 1,664,322 1,664,412 1,664,384 1,664,495 1,664,495 1,664,613 1,664,613 1,664,613 1,664,913 1,665,008 1,665,008 1,665,008 1,665,008 1,665,008 1,665,008 1,665,008 1,665,008 1,665,008 1,665,008 1,665,008 1,665,008 1,665,008 1,665,008 1,665,008 1,665,008 1,665,008 1,665,008 1,665,008\\n 12/31/2012 1,635,366 1,637,682 1,637,311 1,638,033 1,638,465 1,638,833 1,638,905 1,638,937 1,638,937 1,638,937 1,638,937 1,639,096 1,639,096 1,639,096 1,639,096 1,639,096 1,639,096 1,639,096 1,639,096 1,639,096 1,639,096 1,639,096 1,639,096 1,639,096 1,639,096 1,639,096 1,639,096 1,639,096 1,639,096 1,639,094 1,639,094 1,639,094\\n 3/31/2013 1,671,299 1,673,554 1,679,494 1,681,195 1,681,798 1,681,738 1,681,771 1,681,771 1,681,806 1,681,895 1,681,895 1,682,012 1,682,012 1,682,012 1,682,012 1,682,012 1,682,012 1,682,012 1,682,012 1,682,012 1,682,012 1,682,012 1,682,012 1,682,012 1,682,012 1,682,012 1,682,012 1,682,012 1,682,012 1,682,012 1,682,012 1,682,012\\n 6/30/2013 1,734,334 1,738,470 1,739,091 1,740,330 1,740,503 1,740,552 1,740,595 1,740,630 1,740,730 1,740,776 1,740,776 1,740,776 1,740,776 1,740,776 1,740,776 1,740,776 1,740,776 1,740,776 1,740,776 1,740,776 1,740,776 1,740,776 1,740,776 1,740,776 1,740,776 1,740,776 1,740,776 1,740,776 1,740,776 1,740,776 1,740,776 1,740,776\\n 9/30/2013 1,866,817 1,869,309 1,870,759 1,870,605 1,870,787 1,871,197 1,871,197 1,871,332 1,871,789 1,871,789 1,871,789 1,871,789 1,871,789 1,871,789 1,871,789 1,871,789 1,871,789 1,871,789 1,871,789 1,871,789 1,871,789 1,871,789 1,871,789 1,871,862 1,871,862 1,871,862 1,871,862 1,871,862 1,871,862 1,871,862 1,871,862 1,871,862\\n 12/31/2013 1,894,366 1,900,632 1,901,188 1,901,329 1,901,339 1,901,339 1,901,339 1,901,506 1,901,506 1,901,506 1,901,506 1,901,506 1,901,506 1,901,506 1,901,506 1,901,506 1,901,506 1,901,506 1,901,506 1,901,506 1,901,506 1,901,506 1,901,506 1,901,506 1,901,506 1,901,506 1,901,506 1,901,506 1,901,506 1,901,506 1,901,506 1,901,506\\n 3/31/2014 2,144,219 2,149,168 2,149,457 2,150,774 2,151,031 2,151,069 2,151,069 2,151,197 2,151,197 2,151,197 2,151,197 2,151,197 2,151,197 2,151,197 2,151,197 2,151,197 2,151,197 2,151,197 2,151,197 2,151,197 2,151,197 2,151,197 2,151,197 2,151,197 2,151,197 2,151,197 2,151,197 2,151,197 2,151,197 2,151,197 2,151,197 2,151,197\\n 6/30/2014 1,947,772 1,950,442 1,952,016 1,952,512 1,948,991 1,949,487 1,949,487 1,949,538 1,949,538 1,949,538 1,949,538 1,949,538 1,949,538 1,949,538 1,949,538 1,949,633 1,949,633 1,949,633 1,949,633 1,949,633 1,949,633 1,949,633 1,949,633 1,949,633 1,949,633 1,949,633 1,949,633 1,949,633 1,949,633 1,949,633 1,949,633 1,949,633\\n 9/30/2014 1,981,286 1,985,263 1,986,021 1,986,213 1,987,006 1,987,554 1,987,599 1,987,792 1,987,792 1,987,792 1,988,022 1,988,022 1,988,022 1,987,899 1,987,899 1,987,899 1,987,899 1,987,899 1,987,899 1,987,899 1,987,899 1,987,899 1,987,899 1,987,899 1,987,899 1,987,899 1,987,899 1,987,899 1,987,899 1,987,899 1,987,899 1,987,899\\n 12/31/2014 2,051,329 2,054,559 2,055,731 2,057,149 2,058,796 2,058,797 2,058,913 2,058,958 2,058,958 2,058,958 2,058,958 2,058,958 2,058,958 2,058,958 2,058,958 2,058,958 2,058,958 2,058,958 2,058,958 2,058,958 2,058,958 2,058,958 2,058,958 2,058,958 2,058,958 2,058,958 2,058,958 2,058,958 2,058,958 2,058,958 2,058,958 2,058,958\\n 3/31/2015 2,481,649 2,488,922 2,491,735 2,498,216 2,498,861 2,498,927 2,499,077 2,499,077 2,499,122 2,499,122 2,499,122 2,499,213 2,499,267 2,499,267 2,499,267 2,499,267 2,499,267 2,499,267 2,499,267 2,499,267 2,499,267 2,499,267 2,499,267 2,499,267 2,499,267 2,499,267 2,499,267 2,499,267 2,499,267 2,499,267 2,499,267 2,499,267\\n 6/30/2015 1,999,023 2,007,395 2,055,406 2,058,847 2,059,094 2,059,250 2,059,250 2,059,414 2,059,414 2,059,414 2,059,414 2,059,414 2,059,414 2,059,414 2,059,414 2,059,414 2,059,414 2,059,414 2,059,414 2,059,414 2,059,414 2,059,414 2,059,414 2,059,414 2,059,414 2,059,414 2,059,414 2,059,414 2,059,414 2,059,414 2,059,414 2,059,414\\n 9/30/2015 2,164,374 2,190,629 2,195,186 2,195,501 2,196,132 2,196,132 2,196,304 2,196,579 2,196,579 2,196,579 2,196,579 2,196,579 2,196,579 2,196,579 2,196,614 2,196,614 2,196,614 2,196,614 2,196,614 2,196,614 2,196,614 2,196,614 2,196,614 2,196,614 2,196,614 2,196,614 2,196,614 2,196,614 2,196,614 2,196,614 2,196,614 0\\n 12/31/2015 2,248,242 2,253,418 2,254,195 2,254,008 2,253,351 2,252,918 2,253,009 2,253,009 2,253,074 2,253,074 2,253,135 2,253,183 2,253,183 2,253,183 2,253,233 2,253,233 2,253,233 2,253,233 2,253,233 2,253,233 2,253,233 2,253,233 2,253,233 2,253,233 2,253,233 2,253,233 2,253,233 2,253,233 2,253,233 2,253,233 0 0\\n 3/31/2016 2,549,120 2,550,730 2,552,795 2,553,815 2,553,936 2,553,936 2,553,968 2,553,968 2,553,968 2,553,968 2,553,968 2,554,000 2,554,000 2,554,000 2,554,000 2,554,000 2,554,000 2,554,000 2,554,000 2,554,000 2,554,000 2,554,000 2,554,000 2,554,000 2,554,000 2,554,000 2,554,000 2,554,000 2,554,000 0 0 0\\n 6/30/2016 2,414,778 2,417,613 2,417,861 2,418,522 2,418,825 2,419,229 2,419,304 2,419,519 2,419,363 2,419,363 2,419,363 2,419,426 2,419,426 2,419,426 2,419,426 2,419,426 2,419,426 2,419,426 2,419,426 2,419,426 2,419,426 2,419,426 2,419,426 2,419,426 2,419,426 2,419,426 2,419,426 2,419,426 0 0 0 0\\n 9/30/2016 2,960,005 2,964,170 2,965,838 2,967,681 2,968,117 2,968,331 2,968,616 2,968,697 2,968,697 2,968,697 2,968,779 2,968,879 2,968,877 2,969,377 2,969,377 2,969,377 2,969,377 2,969,377 2,969,377 2,969,377 2,969,540 2,969,538 2,969,538 2,969,538 2,969,538 2,969,538 2,969,538 0 0 0 0 0\\n 12/31/2016 2,781,453 2,784,618 2,786,149 2,788,760 2,788,952 2,788,952 2,788,952 2,788,952 2,789,077 2,789,077 2,789,277 2,789,277 2,789,277 2,789,277 2,789,277 2,789,277 2,789,277 2,789,277 2,789,277 2,789,277 2,789,277 2,789,277 2,789,277 2,789,277 2,789,289 2,789,289 0 0 0 0 0 0\\n 3/31/2017 2,683,776 2,686,514 2,687,388 2,688,687 2,689,960 2,690,242 2,690,312 2,690,907 2,691,194 2,691,194 2,691,194 2,691,194 2,691,194 2,691,194 2,691,194 2,691,194 2,691,194 2,691,194 2,691,194 2,691,194 2,691,194 2,691,194 2,691,194 2,691,194 2,691,194 0 0 0 0 0 0 0\\n 6/30/2017 2,802,177 2,805,173 2,806,539 2,807,625 2,807,744 2,807,885 2,807,973 2,808,057 2,808,182 2,808,182 2,808,182 2,808,182 2,808,182 2,808,182 2,808,182 2,808,182 2,808,182 2,808,182 2,808,182 2,808,182 2,808,182 2,808,182 2,808,214 2,808,214 0 0 0 0 0 0 0 0\\n 9/30/2017 3,136,658 3,142,102 3,142,870 3,143,763 3,145,504 3,146,497 3,146,681 3,146,831 3,146,906 3,147,156 3,147,022 3,147,022 3,147,022 3,147,022 3,147,022 3,147,022 3,147,022 3,147,097 3,147,097 3,147,097 3,147,097 3,147,097 3,147,097 0 0 0 0 0 0 0 0 0\\n 12/31/2017 3,121,511 3,125,478 3,126,471 3,128,887 3,130,530 3,130,883 3,130,883 3,130,883 3,130,883 3,130,908 3,130,908 3,130,908 3,130,908 3,130,935 3,130,935 3,130,935 3,130,935 3,130,935 3,130,935 3,130,935 3,130,935 3,130,935 0 0 0 0 0 0 0 0 0 0\\n 3/31/2018 3,375,590 3,375,789 3,376,089 3,381,874 3,382,931 3,383,489 3,383,804 3,383,804 3,383,677 3,383,736 3,383,736 3,383,736 3,383,736 3,383,736 3,383,736 3,383,736 3,383,736 3,383,736 3,383,736 3,383,736 3,383,736 0 0 0 0 0 0 0 0 0 0 0\\n 6/30/2018 3,128,409 3,131,346 3,137,477 3,138,778 3,138,890 3,138,900 3,139,030 3,139,030 3,139,030 3,139,030 3,139,030 3,139,030 3,139,030 3,139,030 3,139,030 3,139,030 3,139,030 3,139,030 3,139,030 3,139,030 0 0 0 0 0 0 0 0 0 0 0 0\\n 9/30/2018 3,490,362 3,497,225 3,500,129 3,500,480 3,500,480 3,500,530 3,500,530 3,500,530 3,500,530 3,500,592 3,500,592 3,500,592 3,500,744 3,500,744 3,500,744 3,500,744 3,500,744 3,500,744 3,500,744 0 0 0 0 0 0 0 0 0 0 0 0 0\\n 12/31/2018 3,569,112 3,572,388 3,575,162 3,576,386 3,576,736 3,576,767 3,576,767 3,576,767 3,576,862 3,576,862 3,576,909 3,576,907 3,576,907 3,576,907 3,576,907 3,576,907 3,576,907 3,576,907 0 0 0 0 0 0 0 0 0 0 0 0 0 0\\n 3/31/2019 3,530,528 3,557,050 3,564,262 3,564,747 3,564,976 3,565,176 3,565,179 3,565,267 3,565,367 3,565,367 3,565,367 3,565,367 3,565,367 3,565,452 3,565,452 3,565,452 3,565,452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0\\n 6/30/2019 3,486,679 3,503,900 3,507,171 3,508,284 3,508,381 3,508,481 3,508,626 3,508,626 3,508,626 3,508,626 3,508,626 3,508,626 3,508,626 3,508,626 3,508,626 3,508,626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0\\n 9/30/2019 4,106,649 4,111,445 4,112,162 4,112,553 4,112,702 4,112,947 4,112,947 4,112,995 4,113,155 4,113,155 4,113,155 4,113,155 4,113,155 4,113,155 4,113,155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0\\n 12/31/2019 4,111,305 4,118,008 4,118,775 4,119,368 4,119,698 4,119,698 4,119,698 4,119,698 4,119,698 4,119,698 4,119,698 4,119,698 4,119,698 4,119,698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0\\n 3/31/2020 3,497,749 3,512,623 3,518,089 3,519,864 3,519,864 3,520,024 3,520,133 3,520,730 3,520,730 3,520,730 3,520,831 3,520,831 3,520,831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0\\n 6/30/2020 3,182,551 3,186,207 3,187,217 3,187,402 3,187,795 3,187,838 3,188,103 3,188,228 3,188,278 3,188,278 3,188,278 3,188,362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0\\n 9/30/2020 3,777,766 3,782,291 3,783,337 3,783,929 3,784,548 3,784,653 3,784,653 3,784,703 3,784,703 3,784,703 3,784,703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0\\n 12/31/2020 3,824,628 3,828,238 3,829,902 3,830,157 3,830,788 3,830,946 3,832,090 3,832,158 3,832,158 3,832,158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0\\n 3/31/2021 4,086,276 4,088,378 4,090,944 4,091,853 4,092,545 4,092,720 4,093,065 4,093,190 4,093,243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0\\n 6/30/2021 4,237,039 4,240,151 4,241,763 4,242,269 4,243,230 4,243,230 4,243,574 4,243,643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0\\n 9/30/2021 4,846,209 4,853,936 4,855,772 4,858,650 4,858,967 4,859,031 4,859,031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0\\n 12/31/2021 4,907,483 4,913,553 4,918,240 4,919,656 4,920,909 4,921,175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0\\n 3/31/2022 5,001,268 5,012,116 5,020,673 5,022,859 5,023,324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0\\n 6/30/2022 4,960,322 4,983,543 4,989,139 4,991,724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0\\n 9/30/2022 5,150,095 5,163,367 5,168,407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0\\n 12/31/2022 4,922,099 4,927,661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0\\n 3/31/2023 3,789,293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0\\n\\n\\n ata_tri Acc Qtr Age to Age Ratios\\n ata_tri Ending 6 - 9 9 - 12 12 -15 15 -18 18 -21 21 -24 24 -27 27 -30 30 -33 33 -36 36 -39 39 - 42 42 - 45 45 - 48 48 -51 51 -54 54 -57 57 -60 60 -63 63 -66 66 -69 69 -72 72 -75 75 -78 78 -81 81 -84 84 -87 87 -90 90 -93 93 -96 96 -99\\n ata_tri 9/30/2012 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 12/31/2012 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 3/31/2013 1.001 1.004 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 6/30/2013 1.002 1.000 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 9/30/2013 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 12/31/2013 1.003 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 3/31/2014 1.002 1.000 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 6/30/2014 1.001 1.001 1.000 0.998 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 9/30/2014 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 12/31/2014 1.002 1.001 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 3/31/2015 1.003 1.001 1.003 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 6/30/2015 1.004 1.024 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 9/30/2015 1.012 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000\\n ata_tri 12/31/2015 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000\\n ata_tri 3/31/2016 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000\\n ata_tri 6/30/2016 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000 1.000\\n ata_tri 9/30/2016 1.001 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000 1.000 1.000\\n ata_tri 12/31/2016 1.001 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 3/31/2017 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 6/30/2017 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 9/30/2017 1.002 1.000 1.000 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 12/31/2017 1.001 1.000 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 3/31/2018 1.000 1.000 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 6/30/2018 1.001 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 9/30/2018 1.002 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 12/31/2018 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 3/31/2019 1.008 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 6/30/2019 1.005 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 9/30/2019 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 12/31/2019 1.002 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 3/31/2020 1.004 1.002 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 6/30/2020 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 9/30/2020 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 12/31/2020 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 3/31/2021 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 6/30/2021 1.001 1.000 1.000 1.000 1.000 1.000 1.000 0.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 9/30/2021 1.002 1.000 1.001 1.000 1.000 1.000 0.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 12/31/2021 1.001 1.001 1.000 1.000 1.000 0.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 3/31/2022 1.002 1.002 1.000 1.000 0.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 6/30/2022 1.005 1.001 1.001 0.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 9/30/2022 1.003 1.001 0.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri 12/31/2022 1.001 0.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n ata_tri\\n ata_tri\\n 3-Year Average Factors\\n 6 - 9 9 - 12 12 -15 15 -18 18 -21 21 -24 24 -27 27 -30 30 -33 33 -36 36 -39 39 - 42 42 - 45 45 - 48 48 -51 51 -54 54 -57 57 -60 60 -63 63 -66 66 -69 69 -72 72 -75 75 -78 78 -81 81 -84 84 -87 87 -90 90 -93 93 -96 96 -99 99 -Ult.\\n smpl 1.002 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n\\n Cumulative to Ultimate Factors\\n 6 - Ult. 9 - Ult. 12 -Ult. 15 -Ult. 18 -Ult. 21 -Ult. 24 -Ult. 27 -Ult. 30 -Ult. 33 -Ult. 36 -Ult. 39 -Ult.\\n smpl 1.003 1.001 1.001 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\", \"page_fill_runs\": [], \"page_lines\": 105}", "page": null, "expected_markdown": null, "tags": ["real", "kind:word"]} {"pdf": "docs/real/6a0ce8a19ef9988400773dbc_Clean_Investment_Monitor_US_Q1_2026_p9.pdf", "category": "real", "id": "6a0ce8a19ef9988400773dbc_Clean_Investment_Monitor_US_Q1_2026_p9", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"RHODIUM GROUP | ENERGY & CLIMATE US Q1 2026 CLEAN INVESTMENT\\n\\nFIGURE 8\\nTop clean electricity investment states with the largest investment growth year-over-year\\nBillion 2024 USD\\n\\n Solar Storage Wind Nuclear Other\\n\\n$2.5 Virginia Colorado\\n\\n$2.0\\n\\n$1.5\\n\\n$1.0\\n\\n$0.5\\n\\n$0.0\\n Q1 Q3 Q1 Q3 Q1 Q3 Q1 Q3 Q1 Q3 Q1 Q3 Q1 Q1 Q3 Q1 Q3 Q1 Q3 Q1 Q3 Q1 Q3 Q1 Q3 Q1\\n 2020 2021 2022 2023 2024 20252026 2020 2021 2022 2023 2024 20252026\\n\\n$2.5 New Mexico Oklahoma\\n\\n$2.0\\n\\n$1.5\\n\\n$1.0\\n\\n$0.5\\n\\n$0.0\\n Q1 Q3 Q1 Q3 Q1 Q3 Q1 Q3 Q1 Q3 Q1 Q3 Q1 Q1 Q3 Q1 Q3 Q1 Q3 Q1 Q3 Q1 Q3 Q1 Q3 Q1\\n 2020 2021 2022 2023 2024 20252026 2020 2021 2022 2023 2024 20252026\\n\\n Michigan New York\\n$2.5\\n\\n$2.0\\n\\n$1.5\\n\\n$1.0\\n\\n$0.5\\n\\n$0.0\\n Q1 Q3 Q1 Q3 Q1 Q3 Q1 Q3 Q1 Q3 Q1 Q3 Q1 Q1 Q3 Q1 Q3 Q1 Q3 Q1 Q3 Q1 Q3 Q1 Q3 Q1\\n 2020 2021 2022 2023 2024 20252026 2020 2021 2022 2023 2024 20252026\\n\\nSource: Rhodium Group/MIT-CEEPR Clean Investment Monitor\\n\\n\\n\\n 9\", \"page_fill_runs\": [], \"page_lines\": 32}", "page": null, "expected_markdown": null, "tags": ["real", "kind:unit"]} {"pdf": "docs/real/805-4_p69.pdf", "category": "real", "id": "805-4_p69", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"……………………………………………………………………………………………\\n……………………………………………………………………………………………\\n……………………………………………………………………………………………\\n\\n……………………………………………………………………………………………\\n…………………………………………………………………………………………..\\n………………………………………………………………………………………….\\n\\n\\n\\n\\n6. Trece adjectivul \\\"calm\\\" la toate gradele de comparaţie:\\n …………………………………………………………………………………………………\\n …………………………………………………………………………………………………\\n …………………………………………………………………………………………………\\n …………………………………………………………………………………………………\\n …………………………………………………………………………………………………\\n …………………………………………………………………………………………………\\n\\n …………………………………………………………………………………………………\\n ………………………………………………………………………………………….…….\\n\\n\\n 7. Alcătuieşte câte un enunţ, în care adjectivul \\\"propriu\\\" să fie în cazul:\\n\\n\\nN…………………………………………………………………………..\\nAC………………………………………………………………………….\\nG…………………………………………………………………………..\\n\\n\\n 8. Realizează câte un enunţ în care să existe:\\n\\n\\n a) Adjectiv provenit din verb la participiu………………………………...……………………\\n b) Adjectiv provenit din adverb…………………………………………………..…………….\\n c) Adjectiv provenit din pronume nehotărât…………………………………..……………….\\n d) Adjectiv propriu-zis invariabil……………………………….……………..………………\\n e) Adjectiv fără grade de comparaţie…………………………………………..………………\\n f) Adjectiv provenit din verb la gerunziu (acordat)……………………………………………\\n\\n\\n 65\", \"page_fill_runs\": [105, 105, 105, 105, 104, 103, 111, 111, 111, 111, 111, 111, 111, 110, 86, 85, 86, 63, 75, 60, 72, 68, 51], \"page_lines\": 27}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:ellipsis"]} {"pdf": "docs/real/811467_p29.pdf", "category": "real", "id": "811467_p29", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"Table 2.1. Differences between heavy stability control technologies in terms of input and outputs.\\nInputs Outputs\\n\\n\\n W\\n h\\n e\\n e\\n l\\n S\\n p\\n e\\n e\\n d L\\n a\\n t\\n e\\n r\\n a\\n l\\n A\\n c\\n c\\n e\\n l\\n e\\n r\\n a\\n t\\n i\\n o\\n n S\\n t\\n e\\n e\\n r\\n A\\n n\\n g\\n l\\n e Y\\n a\\n w\\n R\\n a\\n t\\n e T\\n h\\n r\\n o\\n t\\n t\\n l\\n e\\n R\\n e\\n t\\n a\\n r\\n d\\n e\\n r E\\n n\\n g\\n i\\n n\\n e\\n R\\n e\\n t\\n a\\n r\\n d\\n e\\n r T\\n r\\n a\\n i\\n l\\n e\\n r\\n B\\n r\\n a\\n k\\n e\\n s D\\n r\\n i\\n v\\n e\\n A\\n x\\n l\\n e\\n B\\n r\\n a\\n k\\n e\\n s S\\n t\\n e\\n e\\n r\\n A\\n x\\n l\\n e\\n B\\n r\\n a\\n k\\n e\\n Stability Control Technology s\\n\\n\\n\\n\\nTractor-based ESC (Roll and Yaw) X X X X X X X X X\\n\\n Tractor-based RSC X X X X X X\\n\\n Trailer-based RSC X X X\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n 6\", \"page_fill_runs\": [], \"page_lines\": 117}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:letter"]} {"pdf": "docs/real/ADA553607_p51.pdf", "category": "real", "id": "ADA553607_p51", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" public://************************---PUBLIC---***********************************\\n\\n //****************************OUTSIDE CLASSES*********************************\\n Utilities UTILITY; //..........................Instantiate Utility Class (MKA)\\n Statistics STAT; //.........................Instantiate Statistics Class (MKA)\\n //********************************OUTPUT**************************************\\n //O_FUNCTIONS-----------------------------------------------------------------\\n sSalSeeker();\\n saloutputs S_SALSEEKER(Point3D d_geo, Point3D t_geo, //..Runs all calculations\\n Point3D s_geo, Point2D s_orientation,//.and outputs to struct\\n double t_rotation, int seed);\\n saloutputs programoutput;\\n void PrintOutput(string filename = \\\"\\\", string format = \\\".txt\\\"); // SummaryFile\\n //O_DISPLAY-------------------------------------------------------------------\\n bool printtoscreen;\\n bool printtofile;\\n int surface[8]; //.0 = Left Side, 1 = Front, 2 = Right Side, 3 = Back, 4 = Top\\n //.....5 = Ground (underspill), 6 = DirectIntoSeeker, 7 = Miss\\n string s_desc[8]; //.Create array of target surface names (ref above surfaces)\\n int mainhitsurface; //...........................Surface that got hit the most\\n //******************************PARAMETERS************************************\\n //P_SEEKER--------------------------------------------------------------------\\n double s_fov; //............................deg (half angle of cone swept out)\\n double s_aperture_diameter; //...............................................m\\n double s_background; //...................background noise multiplier W/m^2/sr\\n double s_signalnoise_threshold; //ratio of signal to noise necessary to detect\\n double s_efficiency; //........efficiency factor accounting for various losses\\n //P_DESIGNATOR----------------------------------------------------------------\\n int d_lasertype; //.....................................0 = 1.06 um (Nd:Glass)\\n //..........................................1 = 1.536 um (Er:Glass)\\n int d_raycount; //...................Number of rays to divide laser pulse into\\n double d_divergence; //....................................................rad\\n double d_pulse_energy; //....................................................J\\n double d_pulse_frequency; //................................................Hz\\n double d_pulse_duration; //..................................................s\\n double d_efficiency; //........efficiency factor accounting for various losses\\n double d_h_error, d_v_error; //....designator error (hor and vert, rad, stdev)\\n //P_TARGET--------------------------------------------------------------------\\n Point3D t_size; //....................................length, width, height: m\\n double t_reflect[6]; // target reflectivity for each surface (ref surface des)\\n //P_OTHER---------------------------------------------------------------------\\n int seed; //...........................seed number for random number generator\\n weather sal_weather; //..................struct containing weather information\\n double s_noise; //...........................................................W\\n/******************************************************************************/\\n\\nprivate://************************---PRIVATE---*********************************\\n\\n //********************************VARIABLES***********************************\\n /*\\n Rotations use RIGHT-HANDED coordinate system\\n +z +y\\n | /\\n | /\\n | /\\n | /\\n | /\\n - - - - - - - +x\\n XYZ Zero Points:\\n x = 0 - user-defined\\n y = 0 - user-defined\\n z = 0 - earth's surface\\n\\n\\n 41\", \"page_fill_runs\": [25, 36, 26, 31, 26, 25, 30, 36, 65, 67, 27, 28, 34, 68, 28, 47, 19, 64, 37, 42, 19, 52, 52, 48, 50, 68, 36, 69, 27, 18, 59, 78, 25, 34, 30, 33], \"page_lines\": 60}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:star"]} {"pdf": "docs/real/Afghanistan_2004_p2.pdf", "category": "real", "id": "Afghanistan_2004_p2", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" constituteproject.org PDF generated: 06 Jul 2023, 15:18\\n\\n\\n Table of contents\\n\\n Preamble . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6\\n Chapter I. State . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .6\\n Article 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6\\n Article 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6\\n Article 3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7\\n Article 4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7\\n Article 5 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7\\n Article 6 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7\\n Article 7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7\\n Article 8 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7\\n Article 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7\\n Article 10 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7\\n Article 11 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8\\n Article 12 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8\\n Article 13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8\\n Article 14 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8\\n Article 15 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8\\n Article 16 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8\\n Article 17 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8\\n Article 18 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8\\n Article 19 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9\\n Article 20 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9\\n Article 21 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9\\nChapter II. Fundamental Rights and Duties of Citizens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9\\n Article 22 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9\\n Article 23 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9\\n Article 24 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9\\n Article 25 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9\\n Article 26 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9\\n Article 27 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10\\n Article 28 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10\\n Article 29 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10\\n Article 30 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10\\n Article 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10\\n Article 32 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10\\n Article 33 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10\\n Article 34 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10\\n Article 35 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11\\n Article 36 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11\\n Article 37 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11\\n Article 38 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11\\n Article 39 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11\\n Article 40 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11\\n Article 41 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12\\n Article 42 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12\\n\\n\\n Afghanistan 2004 Page 2\", \"page_fill_runs\": [83, 78, 84, 84, 84, 84, 84, 84, 84, 84, 84, 83, 83, 83, 83, 83, 83, 83, 83, 83, 83, 83, 83, 40, 83, 83, 83, 83, 83, 82, 82, 82, 82, 82, 82, 82, 82, 82, 82, 82, 82, 82, 82, 82, 82], \"page_lines\": 48}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:dot"]} {"pdf": "docs/real/All-Island-Ten-Year-Transmission-Forecast-Statement-2020_p179.pdf", "category": "real", "id": "All-Island-Ten-Year-Transmission-Forecast-Statement-2020_p179", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" Table D-2: Existing and Committed Distribution-Connected Wind Farm Capacity\\n Maximum Export Capacity (MEC)\\nArea 110 kV Station 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029\\n Ardnacrusha 8.2 8.2 8.2 8.2 8.2 8.2 8.2 8.2 8.2 8.2\\n Ballydine 0.0 28.0 28.0 28.0 28.0 28.0 28.0 28.0 28.0 28.0\\n Booltiagh 96.0 109.4 109.4 109.4 109.4 109.4 109.4 109.4 109.4 109.4\\n Bunkimalta 46.5 46.5 46.5 46\\n .5 46.5 46.5 46.5 46.5 46.5 46.5\\n Cahir 0.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0\\n Cauteen 178.1 182.1 182.1 182.1 182.1 182.1 182.1 182.1 182.1 182.1\\n Charleville 84.7 84.7 84.7 84.7 84.7 84.7 84.7 84.7 84.7 84.7\\nMid-West Cureeny T 94.0 94.0 94.0 94.0 94.0 94.0 94.0 94.0 94.0 94.0\\n Drumline 0.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0\\n Ikerrin 36.0 36.0 36.0 36.0 36.0 36.0 36.0 36.0 36.0 36.0\\n Lisheen 39.6 39.6 39.6 39.6 39.6 39.6 39.6 39.6 39.6 39.6\\n Nenagh 14.0 14.0 14.0 14.0 14.0 14.0 14.0 14.0 14.0 14.0\\n Rathkeale 30.0 30.0 30.0 30.0 30.0 30.0 30.0 30.0 30.0 30.0\\n Thurles 41.8 41.8 41.8 41.8 41.8 41.8 41.8 41.8 41.8 41.8\\n Tipperary 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0\\n Tullabrack 31.0 31.0 31.0 31.0 31.0 31.0 31.0 31.0 31.0 31.0\\n Mid-West Area Total 702.7 756.1 756.1 756.1 756.1 756.1 756.1 756.1 756.1 756.1\\n Aghyoule 82.5 82.5 82.5 82.5 82.5 82.5 82.5 82.5 82.5 82.5\\n Agivey 15.0 15.0 15.0 15.0 15.0 15.0 15.0 15.0 15.0 15.0\\n Antrim 0.0 48.3 48.3 48.3 48.3 48.3 48.3 48.3 48.3 48.3\\n Ballymena 56.3 56.3 56.3 56.3 56.3 56.3 56.3 56.3 56.3 56.3\\n Carnmoney 13.8 13.8 13.8 13.8 13.8 13.8 13.8 13.8 13.8 13.8\\n Coleraine 108.0 108.0 108.0 108.0 108.0 108.0 108.0 108.0 108.0 108.0\\n Coolkeeragh 12.0 12.0 12.0 12.0 12.0 12.0 12.0 12.0 12.0 12.0\\n Creagh 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0\\n Drumnakelly 2.6 2.6 2.6 2.6 2.6 2.6 2.6 2.6 2.6 2.6\\n Drumquin 67.9 67.9 67.9 119.5 119.5 119.5 119.5 119.5 119.5 119.5\\n Dungannon 17.5 17.5 17.5 17.5 17.5 17.5 17.5 17.5 17.5 17.5\\n Eden 2.3 2.3 2.3 2.3 2.3 2.3 2.3 2.3 2.3 2.3\\nNorthern Enniskillen 34.4 34.4 34.4 34.4 34.4 34.4 34.4 34.4 34.4 34.4\\nIreland Gort 67.5 67.5 90.0 90.0 90.0 90.0 90.0 90.0 90.0 90.0\\n Kells 0.0 0.0 75.0 75.0 75.0 75.0 75.0 75.0 75.0 75.0\\n Killymallaght 35.7 35.7 35.7 35.7 35.7 35.7 35.7 35.7 35.7 35.7\\n Larne 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0\\n Limavady 37.7 37.7 37.7 37.7 37.7 37.7 37.7 37.7 37.7 37.7\\n Lismore 17.5 17.5 17.5 17.5 17.5 17.5 17.5 17.5 17.5 17.5\\n Loguestown 9.2 9.2 9.2 9.2 9.2 9.2 9.2 9.2 9.2 9.2\\n Magherakeel 208.6 208.6 208.6 208.6 208.6 208.6 208.6 208.6 208.6 208.6\\n Newry 23.0 23.0 23.0 23.0 23.0 23.0 23.0 23.0 23.0 23.0\\n Omagh 140.2 140.2 140.2 140.2 140.2 140.2 140.2 140.2 140.2 140.2\\n Rasharkin 54.8 54.8 54.8 54.8 54.8 54.8 54.8 54.8 54.8 54.8\\n Strabane 28.5 28.5 28.5 28.5 28.5 28.5 28.5 28.5 28.5 28.5\\n Tremogue 68.3 68.3 68.3 68.3 68.3 68.3 68.3 68.3 68.3 68.3\\n Northern Ireland\\n Area Total 1128.3 1176.6 1274.1 1325.7 1325.7 1325.7 1325.7 1325.7 1325.7 1325.7\\n EirGrid Group All-Island Ten-Year Transmission Forecast Statement · 2020\\n Page 173\", \"page_fill_runs\": [], \"page_lines\": 51}", "page": null, "expected_markdown": null, "tags": ["real", "kind:word"]} {"pdf": "docs/real/BailPretrialRelease_CrimHighlights_Sept2025_p2.pdf", "category": "real", "id": "BailPretrialRelease_CrimHighlights_Sept2025_p2", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" crimes.\\\" No credible evidence has been provided that pretrial release has contributed to these problems, or\\n that its increased use could solve them.4 It is easier to make an assertion that \\\"change\\\" is needed than to\\n actually demonstrate that need. The assumption seems to be that imprisoning more people while awaiting\\n trial would, unambiguously, be good policy.\\n This collection of summaries of research papers addresses a number of topics related to pretrial release. In\\n the text that follows, we have attempted to provide an accessible (and brief) overview of the findings. This is\\n followed by the one-page summaries of individual research papers that are the empirical basis of our\\n conclusions. Our purpose in providing all of this information is very simple: many of the issues related to\\n pretrial release and remand are based on empirical assumptions. This collection is an attempt to make these\\n empirical findings easily available for people to judge for themselves.\\n The overview of the research findings should be interpreted as being exactly that: an overview. The details\\n that are contained in the Criminological Highlights summaries is the evidence that is necessary to understand the\\n details of what is known. We would suggest that this introductory overview should be used primarily to\\n identify those Highlights summaries most relevant to each person's interests.5\\n* * * * * * * * * * * * * * * * * * * * * *\\n Bail, Pretrial Detention, and Evidence\\n Anthony N. Doob and Tyler J. King\\n In most areas of life - whether it be medicine, finance, the environment, or anything else - when one is trying\\n to develop policy to improve the situation or to \\\"fix\\\" something, one normally starts with an attempt to\\n understand exactly what the problem is one is trying to fix. In criminal justice, however, this starting point\\n often seems to be skipped. The discussion around bail appears, unfortunately, to be a good example of how\\n those most vocal about the problems appear to be least interested in understanding what the current situation\\n really is. This compendium of Criminological Highlights research summaries, combined with some additional\\n statistics and knowledge about the operation of bail in Canada, is an attempt to render some systematic\\n information about what is happening in this area of the criminal justice more easily accessible. Said\\n differently, this \\\"special issue\\\" represents an attempt to take the blindfolds off of those who are looking at\\n bail issues. We think it is important to examine a more complete picture of bail and pretrial detention.\\n In Canada, as is the case elsewhere, people are routinely imprisoned as punishment for their criminal acts.\\n Pretrial detention is quite different: it is preventive detention. The starting point in the Criminal Code provisions\\n on bail is, first of all, that people are innocent unless proven guilty in a court. Hence \\\"primary consideration\\n [is to be given to] the release of the accused at the earliest reasonable opportunity and on the least onerous\\n conditions that are appropriate in the circumstances, including conditions that are reasonably practicable for\\n the accused to comply with…\\\" (Criminal Code, s. 493.1) unless specific conditions are met justifying the\\n detention of the accused.\\n For the most part, pretrial detention can be justified not because of an accused person's past action. Rather,\\n it is justified because a prediction has been made about future behaviour: that the accused will not show up\\n for court and/or will commit a criminal offence or interfere with the administration of justice while awaiting\\n trial.6 The most important point, however, is that the inquiry relates not to what the accused might have\\n\\n4 https://liberal.ca/wp-content/uploads/sites/292/2025/04/Canada-Strong.pdf p.18\\n5 References to the Highlights summaries are provided throughout this summary. The original Highlights reference and the\\npage6 number in the second part of this collection (bottom right of each page) - is contained in the text.\\n A third justification for detention - that detention is necessary to maintain confidence in the administration of justice -\\nhas been restricted, to some extent, by court decisions. [see Criminal Code of Canada, s. 515(10)].\\n -2-\", \"page_fill_runs\": [], \"page_lines\": 44}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:star"]} {"pdf": "docs/real/Billboard-1987-08-15_p52.pdf", "category": "real", "id": "Billboard-1987-08-15_p52", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" 1111111111111111T1111111111111111111111111111111111111111111111111111111111111111 o\\n\\n BREAKING THE RULES TOGETHE\\n FESTIVAL RECORDS\\nAustralia and New Zealand are proud to have represented\\n TINA TURNER\\n continuously, for the past 18 years\\n and we look forward to being part\\n of The World Tour. FEITIYU\\n\\n www.americanradiohistory.com\", \"page_fill_runs\": [], \"page_lines\": 9}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:digit"]} {"pdf": "docs/real/CBK_MSB_250_en_p18.pdf", "category": "real", "id": "CBK_MSB_250_en_p18", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" June 2022 Monthly Statistics Bulletin\\n\\n\\n\\n25. Exchange rate against euro currency\\n\\n(Period average)\\n\\n160 1.8\\n\\n140 1.6\\n120 1.4\\n100 1.2\\n1.0\\n80\\n0.8\\n60 0.6\\n40 0.4\\n20 0.2\\n\\n0 Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1 -\\n2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022\\n\\n\\n Albanian lek North Mecedonian denar Serbian dinar American dollar, right axis\\n\\n\\n\\n\\n\\n 26. Real effective exchange rate\\n (Index)\\n\\n 120\\n 118\\n 116\\n 114\\n 112\\n 110\\n 108 Appreciation\\n 106\\n 104\\n 102\\n 100 Depreciation\\n 98\\n 96\\n 94\\n 92\\n 90 Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2\\n 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022\\n\\n REER (CEFTA) REER (BE) REER (Total)\\n\\n\\n\\n\\n 27. Trade balance\\n (EUR million: Cumulative data during the reference year)\\n 1,900\\n 1,700\\n 1,500\\n 1,300\\n 1,100\\n 900\\n 700\\n 500\\n 300\\n 100\\n -100\\n -300\\n -500\\n -700\\n -900\\n -1,100\\n -1,300\\n -1,500 Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2\\n 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022\\n\\n Imports Exports Trade balance\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n | 17\", \"page_fill_runs\": [], \"page_lines\": 59}", "page": null, "expected_markdown": null, "tags": ["real", "kind:unit"]} {"pdf": "docs/real/CHN2096_심층분석보고서_p2.pdf", "category": "real", "id": "CHN2096_심층분석보고서_p2", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"[ 목 차 ]\\n\\n\\n\\n\\n\\n\\n1. 규제 개요 ······························································1\\n\\n\\n2. 개정 세부내용 ······················································2\\n\\n\\n3. 관련 법령 및 표준 ··············································6\", \"page_fill_runs\": [62, 54, 46], \"page_lines\": 4}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:middot"]} {"pdf": "docs/real/DCD-2-CFR-Guide-vvh-508_p19.pdf", "category": "real", "id": "DCD-2-CFR-Guide-vvh-508_p19", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" Exhibit F\\n EXAMPLE: Cost Policy Statement (CPS)\\n for Indirect Cost Rate Proposal\\n The following CPS is intended to be used as guidance for organizations that seek reimbursement for\\n indirect costs under Federal awards. This model assumes that ABC Organization uses:\\n A. the direct allocation basis to charge individual elements of costs. That is, in addition to\\n direct costs, ABC has in place accounting procedures which enable it to direct charge some\\n costs that would otherwise be considered indirect costs (see, for example, the description\\n below on how the photocopy costs are charged).\\n B. the direct salaries and wages including applicable fringe benefits, to allocate the indirect\\n cost \\\"pool\\\".\\n IMPORTANT NOTE: The CPS should have a detailed description of all the cost elements in the\\n indirect cost proposal. It should also include the cost element allocation methodology for\\n each element.\\n** * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * ** * * * * * * * * * * * * * * * * *\\n COSTPOLICY STATEMENT\\n ABCORGANIZATION/ADDRESS/PHONE\\n\\n I. General Accounting Policies\\n A. Basis of Accounting - Accrual Basis\\n B. FiscalPeriod - July 1 through June 30\\n C. Allocation Basis for Individual Cost Elements - Direct Allocation Basis\\n D. Indirect Cost Rate Allocation Base - Direct Salaries and Wages including applicable\\n Fringe Benefits.\\n E. If ABC Organization needed a fringe benefit rate, it would describe its fringe benefit\\n allocation base at this point.\\n F. ABC maintains adequate internal controls to insure that no cost is charged\\n both directly and indirectly to Federal contracts or grants. A description of the\\n accounting system software would be described at this point.\\n G. ABC accumulates all indirect costs and revenues in accounts titled, \\\"Indirect Cost-\\n Expense\\\" and \\\"Indirect Cost-Revenue\\\" respectively.\\n II. Description of Cost Allocation Methodology-\\n A. Salaries and Wages\\n 1. Direct Costs - The majority of ABC's employees direct charge their salary\\n costs since their work is specifically identifiable to specific grants,\\n contracts, or other activities of the organization such as lobbying, fund\\n raising or providing services to members. The charges are supported by\\n\\n III-4\", \"page_fill_runs\": [], \"page_lines\": 37}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:star"]} {"pdf": "docs/real/Dec_14_2023_BM_Transcripts_Protected_p3.pdf", "category": "real", "id": "Dec_14_2023_BM_Transcripts_Protected_p3", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" Page 3\\n·1· · · · · · · · · · · · · I N D E X\\n ·2· · · · · · · · · · · · · · · · · · · · · · · · ·PAGE\\n ·3· · Meeting called to order· · · · · · · · · · · · ·4\\n ·4\\n ·5\\n ·6\\n ·7\\n ·8\\n ·9\\n 10\\n 11\\n 12\\n 13\\n 14\\n 15\\n 16\\n 17\\n 18\\n 19\\n 20\\n 21\\n 22\\n 23\\n 24\\n 25\", \"page_fill_runs\": [13, 25, 13], \"page_lines\": 26}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:middot"]} {"pdf": "docs/real/EJ1315651_p5.pdf", "category": "real", "id": "EJ1315651_p5", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"424 / Education and Training in Autism and Developmental Disabilities-December 2021\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nTABLE 1\\n\\nQualityindicators met and unmet for all included studies\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n Quality Indicator\\n\\n1.0 Context and Setting x x x x x x x x x x x x x x x x x x x x\\n2.0 Participants x x x x x x x x x x x x x x x x x x x x\\n3.0Intervention Agent x x x x x x x x x x x x x x x x x x x x\\n4.0Description of Practice x x x x x x x x x x x x x x x x x x x x\\n5.0 ImplementationFidelity x x x x x x x x x x x x x x x x x x x\\n6.0Internal Validity x x x x x x x x x x x x x x x x x x\\n7.0 Outcome measures x x x x x x x x x x x x x x x x x x\\n8.0Data Analysis x x x x x x x x x x x x x x x x x x x x\\nEffects P P M P P P P M P P P P P P P P P P P P\\nEffect size* 1 1 .78 .95 1 1 1 .96 1 .95 .70 1 .87 .96 .91 .96 1 .91 1 .97\\nTotal QIsmet 8 8 5 8 8 8 8 6 8 8 8 8 8 8 8 8 8 8 8 8\\n\\n Note. P = positive effects, M = mixed effects, N = negative effects.Methodologically sound studies meet all 8 quality indicators for relevant researchdesign and have\\npositive effects (CEC, 2014). *Effect size for group design is Cohen's D, forsingle-case Tau-U.\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n Yakubova et al. (2020)\\n\\n Yakubova et al. (2015)\\n\\n Whitby (2013)\\n\\n Saunders (2014)\\n\\n Root et al. (2019)\\n\\n & Browder (2019) Root\\n\\n Henning, et al. (2018) Root,\\n\\n Root, Cox, et al. (2018)\\n\\n Root et al. (2017)\\n\\n Rockwell et al. (2011)\\n\\n Peltier (2020)\\n\\n Davis (2016) Ley\\n\\n Levingston et al. (2009)\\n\\n & Ergenekon (2017) Kasap\\n\\n Gilley et al. (2020)\\n\\n & Root (2020) Cox\\n\\n Chapman et al. (2019)\\n\\n Casner (2016)\\n\\n Burton et al. (2013)\\n\\n & Long (2020) Bdouck\", \"page_fill_runs\": [], \"page_lines\": 37}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:letter"]} {"pdf": "docs/real/ERL_Pulse_Butterflies_2025_p5.pdf", "category": "real", "id": "ERL_Pulse_Butterflies_2025_p5", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"Contents\\n\\n\\nAcknowledgements. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . iv\\nExecutive summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . vi\\n1. Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1\\n 1.1. The European context . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1\\n 1.2. The European policy context. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2\\n 1.3. European butterflies: diversity and endemism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5\\n 1.4. Threatened status of species - assessment of extinction risk. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6\\n 1.5. Objectives of the assessment. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7\\n2. Assessment methodology. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9\\n 2.1. Global and regional assessment - geographic scope. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9\\n 2.2. Taxonomic scope. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9\\n 2.3. Assessment protocol. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10\\n 2.4.Species mapping . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12\\n3. Assessment results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15\\n 3.1. Threatened status of butterflies in Europe.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15\\n 3.2. Comparison with the last assessment. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21\\n 3.3. Status of endemic species. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21\\n 3.4.Status and population trends of European butterflies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22\\n 3.5. Spatial distribution of European butterfly species. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23\\n 3.6. Major threats to butterflies in Europe. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25\\n 3.7. Gaps in knowledge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29\\n4. Conservation action for European butterflies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30\\n 4.1. Conservation management of butterflies in the European Union . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30\\n 4.2.The Red List versus priority for conservation action.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31\\n5. Recommendations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32\\n 5.1. Recommended action. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32\\n 5.2. Application of project outputs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33\\n 5.3. Future work . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34\\nReferences. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35\\nAppendix 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39\\nAppendix 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41\\n\\n\\n\\n\\n\\n\\n\\nEuropean Red List of iii\\nButterflies\", \"page_fill_runs\": [110, 110, 121, 106, 95, 66, 43, 94, 90, 56, 114, 107, 112, 102, 72, 79, 98, 52, 59, 79, 108, 46, 33, 58, 102, 103, 90, 119, 129, 129, 129], \"page_lines\": 34}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:dot"]} {"pdf": "docs/real/ERL_Pulse_Reptiles_2025_p5.pdf", "category": "real", "id": "ERL_Pulse_Reptiles_2025_p5", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" Contents\\n\\n\\n Acknowledgements. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .v\\n Executive summary. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . vi\\n 1. Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1\\n 1.1. The European context . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1\\n 1.2. The European policy context.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2\\n 1.3. European reptiles: diversity and endemism. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4\\n 1.4. Assessment of extinction risk. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10\\n 1.5. Objectives of the assessment. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10\\n 2. Assessment methodology. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12\\n 2.1. Geographic scope. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12\\n 2.2. Taxonomic scope. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12\\n 2.3. Assessment protocol. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15\\n 2.4.Spatial analysis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16\\n 3. Assessment results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .18\\n 3.1. The threatened status of European reptiles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18\\n 3.2. Status by taxonomic group. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20\\n 3.3. Spatial distribution of species . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21\\n 3.4.Population trends . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28\\n 3.5. Gaps in knowledge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28\\n 4. Conservation measures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30\\n 4.1. Comparison with the previous European Red List of Reptiles. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30\\n 4.2.Conservation management of reptiles in the EU. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31\\n 4.3.Red List status versus priority for conservation action. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33\\n5. Recommendations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .35\\n 5.1. Recommended actions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35\\n 5.2. Application of project outputs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35\\n 5.3. Future work . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35\\nReferences. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37\\n Appendices. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41\\n Appendix 1... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41\\n Appendix 2... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n European Red List of iii\\n Reptiles\", \"page_fill_runs\": [112, 111, 121, 106, 95, 71, 93, 93, 89, 111, 113, 107, 116, 102, 69, 95, 92, 110, 108, 92, 40, 62, 53, 104, 101, 90, 119, 129, 128, 130, 128], \"page_lines\": 34}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:dot"]} {"pdf": "docs/real/Elevate-UltraPly-TPO-Roof-Systems-Tested-Assembly-Guide-2906799_p72.pdf", "category": "real", "id": "Elevate-UltraPly-TPO-Roof-Systems-Tested-Assembly-Guide-2906799_p72", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" FM 1-90 | Fully Adhered TPO with Adhered Cover Board\\n Adhered TPO Systems Over22Gauge, 33 ksi Steel Deck\\n Updated: 11/30/2020\\n Mechanically Attached Base Layer of Insulation with Adhered Cover Board\\n Vapor Barrier Mech. Attach. Base Layer Min. Thick. MA Base ISO Insulation /\\n Attachment Insulation Adhesive 2nd Layer Min. Thick. Cover Board Membrane Bonding\\n\\n\\nRoof Nav# Cover Board Notes/ Comments:\\n\\nmax. slope (x:12) Poly V-ForceThermal Barrier Thermal Barrier ISO 95+ GL Resista ISOGARD GL ISOGARD CG Field Perimeter Corner ISO Stick TwinJet Twin Pack ISO Spray ISO Fix ISO 95+ GL Resista ISOGARD GL ISOGARD CG Field Perimeter Corner UltraPly TPO Flex Adhered Platinum TPO SA SP LVOC SP LVOC 1168 UP BA WBBA-P Jet Bond\\n\\n320423-0-0 0.25 O O 1.25 1.25 2.3 2.3 12 18 32 x x x x x x x x\\n400255-0-0 0.25 O O 2 2 2.3 2.3 8 16 32 x x x x x x x\\n384623-0-0 0.25 O 2.2 2.2 2.3 2.3 8 16 32 x x x x x x x x\\n471603-0-0 0.25 O O 2 2 2.3 2.3 8 16 32 x x x x\\n426041-0-0 0.25 R 1.25-24 1.25-24 2.3 2.3 12 18 32 x x x x x x x x\\n422473-0-0 0.25 R 2-24 2-24 2.3 2.3 8 16 32 x x x x x x x x\\n423164-0-0 0.25 R 1.25-24 1.25-24 2.3 2.3 8 16 32 x x x x x x\\n\\n400279-0-0 0.25 O O 2.25 -8 2.25 -8 2.3-13 2.3-13 8 16 32 x x x x 1.5 -4 1.5 -4 2.3-13 2.3-13 12 x x x x x x x x\\n400203-0-0 0.25 O O 2-8 2-8 2.3-13 2.3-13 8 16 32 x x 0.5-4 0.5-4 2.3-13 2.3-13 12 x x x x x x x x\\n384626-0-0 0.25 R 2.2-4 2.2-4 2.3-13 2.3-13 8 16 32 x x x x x 0.5-9 0.5-9 2.3-13 2.3-13 12 x x x x x x x x\\n384627-0-0 0.25 O 2.2-4 2.2-4 2.3-13 2.3-13 8 16 32 x x x x x 0.5-9 0.5-9 2.3-13 2.3-13 12 x x x x x x x x\\n422471-0-0 0.25 R 2-24 2-24 2.3-13 2.3-13 8 16 32 x x 0.5-4 0.5-4 2.3-13 2.3-13 12 x x x x x x x x\\n422584-0-0 0.25 R 1.5 -4 1.5 -4 2.3-13 2.3-13 8 16 32 x x 0.5-20 0.5-20 2.3-13 2.3-13 12 x x x x x x x\\n422481-0-0 0.25 R 2.25 -24 2.25 -24 2.3-13 2.3-13 8 16 32 x x x x x 1.5 -4 1.5 -4 2.3-13 2.3-13 12 x x x x x x x x\\n425643-0-0 0.25 R 1.5 -4 1.5 -4 2.3-13 2.3-13 8 16 32 x x x x x 0.5-24 0.5-24 2.3-13 2.3-13 12 x x x x x x x\\n\\n382858-0-0 0.25 R 2.2-4 2.2-4 2.3-13 2.3-13 8 16 32 x x x x x 0.5-9.8 0.5-9.8 2.3-13 2.3-13 12 0.5HD x x x x x x x x\\n1.0 HD COMP\\n426588-0-0 0.25 R 1.5 -4 1.5 -4 2.3-13 2.3-13 16 24 32 x 0.5-20 0.5-20 2.3-13 2.3-13 12 0.5HD x x x x x x x x\\n1.0 HD COMP\\n384580-0-0 0.25 O 2.2-4 2.2-4 2.3-13 2.3-13 8 16 32 x x x x x 0.5-9.8 0.5-9.8 2.3-13 2.3-13 12 0.5HD See RoofNav for list of acceptable thermal\\n1.0 HD COMP x x x x x x x x barriers.\\n\\n384610-0-0 2.5 R 2.2-4 2.2-4 2.3-13 2.3-13 8 16 32 x x x x x 0.5-9.8 0.5-9.8 2.3-13 2.3-13 12 0.5DDP x x x x x x x x\\n0.5Sec\\n384611-0-0 2.5 O 2.2-4 2.2-4 2.3-13 2.3-13 8 16 32 0.5-9.8 0.5-9.8 2.3-13 2.3-13 12 0.5DDP x x x x x x x x See RoofNav for list of acceptable thermal\\n0.5Sec barriers.\\n\\n342144-0-0 0.25 O O 2-8 2-8 2.3-13 2.3-13 16 24 32 x x x x x 12 0.5HD x x x x x x x x\\n1.0 HD COMP\\n233373-0-0 0.25 O O 1.5 -12 1.5 -12 2.3-13 2.3-13 16 24 32 x x 12 0.5HD x x x x x x\\n1.0 HD COMP\\n304372-0-0 0.25 O O 1.5 -4 1.5 -4 2.3-13 2.3-13 16 24 32 x 12 0.5HD x x x x x x x x\\n1.0 HD COMP\\n450309-0-0 0.25 R 2.2-12 2.2-12 2.3-13 2.3-13 8 16 32 x x x x x 12 0.5HD x x x x x x x x\\n1.0 HD COMP\\n428008-0-0 0.25 R 2-24 2-24 2.3-26 2.3-26 16 24 32 x x x x x 12 0.5HD x x x x x x x\\n1.0 HD COMP\\n424483-0-0 0.25 R 1.5 -24 1.5 -24 2.3-13 2.3-13 16 24 32 x x 12 0.5HD x x x x x x\\n1.0 HD COMP\\n450310-0-0 0.25 O 2.2-12 2.2-12 2.3-13 2.3-13 8 16 32 x x x x x 12 0.5HD x x x x x x x x See RoofNav for list of acceptable thermal\\n1.0 HD COMP barriers.\\n\\n400885-0-0 2.5 O O 1.5 -12 1.5 -12 2.3-13 2.3-13 16 24 32 x x 12 0.25 DDP x x x x x x\\n0.25 Sec\\n388285-0-0 2.5 2-12 2-12 2.3-13 2.3-13 8 16 32 x 12 0.25 DDP x x x x x x\\n450313-0-0 2.5 R 2-12 2-12 2.3-13 2.3-13 8 16 32 x x x x x 12 0.5DDP x x x x x x x x\\n0.5Sec\\n423386-0-0 2.5 R 1.5 -24 1.5 -24 2.3-13 2.3-13 16 24 32 x x 12 0.25 DDP x x x x x x\\n0.25 Sec\\n450314-0-0 2.5 O 2.2-12 2.2-12 2.3-13 2.3-13 8 16 32 x x x x x 12 0.5DDP x x x x x x x x See RoofNav for list of acceptable thermal\\n0.5Sec barriers.\\n\\n439214-0-0 0.5 1.5 -12 2.3-13 16 24 32 x x x 12 1.5 HG/IHG x x x 80 mil. membrane -VSH\\n\\nRefer to RoofNav assembly for complete information/requirements FM Prescriptive Enhancements for assemblies with Field uplift of X or less:Hurricane Region with 90 psf or less or a Non-Hurricane Region with 105 psf or Less\\nIt isthe responsibility of the designer/user to validate assemblies in the chart for accuracy and warrantability. 1. Use assembly to meet each zone uplift requirement\\nDD = DensDeck, DDP = DensDeck Prime,Securock GF= Securock Gypsum Fiber 2. Use assembly to meet max roof uplift across the entire roof FM Prescriptive Enhancements -Adhesive\\nMust use primer when adhering V-Force to substrate board. 3. Perimeter = Perimeter = Minimum 1.5 times the field rate of attachment but not less than 16/board (Contributory Area: 2or less) Install rows not more than 67% of the Field spacing\\nVerify insulation thickness requirements if ISOAGARD GL or ISOGARD CG are used in the assembly. Corner = Minimum 32 per board (Contributory Area: 1) Corner = Install rows not more than 50% of the Field spacing\", \"page_fill_runs\": [], \"page_lines\": 62}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:letter"]} {"pdf": "docs/real/Excellus_IND_BOTHX_EXHP-134113071_Application_p102.pdf", "category": "real", "id": "Excellus_IND_BOTHX_EXHP-134113071_Application_p102", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" 2024 MEMBERS (Should be consistent with DFS Membership Survey) - Only those members currently enrolled in 2024 plans that will continue to be 2024 MEMBERS - Only those members currently enrolled in 2024 plans Including plans that will be discontinued in 2025 ***** Columns CH -\\n 2025 PREMIUM RATES offered in 2025 CO apply to SMALL GROUP ONLY *****\\n\\n\\n\\n\\n\\n Region 1-2024 Region 2 - 2024 Region 3 - 2024 Region 4 - 2024 Region 5 - 2024 Region 6 - 2024 Region 8 - 2024 Region 1-2024 Region 2 - 2024 Region 3 - 2024 Region 4 - 2024 Region 5 - 2024 Region 6 - 2024 Region 8 - 2024\\n Region 3 - 2025 Region 8 - 2025 Members as of Members as of Members as of Members as of Members as of Members as of Region 7 - 2024 Members as of Members as of Members as of Members as of Members as of Members as of Members as of Region 7 - 2024 Members as of\\nRegion 1-2025 Region 2 - 2025 Rate (Mid- Region 4 - 2025 Region 5 - 2025 Region 6 - 2025 Region 7 - 2025 Rate (Long 3/31/2024 3/31/2024 3/31/2024 (Mid- 3/31/2024 (New 3/31/2024 3/31/2024 Members as of 3/31/2024 (Long 3/31/2024 3/31/2024 3/31/2024 (Mid- 3/31/2024 (New 3/31/2024 3/31/2024 Members as of 3/31/2024 (Long\\nRate (Albany) Rate (Buffalo) Hudson) Rate (New York) Rate (Rochester) Rate (Syracuse) Rate (Utica) Island) (Albany) (Buffalo) Hudson) York) (Rochester) (Syracuse) 3/31/2024 (Utica) Island) (Albany) (Buffalo) Hudson) York) (Rochester) (Syracuse) 3/31/2024 (Utica) Island)\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,582.25 0.00 1,582.25 0.00 1,333.89 1,528.63 1,582.25 0.00 0.00 0.00 0.00 0.00 21.00 20.00 5.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,582.25 0.00 1,582.25 0.00 1,333.89 1,528.63 1,582.25 0.00 0.00 0.00 0.00 0.00 0.00 4.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,582.25 0.00 1,582.25 0.00 1,333.89 1,528.63 1,582.25 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,582.25 0.00 1,582.25 0.00 1,333.89 1,528.63 1,582.25 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,578.31 0.00 1,578.31 0.00 1,330.57 1,524.82 1,578.31 0.00 0.00 0.00 0.00 0.00 15.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,552.75 0.00 1,552.75 0.00 1,309.02 1,500.13 1,552.75 0.00 2.00 0.00 20.00 0.00 370.00 204.00 103.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,552.75 0.00 1,552.75 0.00 1,309.02 1,500.13 1,552.75 0.00 4.00 0.00 5.00 0.00 211.00 116.00 44.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,552.75 0.00 1,552.75 0.00 1,309.02 1,500.13 1,552.75 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,552.75 0.00 1,552.75 0.00 1,309.02 1,500.13 1,552.75 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,548.88 0.00 1,548.88 0.00 1,305.76 1,496.39 1,548.88 0.00 0.00 0.00 1.00 0.00 69.00 35.00 9.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 639.73 0.00 639.73 0.00 539.32 618.05 639.73 0.00 0.00 0.00 0.00 0.00 8.00 7.00 2.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 639.73 0.00 639.73 0.00 539.32 618.05 639.73 0.00 0.00 0.00 0.00 0.00 12.00 2.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 639.73 0.00 639.73 0.00 539.32 618.05 639.73 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 639.73 0.00 639.73 0.00 539.32 618.05 639.73 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 638.14 0.00 638.14 0.00 537.97 616.51 638.14 0.00 0.00 0.00 0.00 0.00 0.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,568.19 0.00 1,568.19 0.00 1,322.04 1,515.04 1,568.19 0.00 0.00 0.00 0.00 0.00 5.00 7.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,568.19 0.00 1,568.19 0.00 1,322.04 1,515.04 1,568.19 0.00 0.00 0.00 0.00 0.00 0.00 9.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,568.19 0.00 1,568.19 0.00 1,322.04 1,515.04 1,568.19 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,568.19 0.00 1,568.19 0.00 1,322.04 1,515.04 1,568.19 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,564.28 0.00 1,564.28 0.00 1,318.74 1,511.26 1,564.28 0.00 0.00 0.00 0.00 0.00 0.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,538.95 0.00 1,538.95 0.00 1,297.39 1,486.79 1,538.95 0.00 0.00 0.00 1.00 0.00 225.00 171.00 73.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,538.95 0.00 1,538.95 0.00 1,297.39 1,486.79 1,538.95 0.00 8.00 0.00 7.00 0.00 311.00 165.00 87.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,538.95 0.00 1,538.95 0.00 1,297.39 1,486.79 1,538.95 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,538.95 0.00 1,538.95 0.00 1,297.39 1,486.79 1,538.95 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,535.11 0.00 1,535.11 0.00 1,294.15 1,483.09 1,535.11 0.00 0.00 0.00 0.00 0.00 24.00 18.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,360.71 0.00 1,360.71 0.00 1,147.12 1,314.59 1,360.71 0.00 0.00 0.00 0.00 0.00 10.00 11.00 10.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,360.71 0.00 1,360.71 0.00 1,147.12 1,314.59 1,360.71 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,360.71 0.00 1,360.71 0.00 1,147.12 1,314.59 1,360.71 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,360.71 0.00 1,360.71 0.00 1,147.12 1,314.59 1,360.71 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,357.31 0.00 1,357.31 0.00 1,144.26 1,311.31 1,357.31 0.00 0.00 0.00 0.00 0.00 4.00 5.00 3.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,335.33 0.00 1,335.33 0.00 1,125.73 1,290.08 1,335.33 0.00 1.00 0.00 8.00 0.00 194.00 165.00 151.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,335.33 0.00 1,335.33 0.00 1,125.73 1,290.08 1,335.33 0.00 1.00 0.00 1.00 0.00 273.00 179.00 111.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,335.33 0.00 1,335.33 0.00 1,125.73 1,290.08 1,335.33 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,335.33 0.00 1,335.33 0.00 1,125.73 1,290.08 1,335.33 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,332.00 0.00 1,332.00 0.00 1,122.93 1,286.86 1,332.00 0.00 0.00 0.00 2.00 0.00 49.00 37.00 21.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 550.16 0.00 550.16 0.00 463.80 531.51 550.16 0.00 0.00 0.00 0.00 0.00 2.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 550.16 0.00 550.16 0.00 463.80 531.51 550.16 0.00 0.00 0.00 0.00 0.00 12.00 3.00 3.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 550.16 0.00 550.16 0.00 463.80 531.51 550.16 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 550.16 0.00 550.16 0.00 463.80 531.51 550.16 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 548.79 0.00 548.79 0.00 462.65 530.19 548.79 0.00 0.00 0.00 0.00 0.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,057.47 0.00 1,057.47 0.00 891.48 1,021.63 1,057.47 0.00 0.00 0.00 0.00 0.00 11.00 15.00 2.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,057.47 0.00 1,057.47 0.00 891.48 1,021.63 1,057.47 0.00 0.00 0.00 0.00 0.00 5.00 0.00 5.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,057.47 0.00 1,057.47 0.00 891.48 1,021.63 1,057.47 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,057.47 0.00 1,057.47 0.00 891.48 1,021.63 1,057.47 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,057.47 0.00 1,057.47 0.00 891.48 1,021.63 1,057.47 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,057.47 0.00 1,057.47 0.00 891.48 1,021.63 1,057.47 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,057.47 0.00 1,057.47 0.00 891.48 1,021.63 1,057.47 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,054.83 0.00 1,054.83 0.00 889.26 1,019.08 1,054.83 0.00 0.00 0.00 0.00 0.00 7.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,037.75 0.00 1,037.75 0.00 874.86 1,002.58 1,037.75 0.00 0.00 0.00 22.00 0.00 536.00 320.00 229.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,037.75 0.00 1,037.75 0.00 874.86 1,002.58 1,037.75 0.00 1.00 0.00 22.00 0.00 961.00 569.00 317.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,037.75 0.00 1,037.75 0.00 874.86 1,002.58 1,037.75 0.00 0.00 0.00 0.00 0.00 2.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,037.75 0.00 1,037.75 0.00 874.86 1,002.58 1,037.75 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,037.75 0.00 1,037.75 0.00 874.86 1,002.58 1,037.75 0.00 0.00 0.00 6.00 0.00 287.00 194.00 92.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,037.75 0.00 1,037.75 0.00 874.86 1,002.58 1,037.75 0.00 0.00 0.00 0.00 0.00 6.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n 1,037.75 0.00 1,037.75 0.00 874.86 1,002.58 1,037.75 0.00 0.00 0.00 0.00 0.00 4.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n Exhibit 23 Updated by DFS 3/20/2020 18\", \"page_fill_runs\": [], \"page_lines\": 114}", "page": null, "expected_markdown": null, "tags": ["real", "kind:line"]} {"pdf": "docs/real/Exhibit_D_Gift-Loan_Disclosure_p1.pdf", "category": "real", "id": "Exhibit_D_Gift-Loan_Disclosure_p1", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" Exhibit D\\nDISCLOSURE FORM FOR LOANS OR GIFTS TO PLAYERS\\n\\n INSTRUCTIONS an email to rguerra@mlbpa.org with a cc to agent.reg@mlbpa.org.\\n To ensure a quick determination of your request, please include\\n Section 5(B)(5)(a) of the MLBPA's Agent Regulations prohibit Player information concerning the purpose for the loan, the terms of the\\n Agents and Applicants for certification from providing any gifts or loan, how long you have represented this player, and a copy of the\\n loans of money or any other thing of value with an aggregate value Player Agent designation form.\\n exceeding $500.00 in any calendar year to any professional or amateur\\n player, or his relatives or associates, unless the Player Agent or Gifts should be disclosed prior to being made, if practicable, or as\\n Applicant represents that player, the purpose and terms of each gift or soon thereafter but no more than 48 hours thereafter.\\n loan are disclosed in writing to the MLBPA, and the MLBPA does not Use this form to disclose any loans or gifts exceeding $500.00 in the\\n determine that the gift or loan is prohibited. aggregate during this calendar year which you, the agency you\\n In 2013, the Agent Regulations were amended to require the Players represent, or anyone else on your behalf, intends to make (or has\\n Association's prior written approval before lending money to a player. made) to any player you represent, or any of his relatives or\\n associates. Please send the completed form as an attachment to an e-\\n An Agent may submit a request to make a loan to a player by sending mail message addressed to AGENT.REG@MLBPA.ORG.\\n ________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________\\n\\n I, __________________________________________ of ___________________________________ hereby disclose to the MLBPA,\\n (Your full name) (Your Agency)\\n the loan(s) or gift(s) described below, which I or my firm or associate(s) intend to provide or which have already been provided, to a\\n professional player I represent, or to persons related to or associated with the player.\\n This form is to disclose (Check one):  a GIFT that I intend or have promised to give\\n  a LOAN that I intend or have promised to give\\n  a GIFT I have already given.\\n  a loan I have already made.\\n If the gift or loan has already been made, please state the date it was given and explain why advance disclosure could not be made:\\n\\n ____________________________________________________________________________________________________________\\n\\n The gift or loan recipient is: ___________________________________________, who at the time of the gift or loan was or will be:\\n (full name)\\n  a professional player represented by me\\n (check one)  a relative or associate of player ___________________________________________________\\n (full name)\\n  a Charitable organization associated with player _____________________________________\\n (full name)\\n Value of this loan or gift: $_______________________________ Date of this loan or gift:______________________________\\n Total value of the loan(s) or gift(s) to recipient to date this calendar year: $ _______________________________________________\\n\\n Purpose of this gift or loan: _____________________________________________________________________________________\\n\\n This loan or gift consists of: Money (cash, currency, checks, etc.)\\n Other thing(s) of value ____________________________________________________________\\n (Describe merchandise, services or other things of value provided)\\n\\n If a loan, what are its terms? Repayment date or repayment schedule: _________________________________________________\\n Interest rate: _______________________________________________________________________\\n Other terms and conditions of loan:_____________________________________________________\\n _________________________________________________________________________________\\n A copy of any agreement, promissory note, receipt or other written document providing for, describing or relating to the loan or\\n gift must be submitted along with this form.\\n Your Signature________________________________________ Date ______________\\n _____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________\\n For Official Use Only\\n Loan Approved or Disapproved on ________________ Method of Notification _________________________ Date ________\", \"page_fill_runs\": [272, 42, 35, 43, 51, 37, 31, 30, 47, 85, 60, 49, 71, 53, 81, 40, 14, 269, 16, 25], \"page_lines\": 50}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:underscore"]} {"pdf": "docs/real/FDA-2017-E-6698-0001_attachment_1_p79.pdf", "category": "real", "id": "FDA-2017-E-6698-0001_attachment_1_p79", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" 111111111111111~ 1111111111111111111111111111111111111111111111111111111111\\n US007799900B2\\n\\n c12) United States Patent (10) Patent No.: US 7,799,900 B2\\n Adams et al. (45) Date of Patent: Sep.21,2010\\n\\n (54) IM:viU:\\\\\\\"OGLOBULIN VARIANTS AND USES 6,224,866 BI 5!2001 Barbera-Guillem\\n THEREOF 6,242,195 Bl 6i2001 lc\\\\usogie et aL\\n 6,267,958 BI • 7/2001 Andyaet a!.\\n (75) Inventors: Camellia W. Adams, San Jose, CA 6,287,537 BI 9!2001 Kaminski et al.\\n (US); Andrew C. Chan, Menlo Park, 6,306,393 B I 10!2001 Goldenberg\\n CA (US); Craig W. Crowley, Portola 6,368,596 B I 4/2002 Ghetie et al.\\n Valley, CA (US); Henry B. Lowman, EI 6,399,061 BI 6/2002 Anderson et al.\\n Granada, CA (US); Gerald R. 6,410,391 Bl 6/2002 Zelsacher\\n Nakamura, San Francisco, CA (US); 6,455,043 Bl 9!2002 Grillo-Lopez\\n Leonard G. Presta, San Fraucisco, CA 6,528,624 Bl 3/1003 ldusogie et al.\\n (US) B I 3!2003 ldusogie et al. 6,538, 124\\n (73) Assignee: Genentech, Inc., South San Francisco, 6,565,827 Bl 5!2003 Kaminski et al.\\n . ) CA (US) 6,652,852 Bl 11!2003 Robinson et al.\\n 6,682,734 Bl 1/2004 Anderson et al.\\n ( Notice: Subject to any disclaimer, the term of this 6,737,056 Bl 5!2004 Presta\\n patent is extended or adjusted under 35 7,416,727 B2 8/2008 Presta\\n U.S.C. 154(b) by 394 days. 2001!0018041 AI 8/2001 Hanna et al.\\n 2001/0056066 A I 12!2001 Bugelski et al.\\n (21) Appl. No.: 11/147,780 2002!0004587 A I 1/2002 Miller eta!.\\n (22) Filed: Jun.7,2005 2002/0006404 A I 1!2002 Hanna et al.\\n 2002!0009427 A I 1/2002 Wolin el a!.\\n (65) Prior Publication Data 2002/0009444 A I 1/2002 Grillo-Lopez\\n 2002!00 12665 A I 1!2002 Hanna\\n US 2006/0034835 AI Feb. 16,2006 2002!0041847 AI 4/2002 Goldenberg\\n Related U.S. Application Data 2002!0058029 A I 5/2002 Hanna\\n 2002/0128448 AI 9/2002 Reff\\n (63) Continuation of application No. PCT/US03/40426, 2002!0128~88 AI 9i2007 Yamakawa et al.\\n filed on Dec. 16, 2003. 2002!0136719 AI 9/2002 Shenoy et al.\\n (60) Provisional application No. 60/434,115, filed on Dec. 2002/0197255 AI 12!2002 Anderson et al.\\n 16, 2002, provisional application No. 60/526,163, 2002/0197256 AI 12!2002 Grewal\\n filed on Dec. I, 2003. 2003/0021781 AI Ii2003 Anderson et al.\\n (51) Int. Cl. 2003/002680 I A I 2!2003 Weineret al.\\n Cl2P 21108 (2006.01)\\n (52) U.S. Cl ............... 530/387.3; 530/350; 530/388.85;\\n 530/39l.l; 530/391.3; 530/391.7 (Continued)\\n (58) Field of Classification Search .............. 530/387.3, FOREIGN PATENT DOCUMENTS\\n 530/350,388.85,391.1,391.3,391.7\\n See application file for complete search history. EP 0 332 865 A2 9t1989\\n (56) References Cited\\nU.S. PATENT DOCUMENTS\\n 4.S61,579 A 811989 :vi eyer et al. (Continued)\\n 5.500,362 A 311996 Robinson et al. OTHER PUBLICATIONS\\n 5,576,195 A 1111996 Robinson et al.\\n 5.595,721 A 1/1997 Kaminski et al. Campbell ct a! (Blood Reviews, 17:143-152, 2003)0\\n 5,677,180 A 1011997 Robinson et al.\\n 5,721,108 A 211998 Robinson ct al. (Continued)\\n 5,736,137 A 411998 Anderson et al.\\n 5,776,456 A 711998 Anderson et al. Primary Examiner-Stephen L Rawlings\\n 5,821J37 A • 10/1998 Carteret al. Assistant Examiner-Brad DuffY\\n 5,843,398 A 1211998 Kaminski et al. (74) Allorney, Agent, or Firm-Morrison & roerster LLP\\n 5.843,439 A 1211998 Anderson et al.\\n 5.846,818 A 1211998 Robinson et a!. (57) ABSTRACT\\n 5.849,898 A 1211998 Seed et al.\\n 5.859,205 A • 111999 Adaire! al.\\n 6,015,542 A 1!2000 Kaminski et al. The invention provides humani7.cd and chimeric anti-CD20\\n 6.090,365 A 712000 Kaminski et al. antibodies for treatment of CD20 positive malignancies and\\n 6.1 70,7n7 A 912000 Robinson et al. nutoinunune diseases.\\n 6.171,586 Bl 112001 Lam eta!.\\n 6.194,551 Bl 212001 ldusogie et al.\\n 6.204,023 B I 312001 Robinson et al. 19 Claims, 25 Drawing Sheets\", \"page_fill_runs\": [15, 14], \"page_lines\": 64}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:digit"]} {"pdf": "docs/real/G.R.-NO.-260233-and-266039-1-57_p1.pdf", "category": "real", "id": "G.R.-NO.-260233-and-266039-1-57_p1", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" Supreme Court of the Philippines\\n OFFICE OF THE SPOKESPERSON\\n\\n B;'= r/if \\\"1\\n Date: !/~= Time: ,S7:<73.\\n ~epublic of tbe ~bilippin Document Control No.'\\n~upreme \\n ttinclude \\n ttinclude \\n\\n #define B_CHANNEL (int*)0x804001 /*Address of Channel B */\\n #define A_CHANNEL (int*)0x804000 /*Address of Channel A */\\n #define PRIMCTL (int*)0x808064\\n #define EXPCTL (int*)0x808060\\n #define TIME_CTL (int*)0x808030\\n #define TIME_REG (int*)0x808038\\n\\n int num_data=20; /* Num of data points required. Max=100 */\\n int period=300; /* Sample period (seconds) Max=515s */\\n long int max_value=2*32767; /* Corresponds to 6V span */\\n\\n int des_val[100]={-32767}; /* -3V */\\n FILE * fp;\\n int inA;\\n int outB;\\n int in_val[100];\\n int max_count;\\n int count;\\n int increment;\\n int i ;\\n float count_time;\\n float volts=5;\\n\\n void setup_isr();\\n void c_int01();\\n void record_data(void);\\n void reset(void);\\n void disable(void);\\n void enable(void);\\n int data_count(void);\\n void main_body(void);\\n / * = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =\\n Interrupt Routine\\n = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = * /\\n\\n void c_int01()\\n {\\n\\n *B_CHANNEL=des_val[count] « 16; /* Writes to B Channel */\\n /* B must be read first before change */\\n inA= (*A_CHANNEL) » 16; /* Reads A channel */\", \"page_fill_runs\": [65, 64, 68, 68], \"page_lines\": 49}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:equals"]} {"pdf": "docs/real/Gabriel_p6.pdf", "category": "real", "id": "Gabriel_p6", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" God's Faithfulness․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․246\\n The Sin of Unbelief․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․247\\n The Rebellion in Heaven․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․249\\n Total Submission to God․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․251\\n 17. Apparently Abandoned․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․253\\n The Early Life of Christ․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․253\\nThe Baptism․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․256\\n Sent Into the Wilderness․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․259\\nOur Danger․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․261\\n A Season of High Faith․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․261\\n The Glory Departs․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․262\\n A Difference Between Christ and Moses․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․263\\n A Time of Desperate Need․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․265\\n The Temptation․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․266\\n The Same Battle․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․268\\n 18. Perplexity and Trial․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․269\\n Christ Gives Us the Victory․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․269\\n Faith in His Power․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․271\\n Faith in His Way․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․272\\n Faith That Works by Love․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․275\\n Reacting to Pressure․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․279\\n 19. A Training for Heaven․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․282\\n God's Education Plan․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․282\\n The Time Factor․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․284\\n The Reformation Was the Beginning․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․284\\n The Stages of Education․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․287\\n A Continuing Reformation․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․289\\n The Advent Movement․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․290\\n Understanding the Objectives․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․293\\n 20. Schooling the Inner Man․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․295\\n The Removal of Earthly Support․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․295\\n The School of Adversity and Humility․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․297\\n Human Effort Required․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․303\\n Relating Correctly to Experiences․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․305\\n Enticement and Provocation․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․308\\n 21. In the Household of Jethro․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․312\\n Not by the Will of Man․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․312\\n Training Under God․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․313\\n The Influence of Jethro․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․315\\n A Man of Living Faith․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․․319\", \"page_fill_runs\": [77, 76, 67, 66, 57, 68, 88, 66, 89, 69, 77, 39, 63, 82, 81, 64, 61, 77, 80, 64, 74, 59, 72, 81, 45, 67, 62, 70, 58, 54, 52, 42, 68, 50, 60, 51, 68, 74, 69, 71], \"page_lines\": 40}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:symbol"]} {"pdf": "docs/real/HAMP-134075987_p78.pdf", "category": "real", "id": "HAMP-134075987_p78", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340067 ILS001 2024 Health Alliance InNo\\n20129IL0340070 ILS001 2024 Health Alliance InNo\\n20129IL0340070 ILS001 2024 Health Alliance InNo\\n20129IL0340070 ILS001 2024 Health Alliance InNo\\n20129IL0340070 ILS001 2024 Health Alliance InNo\\n20129IL0340070 ILS001 2024 Health Alliance InNo\\n20129IL0340070 ILS001 2024 Health Alliance InNo\\n20129IL0340070 ILS001 2024 Health Alliance InNo\\n20129IL0340070 ILS001 2024 Health Alliance InNo\", \"page_fill_runs\": [], \"page_lines\": 47}", "page": null, "expected_markdown": null, "tags": ["real", "kind:line"]} {"pdf": "docs/real/IRM-Photos_p42.pdf", "category": "real", "id": "IRM-Photos_p42", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"P38671.tif Lot A-6442 Plan 3981 - Dormitory-Buffet-Lounge - CATALINA - Int Lounge - 5/5/1934 Randall Photo #135\\nP38672.tif Lot A-6442 Plan 3981 - Dormitory-Buffet-Lounge - CATALINA - Int Lounge - 5/5/1934 Randall Photo #136\\nP38674.tif Lot A-6448 Plan 3585-A - Sleeper 10-1-2 - HIDDEN LAKE - Interior - Sections - 6/21/1934 Randall Photo #81\\nP38676.tif Lot A-6448 Plan 3585-A - Sleeper 10-1-2 - HIDDEN LAKE - Ext A/C Detail - 6/21/1934\\nP38677.tif Lot A-6448 Plan 3585-A - Sleeper 10-1-2 - HIDDEN LAKE - Ext A/C Detail - 6/21/1934\\nP38678.tif Lot A-6456 Plan 3419-A - Parlor - ROSA BONHEUR - Ext Side - 6/29/1934 Randall Photo #64\\nP38678-V2.tif Lot A-6456 Plan 3419-A - Parlor - ROSA BONHEUR - Ext Side - 6/29/1934 Randall Photo 64\\nP38679.tif Lot A-6456 Plan 3419-A - Parlor - ROSA BONHEUR - Interior - 6/29/1934 Randall Photo #68\\nP38680.tif Lot A-6456 Plan 3419-A - Parlor - ROSA BONHEUR - Interior - 6/29/1934 Randall Photo #67\\nP38682.tif Lot A-6456 Plan 3416-A - Parlor DAHLIA - Interior - 7/3/1934 Randall Photo #59\\nP38683.tif Lot A-6456 Plan 3416-A - Parlor DAHLIA - Interior - 7/3/1934\\nP38684.tif Lot A-6458 Plan 3991-A - MURRAY BAY - Ext Side 7/3/1934 Randall Photo #159\\nP38684-D.tif Lot A-6458 Plan 3991-A - MURRAY BAY - Ext Side 7/3/1934 Randall Photo 159\\nP38684-O.tif Lot A-6458 Plan 3991-A - MURRAY BAY - Ext Side 7/3/1934 Randall Photo 159\\nP38685.tif Lot A-6458 Plan 3991-A - Sleeper - Compartment-Lounge-Observation - MURRAY BAY - Interior - 7/3/1934 Randall Photo #158\\nP38686.tif Lot A-6458 Plan 3991-A - Sleeper - Compartment-Lounge-Observation - MURRAY BAY - Interior - 7/3/1934 Randall Photo #157\\nP38691.tif Lot UNK Plan 3974-D FORT DEARBORN - Ext Side - 4/8/1935\\nP38692.tif Lot Unk Plan 3974 - Sleeper Lounge - FORT DEARBORN - Ext 3/4 4/8/1935 [PCo Rebuild]\\nP38706.tif Lot A-6456 Plan 3961-B - JENNY LIND Ext Side - 6/30/1934 Randall Photo #100\\nP38789.tif Design - Lightweight Streamlined Articulated Cars - Drawing -\\nP38949.tif Lot 4858 Plan 2931-B - IC Coaches #2272 - Interior - Seats From Front - 3/16/1925\\nP39047.tif Lot A-6448 Plan 4026-A - Sleeper - 8-Section-Compartment-Restaurant - PEPPER PIKE COUNTRY CLUB - Rebuild - No Photo Data Randall Photo #191\\nP39152.tif Lot A-6432 Plan 4042 - 10-2-1 - ROCKFORD COLLEGE - Ext Side - 11/26/1934\\nP39200.tif Design - C&D 34-5483-1 Rendering of an IC 5 Car Train - no date given\\nP39201.tif Design - C&D 34-5483-2 Rendering of an IC 5 Car Train - no date given\\nP39202.tif Design - C&D 34-5483-3 Rendering of an IC 5 Car Train - no date given\\nP39203.tif Design -Rendering of an IC 5 Car Train - no date given\\nP39210.tif Lot 6464 Plan 7366 - IC Diner Lounge Observation #125 - Green Diamond - Construction - Forming Sill - 11/12/1935\\nP39211.tif Lot 6464 Plan 7366 - IC Diner Lounge Observation #125 - Green Diamond - Construction - Forming Sill - 11/12/1935\\nP39213.tif Lot 6464 Plan 7364 - IC Chair Car #123 - Green Diamond - Construction - Framing - 11/19/1935\\nP39214.tif Lot 6464 Plan 7366 - IC Diner Lounge Observation #125 - Green Diamond - Construction - Underframe - 11/26/1935\\nP39216.tif Lot 6464 Plan 7364 - IC Chair Car #123 - Green Diamond - Construction - Underframe Crossbearers - 11/26/1935\\nP39217.tif Lot 6464 Plan 7362 - IC Power Car #121 - Green Diamond - Construction - Underframe Framing - 12/10/1935\\nP39219.tif Lot 6464 Plan 7365 - IC Chair Car #124 - Green Diamond - Construction - Shell on Jacks - 12/10/1935\\nP39223.tif Lot 6464 Plan 7364 - IC Chair Car #123 - Green Diamond - Construction - Shell on Shop Trucks Outside - 1/9/1936\\nP39224.tif Lot 6464 Plan 7363 - IC Mail Baggage Car #122 - Green Diamond - Construction - Shell on Shop Trucks Outside - 1/17/1936\\nP39225.tif Lot 6464 Plan 7366 - IC Diner Lounge Observation #125 - Green Diamond - Construction - Shell on Shop Trucks Outside - 1/22/1936\\nP39230.tif Lot 6464 Plan N/A - Green Diamond - Truck #3 - Broad View - 2/17/1936 - 23651-1\\nP39233.tif Lot 6464 Plan N/A - Green Diamond - Truck #5 - 3/4 View - 2/17/1936 - 23648-1\\nP39234.tif Lot 6464 Plan N/A - Green Diamond - Truck #6 - Broad View - 2/17/1936\\nP39235.tif Lot 6464 Plan N/A - Green Diamond - Truck #6 - 3/4 View - 2/17/1936 - 23651-1\\nP39264.tif Lot Unk Plan 4036-B - Sleeper 8-5 - CLOVER BLUFF - Exterior Side - 11/6/1935\\nP39314.tif Lot 6429 7348 CSL 4001 Streamlined - Construction - BP\\nP39400.tif Lot A-6465 Plan 3410 - Sleeper 12-1 - ORANGE COUNTY - Ext Side - 1/30/1935 Randall Photo #32\\n Lot A-6465 Plan 3410 - Sleeper 12-1 - ORANGE COUNTY - Ext Side -\\n 1/30/1935xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx\\nP39400-V2.tif xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx Randall Photo 32\", \"page_fill_runs\": [], \"page_lines\": 47}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:letter"]} {"pdf": "docs/real/ISO-3452-1-2021-fr_p3.pdf", "category": "real", "id": "ISO-3452-1-2021-fr_p3", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"ISO 3452-1:2021(F)\\n\\n\\nSommaire Page\\n\\nAvant-propos................................................................................................................................................................................................................................v\\n1 Domaine d'application ...................................................................................................................................................................................1\\n2 Références normatives...................................................................................................................................................................................1\\n3 Termes et définitions .......................................................................................................................................................................................2\\n4 Mesures de sécurité...........................................................................................................................................................................................2\\n5 Principes généraux............................................................................................................................................................................................2\\n 5.1 Personnel ..................................................................................................................................................................................................... 2\\n 5.2 Description de la méthode ............................................................................................................................................................ 2\\n 5.5 Séquence des opérations\\n 5.3 Efficacité ................................................................................................................................................................ 2\\n 5.4 ................................................................................................................................................................................................ 3\\n ....................................................................................................................................................................................................... 3\\n6 Produits, sensibilité et désignation ..................................................................................................................................................3\\n 6.1 Famille de produits.............................................................................................................................................................................. 3\\n 6.2 Produits d'essai ...................................................................................................................................................................................... 3\\n 6.3 Sensibilité .................................................................................................................................................................................................... 4\\n 6.4 Désignation ................................................................................................................................................................................................ 4\\n7 Compatibilité............................................................................................................................................................................................................4\\n 7.1 Généralités .................................................................................................................................................................................................. 4\\n 7.2 Compatibilité des produits de ressuage ............................................................................................................................ 4\\n 7.3 Compatibilité des produits de ressuage avec le matériau à examiner .................................................... 5\\n8 Mode opératoire d'essai................................................................................................................................................................................5\\n 8.1 Mode opératoire écrit ....................................................................................................................................................................... 5\\n 8.2 Nettoyage préalable ............................................................................................................................................................................ 5\\n 8.2.1 Généralités ............................................................................................................................................................................ 5\\n 8.2.2 Nettoyage mécanique préliminaire ................................................................................................................. 5\\n 8.2.3 Nettoyage chimique préliminaire ...................................................................................................................... 6\\n 8.2.4 Séchage ..................................................................................................................................................................................... 6\\n 8.3 Température .............................................................................................................................................................................................. 6\\n 8.4 Application du pénétrant ............................................................................................................................................................... 6\\n 8.4.1 Méthodes d'application .............................................................................................................................................. 6\\n 8.4.2 Durée de pénétration ................................................................................................................................................... 6\\n 8.5 Élimination de l'excès de pénétrant ...................................................................................................................................... 6\\n 8.5.1 Généralités ............................................................................................................................................................................ 6\\n 8.5.2 Eau ................................................................................................................................................................................................ 6\\n 8.5.3 Solvants .................................................................................................................................................................................... 7\\n 8.5.6 7\\n 8.5.5 Eau et solvant 7\\n ....................................................................... 7\\n 8.5.7 Séchage après élimination de l'excès de pénétrant ........................................................................... 7\\n 8.6 Révélation .................................................................................................................................................................................................... 8\\n 8.6.1 Généralités ............................................................................................................................................................................ 8\\n 8.6.2 Révélateur sec .................................................................................................................................................................... 8\\n 8.6.3 Révélateur en suspension dans l'eau.............................................................................................................. 8\\n 8.6.4 Révélateur à base de solvant ................................................................................................................................. 9\\n 8.6.5 Révélateur hydrosoluble ........................................................................................................................................... 9\\n 8.6.6 Révélateur à base d'eau ou de solvant pour applications spéciales (par\\n exemple révélateur pelable) .................................................................................................................................. 9\\n 8.6.7 Sans révélateur (uniquement pour le type I) .......................................................................................... 9\\n 8.7 Examen .......................................................................................................................................................................................................... 9\\n 8.7.1 Généralités ............................................................................................................................................................................ 9\\n 8.7.2 Conditions d'observation ......................................................................................................................................10\\n 8.7.3 Technique de levée de doute ..............................................................................................................................10\\n\\n© ISO 2021 - Tous droits réservés iii\", \"page_fill_runs\": [224, 179, 179, 183, 187, 188, 197, 156, 160, 192, 199, 146, 174, 182, 196, 192, 204, 194, 124, 52, 176, 167, 172, 172, 113, 118, 181, 190, 159, 142, 147, 134, 172, 192, 180, 71, 75, 196, 172, 164, 110, 129, 139, 130, 90, 202, 172, 134, 126], \"page_lines\": 56}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:dot"]} {"pdf": "docs/real/ISO-3452-2-2021-en_p3.pdf", "category": "real", "id": "ISO-3452-2-2021-en_p3", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"ISO 3452-2:2021(E)\\n\\n\\n\\nContents Page\\n\\nForeword..........................................................................................................................................................................................................................................v\\n1 Scope .................................................................................................................................................................................................................................1\\n2 Normative references......................................................................................................................................................................................1\\n3 Terms and definitions .....................................................................................................................................................................................1\\n4 Classification\\n 4.2 ............................................................................................................................................................................................................2\\n 4.1 Testing products .................................................................................................................................................................................... 2\\n .................................................................................................................................................................................... 2\\n\\n .............................................................................................................................. 2\\n ........................................................................................................................................ 2\\n 4.2.6 Dual-purpose product family\\n ..................................................................................................................................................... 2\\n ............................................................................................................................................ 3\\n ................................................................................................................................ 3\\n5 Testing of penetrant materials...............................................................................................................................................................3\\n 5.2.1 Type testing 3\\n 5.1 Personnel.....................................................................................................................................................................................................\\n 5.2 Testing facilities...................................................................................................................................................................................... 3\\n .......................................................................................................................................................................... 3\\n 5.2.2 Batch testing ........................................................................................................................................................................ 3\\n 5.3.1 Process and control testing\\n 5.2.3 Type testing .................................................................................................................................... 3\\n 5.3 Reporting ..................................................................................................................................................................................................... 3\\n .......................................................................................................................................................................... 3\\n 5.3.2 Batch testing ........................................................................................................................................................................ 4\\n 5.4 Tests.................................................................................................................................................................................................................. 4\\n .................................................................................................................................................................... 4\\n 5.4.2 Penetrants.............................................................................................................................................................................. 4\\n 5.4.5 ............................................................................ 4\\n 5.4.4 Developers............................................................................................................................................................................. 5\\n ......................................................................................................................................... 5\\n 6.2 ..........................................................................................................................................................5\\n6 Test methods and requirements\\n 6.1 Appearance ................................................................................................................................................................................................ 5\\n Colour contrast penetrants (type II)\\n ....................................................................................................................................................... 6\\n 6.3 .......................................................................................................................... 6\\n ............................................................................................................... 9\\n ........................................................................................................................................................................................................10\\n 6.4 6.3.1 Requirements\\n Test method.......................................................................................................................................................................10\\n 6.4.2 Requirements ..................................................................................................................................................................10\\n .....................................................................................................................................................................................................10\\n 6.4.1 Test method.......................................................................................................................................................................10\\n ..................................................................................................................................................................10\\n Flashpoint.................................................................................................................................................................................................10\\n 6.5 6.5.2\\n 6.6 Washability (method A penetrants)\\n 6.5.1 Test method.......................................................................................................................................................................10\\n ..................................................................................................................................................................11\\n ..................................................................................................................................11\\n 6.7 Requirements .................................................................................................................................................................11\\n 6.8 6.7.1 Test method.......................................................................................................................................................................11\\n 6.8.2 Requirements ..................................................................................................................................................................11\\n ..............................................................................................................................................................................................11\\n 6.9 Thermal stability of fluorescent brightness................................................................................................................12\\n 6.8.1 Test method.......................................................................................................................................................................11\\n 6.9.2 Requirements ..................................................................................................................................................................11\\n 6.9.1 Test method.......................................................................................................................................................................12\\n ..................................................................................................................................................................12\\n\\n\\n© ISO 2021 - All rights reserved iii\", \"page_fill_runs\": [234, 225, 182, 181, 204, 180, 180, 126, 136, 149, 140, 128, 159, 197, 182, 170, 168, 132, 197, 170, 168, 210, 164, 174, 76, 173, 137, 154, 192, 151, 122, 111, 200, 167, 162, 197, 167, 162, 193, 167, 162, 130, 161, 167, 162, 190, 112, 167, 162, 167, 162], \"page_lines\": 63}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:dot"]} {"pdf": "docs/real/L16_p15.pdf", "category": "real", "id": "L16_p15", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" Weight Gain Effect\\n\\n 5 10 15 20 25 30\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n Weight Gain Effect\\n\\n5 10 15 20 25\\n\\n\\n\\n\\n\\n\\n Weight\\n Gain\\n Effect 8\\n 9\\n 10\\n 11\\n 12\\n 13 Weight\\n Gain\\n Effect 7.5\\n 8.5\\n 9.5\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n 15\\n\\n\\n Mother's Weight Gain 15 Lbs Mother's Weight Gain 22 Lbs\\n\\n • •\\n\\n\\n\\n\\n • •\\n • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •\\n\\n 0.2 0.4 0.6 0.8 0.2 0.4 0.6 0.8\\n\\n Quantile Quantile\\n\\n\\n Mother's Weight Gain 39 Lbs Mother's Weight Gain 47 Lbs\\n\\n • • •\\n\\n •\\n •\\n • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •\\n\\n 0.2 0.4 0.6 0.8 0.2 0.4 0.6 0.8\\n\\n Quantile Quantile\\n\\n Figure 6. Mother's Weight Gain Marginal Effect: The marginal effect of the mother's weight\\n gain, again parameterized as a quadratic effect, tends to decrease over the entire range of the\\n conditional distibution of birthweights. Thus incremental weight gain is most influential in\\n increasing the weight of low birthweight infants. But for mothers with unusually large weight\\n gains, this pattern is reversed and effect is largest in the upper tail of the conditional birthweight\\n distribution.\", \"page_fill_runs\": [34, 33], \"page_lines\": 36}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:symbol"]} {"pdf": "docs/real/LRG_User_Manual_p2.pdf", "category": "real", "id": "LRG_User_Manual_p2", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" Safety andwarnings\\n\\n\\nLRG Range Manuals\\n1. Warnings.........................................................................................................................................................................................................4\\n2. Welcome.........................................................................................................................................................................................................5\\n3. Before you start ............................................................................................................................................................................................6\\n4. Safety and Warnings ..................................................................................................................................................................................7\\n Safety Symbols ......................................................................................................................................................................................................7\\n Tipping Hazard .......................................................................................................................................................................................................8\\n Explosion Hazard ...................................................................................................................................................................................................9\\n Fire Hazard.............................................................................................................................................................................................................9\\n Poisoning Hazard................................................................................................................................................................................................ 10\\n Hot SurfaceHazard ............................................................................................................................................................................................. 10\\n Other Safety Tips ................................................................................................................................................................................................ 10\\n5. Gas Supply Requirements .................................................................................................................................................................... 12\\n Safety Tips for Gas Operation............................................................................................................................................................................ 12\\n6. Dimensions and Clearances................................................................................................................................................................. 13\\n BTU Design.......................................................................................................................................................................................................... 14\\n Top Hood and cabinet specifications ................................................................................................................................................................ 21\\n7. Electric Power Supply Requirements ................................................................................................................................................ 23\\n8. Electrical Grounding Instructions........................................................................................................................................................ 26\\n9. Connect Range to GasSupply.............................................................................................................................................................. 26\\n After installation: ................................................................................................................................................................................................ 27\\n 10. First Use........................................................................................................................................................................................................ 28\\n Conditioning the oven......................................................................................................................................................................................... 28\\n11. Cooktop Safety Guidelines................................................................................................................................................................ 28\\n Surface BurnerIgnition ....................................................................................................................................................................................... 29\\n Simmer and Boil ................................................................................................................................................................................................. 30\\n Flame Size........................................................................................................................................................................................................... 30\\n Power Failure ...................................................................................................................................................................................................... 30\\n Cooktop ............................................................................................................................................................................................................... 30\\n Burner Grates...................................................................................................................................................................................................... 30\\n Oven burner use.................................................................................................................................................................................................. 30\\n Broil burner use .................................................................................................................................................................................................. 30\\n Oven cookingguidelines ..................................................................................................................................................................................... 30\\n12. Oven Function ......................................................................................................................................................................................... 32\\n Natural AirflowBake ........................................................................................................................................................................................... 32\\n Infrared Broil ....................................................................................................................................................................................................... 32\\n Convection Bake................................................................................................................................................................................................. 32\\n Convection Roast................................................................................................................................................................................................ 33\\n Convection Defrost ............................................................................................................................................................................................. 33\\n Defrosting............................................................................................................................................................................................................ 33\\n Convection Dehydration..................................................................................................................................................................................... 33\\n 13. Broiler Operation......................................................................................................................................................................................... 34\\n Preheating........................................................................................................................................................................................................... 34\\n To Broil................................................................................................................................................................................................................. 34\\n Setting Broil......................................................................................................................................................................................................... 34\\n Broiling guidelines ............................................................................................................................................................................................ 35\\n For the models with Griddle ............................................................................................................................................................................ 35\\n 2\", \"page_fill_runs\": [201, 201, 188, 178, 198, 199, 195, 205, 192, 189, 192, 164, 172, 161, 202, 160, 144, 152, 158, 192, 200, 185, 160, 183, 193, 203, 198, 207, 198, 194, 194, 181, 185, 187, 199, 193, 192, 189, 204, 181, 185, 203, 209, 201, 188, 172], \"page_lines\": 49}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:dot"]} {"pdf": "docs/real/LandmarksPaper_p20.pdf", "category": "real", "id": "LandmarksPaper_p20", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" B\\n\\n L P Q R\\n 1 y τ x\\n e O\\n 1 e\\n S\\n A\\n 0 τ π\\n e e\\nFig. 3.2. Wren's contracted cycloid; upper right: Newton's picture from the Principia, Prop. 31.\\n\\n All these corrections together, 2 + p + q + r = 2.09455148, give an excellent approxi-\\n mation for the root. If we continue like this with high precision, we obtain a \\\"so very\\n fast\\\" convergence (see the Newton quote in the next subsection after equation (3.6)):\\n\\n 2.100000000000000000000000000000000000000000000000000000000000000000000000000000000\\n 2.094568121104185218165627782724844167408726625111308993766696349065004452359750668\\n 2.094551481698199302883823703544265865480663245555184701899797299345913774193982985 (3.5)\\n 2.094551481542326591496064847153713995469461240058543407800340846337222863834424107\\n 2.094551481542326591482386540579302963857411436776905586271895363800201413283382167\\n 2.094551481542326591482386540579302963857306105628239180304128529045312189983483673\\n\\n 3.2. Newton and Wren's Graphical Solution of Kepler's Problem.\\n \\\"It is extraordinary how much Kepler sweated over this problem --\\n volvens nitendo neque proficit hilum13 . Finally, out of breath, he implored\\n the help of geometers; meanwhile fearing that on account of the hetero-\\n geneity of arcs and sines the problem would be found insoluble. Which\\n nonetheless by the help of the contracted cycloid (\\\"Cycloidis protractæ\\\")\\n traced out we resolved some time ago as follows.\\\"\\n (Wallis [175, p. 80 (72)], trans. [179, pp. 127-128])\\n The famous architect Christopher Wren (1632-1723) discovered that, if the time\\n 2π t = e sin τ + τ from Kepler's law (2.12) is properly scaled and \\\"traced out\\\" against\\n T\\n the distance LO = y = cos τ in Fig. 2.4, we obtain\\n x = 2π t = sin τ + 1 τ , y = cos τ .\\n T e e\\n Here the first term in the expression of x constitutes a circular movement of radius 1,\\n while the second term is a linear movement 1 e times faster than the rotational speed.\\n This curve is thus a contracted cycloid and constitutes a graphical solution to Kepler's\\n Problem (see Fig. 3.2). Wren concludes: \\\"since the cycloid is a mechanical line, non\\n geometric, the problem is not really solved but mechanically finished\\\" [175, p. 82 (74)].\\n Wren' solution was published at the end of John Wallis' treatise on the cycloid\\n [175, pp. 80-81 (72-73)] and republished by Newton (without mentioning Wren) in\\n\\n 13An allusion to Cicero's Tusculanae Disputationes, desrcibing the vain efforts of Sisyphus\\n 20\", \"page_fill_runs\": [], \"page_lines\": 42}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:digit"]} {"pdf": "docs/real/MB85RS1MT-DS9v1-E_p33.pdf", "category": "real", "id": "MB85RS1MT-DS9v1-E_p33", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"MB85RS1MT\\n\\n\\n1.3 IC Orientation\\n\\n Index mark\\n IC\\n\\n 3URGXFW IC)\\n \\u00037UD\\\\\\n &KDPIHUHG\\u0003FRUQHU\\n\\n\\n\\n1.4 Product label indicators (an example)\\nLabel on Inner box/Moisture Barrier Bag\\n [C-3 Label (50mm x 100mm) Supplemental Label (20mm x 100mm)]\\n XXXXXXXXXXXXXX (Part number) C-3 Label\\n (3N)1 XXXXXXXXXXXXXX XXX (LEAD FREE mark)\\n (Part number and quantity)\\n QC PASS\\n (3N)2 XXXXXXXXXX XXXXXX\\n (Control number bar code)\\n\\n XXX pcs (Quantity)\\n XXXXXXXXXXXXXX (Part number)\\n (Part number bar code)\\n XXXX/XX/XX (Packed years/month/day) ASSEMBLED IN xxxx Perforated line\\n XXXXXXXXXXXXXX (Part number) Supplemental Label\\n (Control number bar code)\\n XX/XX XXXX-XXX XXX\\n (Package count) XXXX-XXX XXX\\n XXXXXXXXXX (Control number ) (Lot Number and quantity)\\n XXXXXXXXXXXXXX (Comment)\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nDS501-00022-9v1-E 33\", \"page_fill_runs\": [], \"page_lines\": 27}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:letter"]} {"pdf": "docs/real/MB85RS2MTY-DS3v1-E_p29.pdf", "category": "real", "id": "MB85RS2MTY-DS3v1-E_p29", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" MB85RS2MTY\\n\\n\\n 1.2 Product label indicators (example)\\n Label I: Label on Inner box/Moisture Barrier Bag/ (It sticks it on the reel for the emboss taping)\\n [C-3 Label (50mm  100mm) Supplemental Label (20mm  100mm)]\\n\\n XXXXXXXXXXXXXX (Customer part number or FJ part number)\\n (3N)1 XXXXXXXXXXXXXX XXX (LEAD FREE mark) C-3 Label\\n (Part number and quantity)\\n QC PASS\\n (3N)2 XXXXXXXXXX XXXXXX\\n (FJ control number)\\n\\n XXX pcs (Quantity)\\n XXXXXXXXXXXXXX (Customer part number or FJ part number)\\n (Customer part number or FJ part number\\n bar code)\\n XXXX/XX/XX (Packed years/month/day) ASSEMBLED IN xxxx Perforated line\\n XXXXXXXXXXXXXX (Customer part number or FJ part number) Supplemental Label\\n (FJ control number bar code)\\n XX/XX XXXX-XXX XXX\\n(Package count) XXXX-XXX XXX\\n XXXXXXXXXX (FJ control number ) (Lot Number and quantity)\\n XXXXXXXXXXXXXX (Comment)\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n DS501-00063-3v1-E 29\", \"page_fill_runs\": [], \"page_lines\": 22}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:letter"]} {"pdf": "docs/real/MI_05_2023_601680_1596048_p271.pdf", "category": "real", "id": "MI_05_2023_601680_1596048_p271", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" Profit and Contingencies Provision\\n Homeowners\\n\\n Year 0.00 0.25 0.50 0.75 1.00 1.25 1.50 1.75 2.00 2.25 2.50 2.75 3.00 3.25 3.50 3.75 4.00 4.25 4.50 4.75 5.00\\n Earned Premium 0.000 0.250 0.500 0.750 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n UEPR 1.000 0.750 0.500 0.250 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000\\n Investable UEPR 0.350 0.263 0.175 0.088 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000\\n Loss+ LAE 0.000 0.163 0.325 0.488 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650\\n Loss% Paid 0.0% 32.4% 53.5% 69.7% 75.2% 87.0% 91.6% 94.9% 96.3% 97.2% 97.8% 98.4% 98.9% 99.0% 99.2% 99.3% 99.5% 99.7% 99.8% 99.8% 99.9%\\n L+LAE Reserves 0.000 0.110 0.151 0.148 0.161 0.084 0.054 0.033 0.024 0.018 0.014 0.011 0.007 0.006 0.005 0.004 0.004 0.002 0.001 0.001 0.001\\n Total Reserves 1.000 0.860 0.651 0.398 0.161 0.084 0.054 0.033 0.024 0.018 0.014 0.011 0.007 0.006 0.005 0.004 0.004 0.002 0.001 0.001 0.001\\n UW Capital 0.363 0.363 0.363 0.363 - - - - - - - - - - - - - - - - -\\n Reserve Capital - 0.021 0.029 0.028 0.031 0.016 0.010 0.006 0.005 0.003 0.003 0.002 0.001 0.001 0.001 0.001 0.001 0.000 0.000 0.000 0.000\\n Investment Capital 0.084 0.089 0.084 0.074 0.023 0.012 0.008 0.005 0.003 0.003 0.002 0.001 0.001 0.001 0.001 0.001 0.000 0.000 0.000 0.000 0.000\\n Total Capital 0.447 0.473 0.477 0.465 0.053 0.028 0.018 0.011 0.008 0.006 0.005 0.004 0.002 0.002 0.002 0.001 0.001 0.001 0.000 0.000 0.000\\n Investable Assets 0.797 0.846 0.803 0.700 0.214 0.112 0.072 0.044 0.032 0.024 0.019 0.014 0.010 0.008 0.007 0.006 0.005 0.003 0.002 0.002 0.001\\n Investment Income - 0.009 0.009 0.008 0.007 0.002 0.001 0.001 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000\\n UW Expenses 0.093 0.054 0.054 0.054 0.054 - - - - - - - - - - - - - - - -\\n UW Income (0.093) 0.034 0.034 0.034 0.034 - - - - - - - - - - - - - - - -\\n Equity Flow Pre Tax (0.540) 0.016 0.039 0.053 0.453 0.027 0.011 0.008 0.003 0.002 0.002 0.001 0.001 0.000 0.000 0.000 0.000 0.001 0.000 0.000 0.000\\nEquity Flow Post Tax (0.520) 0.007 0.030 0.044 0.444 0.027 0.011 0.007 0.003 0.002 0.002 0.001 0.001 0.000 0.000 0.000 0.000 0.001 0.000 0.000 0.000\\n\\n\\n Year 5.25 5.50 5.75 6.00 6.25 6.50 6.75 7.00 7.25 7.50 7.75 8.00 8.25 8.50 8.75 9.00 9.25 9.50 9.75 10.00 10.25\\n Earned Premium 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n UEPR 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000\\n Investable UEPR 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000\\n Loss+ LAE 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650\\n Loss% Paid 99.9% 99.9% 99.9% 99.9% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%\\n L+LAE Reserves 0.001 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000\\n Total Reserves 0.001 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000\\n UW Capital - - - - - - - - - - - - - - - - - - - - -\\n Reserve Capital 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000\\n Investment Capital 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000\\n Total Capital 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000\\n Investable Assets 0.001 0.001 0.001 0.001 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000\\n Investment Income 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000\\n UW Expenses - - - - - - - - - - - - - - - - - - - - -\\n UW Income - - - - - - - - - - - - - - - - - - - - -\\n Equity Flow Pre Tax 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000\\n Equity Flow Post Tax 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000\\n\\n Year 10.50 10.75 11.00 11.25 11.50 11.75 12.00 12.25 12.50 12.75 13.00 13.25 13.50 13.75 14.00 14.25 14.50 14.75 15.00 15.25 15.50\\n Earned Premium 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n UEPR 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000\\n Investable UEPR 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000\\n Loss+ LAE 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650\\n Loss% Paid 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%\\n L+LAE Reserves 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000\\n Total Reserves 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000\\n UW Capital - - - - - - - - - - - - - - - - - - - - -\\n Reserve Capital 0.000 0.000 0.000 0.000 0.000 0.000 (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000)\\n Investment Capital 0.000 0.000 0.000 0.000 0.000 0.000 (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000)\\n Total Capital 0.000 0.000 0.000 0.000 0.000 0.000 (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000)\\n Investable Assets 0.000 0.000 0.000 0.000 0.000 0.000 (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000)\\n Investment Income 0.000 0.000 0.000 0.000 0.000 0.000 0.000 (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000)\\n UW Expenses - - - - - - - - - - - - - - - - - - - - -\\n UW Income - - - - - - - - - - - - - - - - - - - - -\\n Equity Flow Pre Tax 0.000 0.000 (0.000) (0.000) (0.000) 0.000 0.000 (0.000) (0.000) (0.000) 0.000 (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000)\\n Equity Flow Post Tax 0.000 0.000 (0.000) (0.000) (0.000) 0.000 0.000 (0.000) (0.000) (0.000) 0.000 (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000)\\n\\n Year 15.75 16.00 16.25 16.50 16.75 17.00 17.25 17.50 17.75 18.00 18.25 18.50 18.75 19.00 19.25 19.50 19.75 20.00\\n Earned Premium 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000\\n UEPR 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 IRR Pre-Tax 15.0%\\n Investable UEPR 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000\\n Loss+ LAE 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 0.650 IRR Post Tax 12.0%\\n Loss% Paid 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%\\n L+LAE Reserves 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Target Combined Ratio\\n Total Reserves 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Net 95.9%\\n UW Capital - - - - - - - - - - - - - - - - - - Direct 92.0%\\n Reserve Capital (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) -\\n Investment Capital (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) -\\n Total Capital (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) -\\n Investable Assets (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) -\\n Investment Income (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000)\\n UW Expenses - - - - - - - - - - - - - - - - - -\\n UW Income - - - - - - - - - 15 - - - - - - - - -\\n Equity Flow Pre Tax (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000)\\n Equity Flow Post Tax (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000)\", \"page_fill_runs\": [17, 16, 16, 21, 21, 21, 21, 21, 21, 18, 18], \"page_lines\": 74}", "page": null, "expected_markdown": null, "tags": ["real", "kind:word"]} {"pdf": "docs/real/ML20087K371_p74.pdf", "category": "real", "id": "ML20087K371_p74", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"_ __ _ _ _ _ _ _ _ _._ _ _ _ _ _ _ _ __ _ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n 5 mil Thermocouple -= 10 mil Thermocouple -\\n\\n a%n\\n\\n| 1.5 30\\n\\n\\n\\n ._\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n _ , . . . . .\\n 46 So 76 96 110 125 146 17o 46 6o 76 96 110 125 146 170\\n\\n 6*\\n 15 mil Thermocouple ui 20 mil Thermocouple u,\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n . , , . , , , , , , , . ,\\n 4e So 7e 9e sto 12s $4s tro 48 so 7e n iio srs ie 57o\\n\\n\\n\\n\\n Figure 8.2 Comparison of Plunge and LCSR Test Results\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n - - _ - _ - -_________ -_. _.\", \"page_fill_runs\": [42, 21], \"page_lines\": 13}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:underscore"]} {"pdf": "docs/real/NIH_Guidelines_p9.pdf", "category": "real", "id": "NIH_Guidelines_p9", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" NIH is in the process of strengthening and modernizing biosafety oversight.\\nFor more details, please visit: https://osp.od.nih.gov/policies/biosafety-and-biosecurity-policy#tab2/\\n\\n Page 9 - NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (April 2024)\\n\\n Appendix M-II-C-1-f. Transfer of Materials (BL3-N) ....................................................................... 123\\n Appendix M-II-C-1-g. Other (BL3-N) ............................................................................................... 124\\n Appendix M-II-C-2. Animal Facilities (BL3-N) .............................................................................. 125\\n Appendix M-II-D. Biosafety Level 4 - Animals (BL4-N) (See Appendix M-III-C, Footnotes and\\n References for Appendix M)......................................................................... 126\\n Appendix M-II-D-1. Standard Practices (BL4-N).......................................................................... 126\\n Appendix M-II-D-1-a. Animal Facility Access (BL4-N) .................................................................... 126\\n Appendix M-II-D-1-b. Decontamination and Inactivation (BL4-N)................................................... 126\\n Appendix M-II-D-1-c. Signs (BL4-N) ............................................................................................... 127\\n Appendix M-II-D-1-d. Protective Clothing (BL4-N).......................................................................... 127\\n Appendix M-II-D-1-e. Records (BL4-N)........................................................................................... 128\\n Appendix M-II-D-1-f. Transfer of Materials (BL4-N) ....................................................................... 128\\n Appendix M-II-D-1-g. Other (BL4-N) ............................................................................................... 129\\n Appendix M-II-D-2. Animal Facilities (BL4-N) .............................................................................. 130\\n Appendix M-III. Footnotes and References for Appendix M .................................................. 131\\n\\n\\n\\n\\n\\n\\n\\n ************************************************************************************************************************\\n\\n LIST OF TABLES\\n\\n Appendix B - Table 1. Basis for the Classification of Biohazardous Agents by Risk Group .............. 39\\n\\n Appendix G - Table 1. Possible Alternate Combinations Of Physical And Biological Containment\\n Safeguards...................................................................................................... 98\\n\\n Appendix K - Table 1. Comparison of Good Large Scale Practice (GLSP) and Biosafety Level (BL) -\\n Large Scale (LS) Practice ............................................................................. 104\\n\\n ************************************************************************************************************************\", \"page_fill_runs\": [71, 95, 78, 73, 74, 68, 51, 95, 74, 91, 71, 95, 78, 50, 14, 102, 77], \"page_lines\": 26}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:star"]} {"pdf": "docs/real/NSA50YrsMathCrypt1988_p119.pdf", "category": "real", "id": "NSA50YrsMathCrypt1988_p119", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" 1 101 SLCIED! GiiB!M !MiSS!f!!S 111,.\\n 4 3 '·\\n rmicroprocessor - 7, 11\\n Ministry of Defense - 65 \\\"\\n 4 7 .\\n Moise Edwin E. - 59 I\\n I : So I. ¾, • • • • • • . . . . : • . .\\n • '. • ,: .. ..\\n , .. : I,·1 PL 86-36/50 USC 3605\\n . '. ·: .. .. •\\n i l,· • . . ::· •. .\\n I 7 · · · · · · · · · · · · ·· '... • • • • ----\\n N . 6. • . . .. PL 86-36/50 USC 3605\\n70.• . • ..\\n NEMA - 11 0 ♦♦\\n • ♦ ♦\\n .... Newman, M. H. A. - 14•. 56 . • • ♦ ♦\\n Nacke - 68 ____ r • ♦ .\\n ........\\n\\n\\n\\n i 7\\n NSA - 3, 4 , 5, 6, 8, 11 , 14 , 15, 17 , 20, 23 , 21\\n 5, 28 , 30, 60 , 37,\\n 39, 4 0, 4 1 , 4 2, 4 3, 44 , 4 5, 4 7, 48, 4 9, 50, 55, 58 , 59 , 31, 62 ,\\n NYLAND - 21 , 4 2 , 4 3 , . 7 6 -109-\\n Declassified and Approved for Re le ase by NSA on 04 - 29- 2025 pursuant to E.O. 13526, MOR Case #\\n 1144 65\", \"page_fill_runs\": [10, 14, 11], \"page_lines\": 26}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:middot"]} {"pdf": "docs/real/National_Seafood_Fraud_Testing_Results_FINAL_p3.pdf", "category": "real", "id": "National_Seafood_Fraud_Testing_Results_FINAL_p3", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"Table of Contents\\n\\nPart I: Nationwide Study\\nIntroduction>>>>>>>>>>>>>>>>>>>>>>. 4\\nMethods >>>>>>>>>>>>>>>>>>>>............ 4\\nResults and Discussion>>>>>>>>>>>>>>>>>. 5\\nTop Fish Types Collected and Mislabeled\\n By Retail Outlet >>>>>>>>>>>>>>>>>>.. 8\\n By Geographic Location >>>>>>>>>>>>......... 9\\nBy Fish:\\n Snapper >>>>>>>>>>>>>>>................ 12\\n Tuna >>>>>>>>>>>>>>>>>>>>>. 16\\n Salmon >>>>>>>>>>>>>>>>>>>> 17\\n Cod >>>>>>>>>>>>>>>>>>>>>.. 19\\n Grouper >>>>>>>>>>>>>>>>>>>> 20\\n Chilean Seabass >>>>>>>>>>>>>>>>. 22\\n Halibut >>>>>>>>>>>>>>>>>>>>. 22\\n Sole >>>>>>>>>>>>>>>>>>>>>. 23\\n Yellowtail >>>>>>>>>>>>>>>>>>> 24\\n Summary >>>>>>>>>>>>>>>>>>>>>>.. 25\\n Conclusions >>>>>>>>>>>>>>>>>>>>>. 27\\n What Consumers Can Do >>>>>>>>>>>>>>>.. 28\\nAcknowledgments >>>>>>>>>>>>>>>>>>> 28\\n\\nPart II: Regional Studies\\n\\nLarge Studies\\nPortland, OR >>>>>>>>>>>>>>>>>>>>>>>>> 29\\nSeattle, WA >>>>>>>>>>>>>>>>>>>>>>>>>. 32\\nNorthern California >>>>>>>>>>>>>>>>>>>>>>. 35\\nSouthern California >>>>>>>>>>>>>>>>>>>>>> 38\\nChicago, IL >>>>>>>>>>>>>>>>>>>>>>>>>.. 41\\nMN, WI\\nBoston, MA >>>>>>>>>>>>>>>>>>>>>>>>>. 44\\nNew York, NY >>>>>>>>>>>>>>>>>>>>>>>>. 47\\nWashington, DC >>>>>>>>>>>>>>>>>>>>>>>. 49\\nSouth Florida >>>>>>>>>>>>>>>>>>>>>>>>.. 52\\n\\nMedium Studies\\n Kansas City, MO/KS>>>>>>>>>>>>>>>>>>>>>> 55\\n Austin/Houston, TX >>>>>>>>>>>>>>>>>>>>>>. 57\\n Denver, CO >>>>>>>>>>>>>>>>>>>>>>>>>.. 59\\nSanta Fe, NM\\n\\nSmall Studies\\nAtlanta, GA >>>>>>>>>>>>>>>>>>>>>>>>>. 61\\nPittsburg, PA >>>>>>>>>>>>>>>>>>>>>>>>.. 63\\n\\nEndnotes (Part 1) >>>>>>>>>>>>>>>>>>>>>>... 65\\n\\n\\n\\n 3\", \"page_fill_runs\": [12, 16, 22, 20, 17, 18, 12, 15, 21, 20, 21, 20, 16, 20, 21, 19, 22, 21, 15, 19, 25, 25, 22, 22, 25, 25, 24, 23, 24, 22, 22, 25, 25, 24, 22], \"page_lines\": 44}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:symbol"]} {"pdf": "docs/real/Rapport-de-stage-Departement-de-francais_p7.pdf", "category": "real", "id": "Rapport-de-stage-Departement-de-francais_p7", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" 3- Evaluation de l'opération de l'apprentissage\\n\\n\\n\\n\\n 1- Donnez des exemples de questions\\nsuggestives que le maître/ professeur …………………………………………………………………………………………………………………\\nd'application propose pour aider les …………………………………………………………………………………………………………………\\n …………………………………………………………………………………………………………………\\n apprenants. …………………………………………………………………………………………………………………\\n …………………………………………………………………………………………………………………\\n\\n\\n\\n\\n2- Comment procède t'il pour poser …………………………………………………………………………………………………………………\\n la reformulation de la question à …………………………………………………………………………………………………………………\\n d'autres apprenants? …………………………………………………………………………………………………………………\\n …………………………………………………………………………………………………………………\\n …………………………………………………………………………………………………………………\\n\\n\\n\\n3- Pose t'il des questions qui …………………………………………………………………………………………………………………\\n nécessitent des réponses …………………………………………………………………………………………………………………\\n individuelles ?Précisez …………………………………………………………………………………………………………………\\n …………………………………………………………………………………………………………………\\n …………………………………………………………………………………………………………………\\n\\n\\n\\n\\n4- Que fait- il face à des réponses …………………………………………………………………………………………………………………\\nincomplètes ou insuffisantes? …………………………………………………………………………………………………………………\\n …………………………………………………………………………………………………………………\\n …………………………………………………………………………………………………………………\\n …………………………………………………………………………………………………………………\\n\\n\\n\\n\\n5- Que fait- il face à des réponses …………………………………………………………………………………………………………………\\nfausses? …………………………………………………………………………………………………………………\\n …………………………………………………………………………………………………………………\\n …………………………………………………………………………………………………………………\\n …………………………………………………………………………………………………………………\\n\\n\\n\\n\\n6- Comment procède t'il pour utiliser …………………………………………………………………………………………………………………\\n les contributions des apprenants? …………………………………………………………………………………………………………………\\n …………………………………………………………………………………………………………………\\n …………………………………………………………………………………………………………………\\n …………………………………………………………………………………………………………………\\n\\n\\n\\n\\n7- Comment suit-il et contrôle …………………………………………………………………………………………………………………\\n t'il l'assimilation des …………………………………………………………………………………………………………………\\n apprenants? …………………………………………………………………………………………………………………\\n …………………………………………………………………………………………………………………\\n …………………………………………………………………………………………………………………\\n\\n\\n\\n\\n 8- Comment fait-il la synthèse de la …………………………………………………………………………………………………………………\\n leçon ou d'un chapitre de celle-ci? …………………………………………………………………………………………………………………\\n …………………………………………………………………………………………………………………\\n …………………………………………………………………………………………………………………\\n …………………………………………………………………………………………………………………\\n\\n\\n\\n9- Comment évalue t'il avec précision …………………………………………………………………………………………………………………\\n les connaissances acquises par les …………………………………………………………………………………………………………………\\n apprenants? …………………………………………………………………………………………………………………\\n …………………………………………………………………………………………………………………\\n …………………………………………………………………………………………………………………\", \"page_fill_runs\": [129, 129, 129, 130, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129, 129], \"page_lines\": 47}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:ellipsis"]} {"pdf": "docs/real/Rapport_cartographie_des_infrastructures_2017_p7.pdf", "category": "real", "id": "Rapport_cartographie_des_infrastructures_2017_p7", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" Institut national de la statistique\\n\\n SOMMAIRE\\nPREFACE--------------------------------------------------------------------------------------------------------------------------- 5\\n SOMMAIRE------------------------------------------------------------------------------------------------------------------------- 7\\n LISTE DES TABLEAUX--------------------------------------------------------------------------------------------------------11\\n LISTE DES GRAPHIQUES----------------------------------------------------------------------------------------------------13\\n LISTE DES CARTES------------------------------------------------------------------------------------------------------------15\\n ABREVIATIONS------------------------------------------------------------------------------------------------------------------17\\n SYNTHESE ------------------------------------------------------------------------------------------------------------------------19\\n CHAPITRE 1: CONTEXTE ET METHODOLOGIE ----------------------------------------------------------------------31\\n 1.1 Contexte de l'étude -------------------------------------------------------------------------------------------------31\\n 1.1.1. Présentation contextuelle -----------------------------------------------------------------------------------31\\n 1.1.2. Objectifs de l'étude -------------------------------------------------------------------------------------------32\\n 1.1.3. Résultats attendus--------------------------------------------------------------------------------------------32\\n 1.2. Méthodologie ---------------------------------------------------------------------------------------------------------33\\n 1.2.1. Cadre institutionnel -------------------------------------------------------------------------------------------33\\n 1.2.2. Champs de l'étude--------------------------------------------------------------------------------------------33\\n 1.2.3. Type d'enquête et population cible -----------------------------------------------------------------------33\\n 1.2.4. Outils de collecte----------------------------------------------------------------------------------------------34\\n 1.2.5. Étapes de l'enquête ------------------------------------------------------------------------------------------34\\n 1.2.6. Organisation de la collecte ---------------------------------------------------------------------------------36\\n 1.2.7. Traitement des données ------------------------------------------------------------------------------------37\\n 1.2.8. Définition des concepts--------------------------------------------------------------------------------------38\\n CHAPITRE 2 : CARACTERISTIQUES DES REPONDANTS---------------------------------------------------------39\\n CHAPITRE 3 : TYPES D'INFRASTRUCTURES-------------------------------------------------------------------------41\\n 3.1. Typologie des infrastructures-----------------------------------------------------------------------------------------41\\n 3.2. Répartition spatiale des infrastructures ----------------------------------------------------------------------------41\\n INFRASTRUCTURES ECONOMIQUES --------------------------------------------------------------------------------------43\\n CHAPITRE 4 : BOULANGERIES--------------------------------------------------------------------------------------------45\\n 4.1. Couverture des boulangeries -----------------------------------------------------------------------------------------45\\n 4.2. Répartition spatiale------------------------------------------------------------------------------------------------------46\\n 4.3. Ratio ménages / boulangerie -----------------------------------------------------------------------------------------48\\n 4.4. Ratio boulangeries / commune---------------------------------------------------------------------------------------48\\n 4.5. Catégorie et typologie --------------------------------------------------------------------------------------------------49\\n 4.6. Période d'implantation--------------------------------------------------------------------------------------------------49\\n 4.7. Éléments de confort-----------------------------------------------------------------------------------------------------50\\n CHAPITRE 5 : GARES ROUTIERES URBAINES-----------------------------------------------------------------------51\\n 5.1. Répartition spatiale------------------------------------------------------------------------------------------------------51\\n 5.2. Ratio gares routières / Commune urbaine (CU) -----------------------------------------------------------------52\\n 5.3. Période d'implantation--------------------------------------------------------------------------------------------------53\\n\\n Recensement et cartographie des infrastructures socio-économiques de base en 2017 7\", \"page_fill_runs\": [123, 121, 104, 100, 108, 114, 120, 70, 97, 83, 91, 92, 105, 91, 92, 71, 94, 90, 81, 84, 86, 57, 73, 89, 76, 86, 92, 89, 102, 89, 87, 98, 98, 101, 71, 102, 65, 98], \"page_lines\": 41}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:dash"]} {"pdf": "docs/real/Red-Hook-Milan-2025-School_p196.pdf", "category": "real", "id": "Red-Hook-Milan-2025-School_p196", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"STATE OF NEW YORK 2 0 2 5 S C H O O L T A X R O L L PAGE 196\\nCOUNTY - Dutchess S C H O O L T O T A L S 134801 VALUATION DATE-JUL 01, 2024\\nSCHOOL - Red Hook CSD TAXABLE STATUS DATE-MAR 01, 2025\\n RPS155/V04/L015\\n CURRENT DATE 8/19/2025\\n\\n\\n\\n *** E X E M P T I O N S U M M A R Y ***\\n TOTAL\\nCODE DESCRIPTION PARCELS SCHOOL\\n41130 Alt Vet Cb 6 120,000\\n41140 Alt Vet Di 6 206,625\\n41144 Alt Vet Di 1 40,000\\n41634 VOL FIRE - 3 139,990\\n41720 AG In Dist 33 11122,000\\n41730 AG Outside 9 1632,600\\n41800 SENIOR 17 3716,800\\n41804 SENIOR-S 3 283,920\\n41834 ENH STAR 75 9518,630\\n41854 BAS STAR 98 4373,740\\n47460 FOREST LAN 15 7165,500\\n49500 SOLAR EN 35 1537,000\\n T O T A L 324 42963,805\\n\\n\\n *** G R A N D T O T A L S ***\\nROLL TOTAL ASSESSED ASSESSED EXEMPT TOTAL TOTAL\\nSEC DESCRIPTION PARCELS LAND TOTAL AMOUNT TAXABLE TAX\\n ----------- ------------ TAX\\n STAR AMOUNT STAR TAXABLE RATE\\n\\n ** GRAND TOTAL 726 142662,300 461438,556 29,071,435 432,367,121\\n 13892,370 418,474,751 6,416,018.28\\n\\n\\n\\n*COPYRIGHT * * * * * * * * * * * *NEW YORK STATE REAL PROPERTY SYSTEM* * * * * * * * * * * * * * * * * *\\n* *\\n* PROPRIETARY PROGRAM MATERIAL *\\n* *\\n* THIS MATERIAL IS PROPRIETARY TO THE NEW YORK STATE OFFICE OF REAL PROPERTY SERVICES (OFFICE) *\\n* AND IS NOT TO BE REPRODUCED, USED OR DISCLOSED EXCEPT IN ACCORDANCE WITH PROGRAM LICENSE OR *\\n* UPON WRITTEN AUTHORIZATION OF THE NEW YORK STATE REAL PROPERTY INFORMATION SYSTEM SECTION OF\\n* THE OFFICE, SHERIDAN HOLLOW PLAZA, 16 SHERIDAN AVENUE, ALBANY, NEW YORK 12210-2714. *\\n* *\\n* COPYRIGHT (C) 1999 *\\n* *\\n* NEW YORK STATE OFFICE OF REAL PROPERTY SERVICES *\\n* *\\n* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *\\n* *\\n* THE OFFICE BELIEVES THAT THE SOFTWARE FURNISHED HEREWITH IS ACCURATE AND RELIABLE, AND MUCH *\\n* CARE HAS BEEN TAKEN IN ITS PREPARATION. HOWEVER, NO RESPONSIBILITY, FINANCIAL OR OTHERWISE, *\\n* CAN BE ACCEPTED FROM ANY CONSEQUENCES ARISING OUT OF THE USE OF THIS MATERIAL, INCLUDING *\\n* LOSS OF PROFIT, INDIRECT, SPECIAL OR CONSEQUENTIAL DAMAGES. THERE ARE NO WARRANTIES WHICH *\\n* EXTEND BEYOND THE PROGRAM SPECIFICATION. *\", \"page_fill_runs\": [23, 12, 18], \"page_lines\": 48}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:star"]} {"pdf": "docs/real/Red_Line_Extension_Transit_Supportive_Development_Plan-_FINAL_WEB_VERSION_5-18-2_p43.pdf", "category": "real", "id": "Red_Line_Extension_Transit_Supportive_Development_Plan-_FINAL_WEB_VERSION_5-18-2_p43", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" STEWART AVE 110TH STREET\\n 110TH PLACE EGGLESTON AVENUE\\n 111TH STREET 111TH STREET\\n Figure 3-35: 111th Street Catalyst Site 1 Massing Concept Figure 3-36: 111th Street Catalyst Site 2 Massing Concept 110TH PLACE SITE 2\\n CATALYST SITE #1 CATALYST SITE #2\\n Catalyst Site 1 in the 111th Street station area is The concept proposed for Catalyst Site 2 consists\\n comprised of a single privately-owned parcel, of mixed-use and multifamily buildings on the\\n currently occupied by a vacant automotive privately-owned parcels fronting on 111th Street,\\n services shop building that represents an accompanied by a mix of 20 smaller-scale six-flats,\\n ideal location for future transit-supportive two-flats, and townhouses on the City-owned P P\\n development. lots to the north. This concept also proposes an P\\n Proposed is a four-story, mixed-use structure extension of the existing Eggleston Avenue spur\\n with approximately 4,000 square feet of ground to the north, terminating in a cul-de-sac, and\\n floor commercial space and roughly 18 residential a new east-west connection to 110th Place. The 111TH STREET\\n units above. mixed-use development on the southeast corner X\\n of the site rises to five stories, with nearly 7,000 P\\n The conceptual massing holds the corner of 111th square feet of ground floor commercial space, and SITE 1\\n Street and Stewart Avenue, but steps back along roughly 58 residential units above.\\n the 111th Street frontage to the west to allow for The four-story multifamily structure proposed\\n a small patio that could accommodate a few trees on the southwestern corner would accommodate\\n and cafe tables. The upper levels of the building approximately 30 units. The proposed six-flats\\n adopt a staggered, sawtooth form to optimize the and two-flats front on the extension of Eggleston P\\n potential sizing and organization of residential Avenue, and are setback from the street to allow\\n units. The residential lobby and any necessary for a generous parkway and front yards. Four\\n support spaces are located at the eastern site townhouses front onto the extension of 110th\\n frontage along Stewart Avenue. Surface parking Place, opposite a proposed neighborhood park.\\n for building residents is tucked behind the\\n building at the southern edge of the site and is Site Boundary RLE Elevated Tracks\\n accessible from the existing alley that opens off of Catalyst\\n Catalyst Site Mixed-Use UPRR Tracks\\n Stewart Avenue. Catalyst Site Residential Existing Structure\\n Station Entry Parks & Open Space\\n Residential Infill Sidewalk / Paver\\n A-1: RLE North Station House P RLE Station Parking\\n A-2: RLE South Station House P TSD Proposed Parking\\n P Existing Surface Parking\\n Figure 3-37: 111th Street\\n 84 | S3 STATION AREA DEVELOPMENT CONCEPTS Station Node Illustrative Plan\\n * FOR ILLUSTRATIVE PURPOSES ONLY\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n NOR MAL AVENUE\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n X X X\\n\\n\\n X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X\\n A-2 A-1\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n N OR MA L AVE N UE\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n E GGLE S TON AV EN UE\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n S TE WAR TTAV EN UEE\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nX\\n\\nX\\nX\\nX\\nX\\nX\\nX\\nX\", \"page_fill_runs\": [], \"page_lines\": 54}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:letter"]} {"pdf": "docs/real/Republic_of_Korea_1987_p2.pdf", "category": "real", "id": "Republic_of_Korea_1987_p2", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"constituteproject.org PDF generated: 15 Jun 2026, 17:29\\n\\n\\nTable of contents\\n\\nPreamble . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5\\nCHAPTER I. GENERAL PROVISIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5\\nArticle 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5\\nArticle 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5\\nArticle 3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5\\nArticle 4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5\\nArticle 5 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6\\nArticle 6 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6\\nArticle 7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6\\nArticle 8 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6\\nArticle 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6\\n CHAPTER II. RIGHTS AND DUTIES OF CITIZENS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6\\nArticle 10 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6\\nArticle 11 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7\\nArticle 12 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7\\nArticle 13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7\\nArticle 14 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7\\nArticle 15 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7\\nArticle 16 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8\\nArticle 17 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8\\nArticle 18 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8\\nArticle 19 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8\\nArticle 20 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8\\nArticle 21 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8\\nArticle 22 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8\\nArticle 23 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8\\nArticle 24 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8\\nArticle 25 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9\\nArticle 26 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9\\nArticle 27 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9\\nArticle 28 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9\\nArticle 29 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9\\nArticle 30 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9\\nArticle 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9\\nArticle 32 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10\\nArticle 33 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10\\nArticle 34 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10\\nArticle 35 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10\\nArticle 36 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11\\nArticle 37 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11\\nArticle 38 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11\\nArticle 39 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11\\nCHAPTER III. THE NATIONAL ASSEMBLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11\\nArticle 40 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11\\nArticle 41 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11\\n\\n\\nKorea (Republic of) 1948 (rev. 1987) Page 2\", \"page_fill_runs\": [83, 56, 84, 84, 84, 84, 84, 84, 84, 84, 84, 44, 83, 83, 83, 83, 83, 83, 83, 83, 83, 83, 83, 83, 83, 83, 83, 83, 83, 83, 83, 83, 83, 83, 82, 82, 82, 82, 82, 82, 82, 82, 50, 82, 82], \"page_lines\": 48}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:dot"]} {"pdf": "docs/real/Rules_of_Court_2012.01.07.2012_p535.pdf", "category": "real", "id": "Rules_of_Court_2012.01.07.2012_p535", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"P.U. (A)\\n\\n\\n112. Memorandum of Appeal… … … … … … … … … … … … … … … … 55 … 4\\n\\n113. Notice of Cross Appeal … … … … … … … … … … … … … … … … … 55 … 8\\n\\n114. Notice to Judge in Chambers… … … … … … … … … … … … … … 56 … 1\\n\\n115. Notice of Transfer of Action to High Court… … … … … … … … 57 … 2\\n\\n116. Notice of Hearing of Action Transferred from High Court… … 57 … 4\\n\\n117. Bill of Costs … … … … … … … … … … … … … … … … … … … … … 59 … 7\\n\\n118. Cause Book … … … … … … … … … … … … … … … … … … … … … 60 … 2\\n\\n119. Originating Applications Book… … … … … … … … … … … … … 60 … 2\\n\\n120. Interpleader Notice Summons Book… … … … … … … … … … … 60 … 2\\n\\n121. Interlocutory Applications Book… … … … … … … … … … … … … 60 … 2\\n\\n122. Judgment Book… … … … … … … … … … … … … … … … … … … … 60 … 2\\n\\n123. Writs of Execution Book… … … … … … … … … … … … … … … … 60 … 2\\n\\n124. Distress Book… … … … … … … … … … … … … … … … … … … … … 60 … 2\\n\\n125. Probate Book… … … … … … … … … … … … … … … … … … … … … 60 … 2\\n\\n126. Caveat Book… … … … … … … … … … … … … … … … … … … … … 60 … 2\\n\\n127. Service Book… … … … … … … … … … … … … … … … … … … … … 60 … 2\\n\\n128. Adoption Book … … … … … … … … … … … … … … … … … … … … 60 … 2\\n\\n129. Direction to Accountant General … … … … … … … … … … … … 60 … 2\\n\\n130. Index of Wills… … … … … … … … … … … … … … … … … … … … 60 … 2\\n\\n131. Register of Appeals to the Court of Appeal… … … … … … … … 60 … 2\\n\\n132. Register of Appeals from Subordinate Courts… … … … … … … 60 … 2\\n\\n133. Order for Substituted Service… … … … … … … … … … … … … … 62 … 5\\n\\n134. Affidavit on Application for Substituted Service… … … … … … 62 … 5\\n\\n135. Affidavits of Service… … … … … … … … … … … … … … … … … … 62 … 9\\n\\n136. Notice of Change of Solicitor… … … … … … … … … … … … … … 64 … 1\\n\\n137. Notice of Intention of Party to Act in Person in place of 64 … 3\\n Solicitor… … … … … … … … … … … … … … … … … … … … … … …\\n\\n138. Notice to Remove Solicitor from Record… … … … … … … … … 64 … 4\\n\\n139. Order Removing Solicitor from the Record… … … … … … … … 64 … 4\\n\\n140. Notice of Application for Withdrawal of Solicitor … … … … … 64 … 5\\n\\n141. Order for Withdrawal of Solicitor… … … … … … … … … … … … 64 … 5\\n\\n142. Certificate of Service of Foreign Process… … … … … … … … … 65 … 2\\n\\n\\n\\n 535\", \"page_fill_runs\": [48, 51, 42, 24, 63, 63, 39, 33, 39, 60, 48, 63, 63, 63, 63, 60, 36, 60, 24, 21, 42, 18, 54, 42, 69, 27, 24, 15, 36, 27], \"page_lines\": 34}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:ellipsis"]} {"pdf": "docs/real/SPANISH-SPAIN-Awesome-Words-demo_p7.pdf", "category": "real", "id": "SPANISH-SPAIN-Awesome-Words-demo_p7", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" The Most AWESOME WORDLIST You Have Ever Seen\\n● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ●\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ●\\n\\n\\n\\n\\n Spanish (Spain)\\n\\n\\n\\n\\n● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ●\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n 5\", \"page_fill_runs\": [44, 45, 45], \"page_lines\": 6}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:symbol"]} {"pdf": "docs/real/ScipyLectures-simple_p591.pdf", "category": "real", "id": "ScipyLectures-simple_p591", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" Scipy lecture notes, Edition 2022.1\\n\\n\\n\\n (continued from previous page)\\n >>> print(n_samples)\\n 150\\n >>> print(n_features)\\n 4\\n >>> print(iris.data[0])\\n [5.1 3.5 1.4 0.2]\\n\\n The information about the class of each sample is stored in the target attribute of the dataset:\\n\\n >>> print(iris.target.shape)\\n (150,)\\n >>> print(iris.target)\\n [0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0\\n 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1\\n 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 2 2 2 2 2 2 2 2 2 2\\n 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2\\n 2 2]\\n\\n The names of the classes are stored in the last attribute, namely target_names:\\n\\n >>> print(iris.target_names)\\n ['setosa' 'versicolor' 'virginica']\\n\\n This data is four-dimensional, but we can visualize two of the dimensions at a time using a scatter plot:\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nExercise:\\n\\nCan you choose 2 features to find a plot where it is easier to seperate the different classes of irises?\\nHint: click on the figure above to see the code that generates it, and modify this code.\\n\\n\\n\\n\\n\\n\\n\\n 21.1. Introduction: problem settings 586\", \"page_fill_runs\": [], \"page_lines\": 25}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:digit"]} {"pdf": "docs/real/SymondsEtAl_2004_RiM_v30_pp1-66_VolcanicGasStudies_p58.pdf", "category": "real", "id": "SymondsEtAl_2004_RiM_v30_pp1-66_VolcanicGasStudies_p58", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" 58 Symonds, Rose, Bluth & Gerlach: Volcanic-Gas Studies\\n 600 1 1 ' 1 ' • ' 1 1\\n 450\\n 300 - Sulfur Dioxide Emission Rate .\\n 150 i 1 1 1 1 1 i\\\"i (i n w ' n '\\n 60 -LONE Reducing Gas (air): . . \\\\/ 1 1 1 1 1 1 1 ,+ r ' 'M- 1-^\\n 40\\n 20\\n 0 V- , . j\\n 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 11\\n 16000 -FAMS Radial Tilt <\\n 12000\\n 8000\\n 4000\\n 5.0 -TNKR-RUBY Contraction Rate\\n -5.0\\n o -15.0\\n -25.0\\n : ' ' ' 1 ' 1 ' -\\n 4000 [•YELS RSAM J\\n 3000\\n 2000\\n 1000 '. . wudL... ..^UAWdUlJr IIA.jlui . -j . .1\\n 0 Oct 5 10 15 20 25 Nov 6\\n 1986\\n\\n Figure 33. Plot of S0 2 emission rates, reducing-gas sensor data, tilt, electronic distance measurements\\n (EDM), and seismic data at Mount St. Helens during October and November, 1986. Air reducing-gas data\\n are from station LONE on the east side of the dome. The single datum on October 22 is shown enlarged\\n and the dotted line represents the missing early portion of the reducing-gas peak. Tilt data are from FAMS\\n (north side of dome); EDM data are from the line between TNKR (north crater floor) and RUBY (north side\\n of dome); Seismicity is represented by hourly-averaged RSAM data from YELS (north crater floor).\\n Vertical line represents the beginning of lava extrusion on 21 October 1986. Note that the increases in\\n SO2 fluxes and reducing-gas signals coincide with changes in tilt, EDM, and seismic data. From McGee\\n and Sutton (1994).\\n\\n eruptions. TOMS is useful (for SO2) during the large explosive eruptions, but can't be\\n used to measure lower-level emissions. The example shown in Figure 34 documents SO2\\n emissions throughout 1980 at Mount St. Helens. Most of the data come from COSPEC\\n observations, but the high spikes are TOMS data, taken during the major eruption of May\\n 18. The ratio of explosive to non explosive degassing at Mount St. Helens in 1980 is\\n roughly 5:1; ~1 Mt during the May 18 event and 220 Kt during non-eruptive days of 1980.\\n\\nCONCLUSIONS\\n Volcanic gases contain H2O, CO2, SO2, H2, H2S, HC1, HF, CO, S2, COS, rare\\n gases, and a number of trace-metal species. The main volcanic gases are H2O, CO2, and\\n SO2, although H2S may be the dominant sulfur gas in equilibrium with some convergent-\\n plate magmas at depth, and HC1 may exceed total S in some convergent-plate volcanic\\n gases. Gases discharging from convergent-plate volcanoes contain much more H2O than\\n gases from divergent-plate or hot-spot volcanoes, which have higher proportions of CO2\\n and SO2. Convergent-plate-volcano gases are also relatively enriched in HC1. These\\n patterns reflect the tectonic origins of the respective magmas. Magmas from divergent-plate\\n and hot-spot volcanoes derive volatiles primarily from the mantle, so they contain moderate\\n amounts of C and S but are relatively depleted in H2O and CI compared to magmas from\\n convergent-plate volcanoes, which contain volatiles from the subducted slab as well as the\\n mantle, making them richer in H2O and CI.\", \"page_fill_runs\": [], \"page_lines\": 53}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:digit"]} {"pdf": "docs/real/The-Most-Awesome-Word-List-English-Free_p8.pdf", "category": "real", "id": "The-Most-Awesome-Word-List-English-Free_p8", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ●\\n\\n\\n\\n\\n\\n Your First 625 Words\\n\\n\\n\\n\\n\\n● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ●\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n 5\", \"page_fill_runs\": [45, 45], \"page_lines\": 4}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:symbol"]} {"pdf": "docs/real/UHC_Insurance_Small_Group_ACA_PY2026_1_p74.pdf", "category": "real", "id": "UHC_Insurance_Small_Group_ACA_PY2026_1_p74", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"Press TAB and directional arrow Product-Plan Data Collection [assistive technology users, please reference cell A1 for instructions] To add a product to Worksheet 2 - Plan Product Infoselect the Add Product button or Ctrl + Shift + P\\nTo add a plan to Worksheet 2 - Plan Product Info, select the Add Plan button or Ctrl + Shift + L.\\n Company Legal Name: UnitedHealthcare Insurance Company To validate, select the Validate button or Ctrl + Shift + I.\\n HIOS Issuer ID: 41842 State: DC To finalize, select the Finalize button or Ctrl + Shift + F.\\n Effective Date of Rate Change(s): 1/1/2026 Market: Small Group To remove a product, navigate to the corresponding Product Name/Product ID field and select the Remove Product button or Ctrl + Shift + Q.\\n To remove a plannavigate to the corresponding Plan Name/Plan ID field and select the Remove Plan button or Ctrl + Shift + A\\n Product/Plan Level Calculations\\n\\n Field # Section I: General Product and Plan Information\\n 11 Product Name Choice Plus Choice Choice Essential Choice Plus Essential\\n 1\\n 2 Product ID 41842DC001 41842DC004 41842DC007 41842DC008\\n 1\\n 3 Plan Name EOIM CCFA DGRO DGRI DGQH DGQM DGQO DGQK DGRG DGQ4 DGQ9 DGRE DGQ6 DGQ8 DGRM DGQP CU SE CU S8 DGRR DGQU EOIT EOIU EOIE EOIN EOID DXRP DXSP DXSS DXSN DXSR DXSM DXSO DXSV DXRT DXRU DXRV DXRM DXRS DXRQ DXRR EOIL DXSX EOIO EOIP EOIQ DXRW EOIC EOIR EOIS CUR2 CU R3 DXSL DXSK DXSU CU SF DXSJ CUS5 CUS6 CU S7 DXSZ\\n 1\\n 4 Plan ID (Standard Component ID) 41842DC0010078 41842DC0010032 41842DC0040057 41842DC0070003 41842DC0070004 41842DC0070005 41842DC0070006 41842DC0070007 41842DC0070008 41842DC0070009 41842DC0070010 41842DC0070011 41842DC0070012 41842DC0070013 41842DC0070014 41842DC0070015 41842DC0070016 41842DC0070017 41842DC0070018 41842DC0070020 41842DC0080041 41842DC0080042 41842DC0080001 41842DC0080003 41842DC0080006 41842DC0080007 41842DC0080008 41842DC0080009 41842DC0080011 41842DC0080013 41842DC0080014 41842DC0080015 41842DC0080017 41842DC0080018 41842DC0080019 41842DC0080020 41842DC0080021 41842DC0080022 41842DC0080023 41842DC0080025 41842DC0080026 41842DC0080031 41842DC0080032 41842DC0080034 41842DC0080035 41842DC0080036 41842DC0080037 41842DC0080039 41842DC0080040 41842DC0080004 41842DC0080005 41842DC0080010 41842DC0080012 41842DC0080016 41842DC0080024 41842DC0080027 41842DC0080028 41842DC0080029 41842DC0080030 41842DC0080033\\n 1\\n 5 Metal Gold Gold Gold Silver Bronze Gold Platinum Gold Gold Gold Gold Gold Platinum Platinum Silver Gold Gold Silver Silver Silver Gold Silver Gold Silver Platinum Platinum Gold Gold Gold Gold Platinum Platinum Silver Platinum Gold Silver Bronze Bronze Gold Silver Gold Silver Silver Gold Platinum Platinum Bronze Silver Gold Gold Gold Gold Gold Silver Gold Gold Silver Platinum Silver Silver\\n 1\\n 6 AV Metal Value 0817 0808 0820 0719 0650 0815 0887 0819 0803 0807 0790 0812 0911 0904 0704 0817 0816 0704 0689 0716 0\\n 812 0\\n 705 0817 0719 0914 0904 0815 0814 0792 0814 0916 0908 0703 0920 0820 0718 0650 0650 0817 0715 0795 0696 0715 0819 0919 0888 0649 0711 0813 0820 0820 0802 0805 0000 0816 0000 0719 0896 0704 0000\\n 1\\n 7 Plan Category Renewing Terminated Terminated Terminated Terminated Terminated Terminated Terminated Terminated Terminated Terminated Terminated Terminated Terminated Terminated Terminated Terminated Terminated Terminated Terminated New New Renewing Renewing Renewing Renewing Renewing Renewing Renewing Renewing Renewing Renewing Renewing Renewing Renewing Renewing Renewing Renewing Renewing Renewing Renewing Renewing Renewing Renewing Renewing Renewing Renewing Renewing Renewing Terminated Terminated Terminated Terminated Terminated Terminated Terminated Terminated Terminated Terminated Terminated\\n 1 Plan Type\\n 8 POS POS EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO POS POS POS POS POS POS POS POS POS POS POS POS POS POS POS POS POS POS POS POS POS POS POS POS POS POS POS POS POS POS POS POS POS POS POS POS POS POS POS POS\\n 1\\n 9 Exchange Plan? Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes\\n 1\\n 10 Effective Date of Proposed Rates 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026\\n 1\\n 11 Cumulative Rate Change % (over 12 mos prior) 780% 000% 000% 000% 000% 000% 000% 000% 000% 000% 000% 000% 000% 000% 000% 000% 000% 000% 000% 000% 000% 000% 755% 926% 651% 761% 803% 851% 825% 840% 750% 752% 923% 935% 913% 988% 1062% 923% 947% 920% 792% 971% 914% 820% 585% 856% 830% 939% 806% 000% 000% 000% 000% 000% 000% 000% 000% 000% 000% 000%\\n 1\\n 12 Product Rate Increase % 7.80% 000% 0.00% 7.74%\\n 1\\n 13 Submission Level Rate Increase % 7.74%\\n\\nWorksheet 1 Totals Section II: Experience Period and Current Plan Level Information\\n 2\\n 1 Plan ID (Standard Component ID) Total 41842DC0010078 41842DC0010032 41842DC0040057 41842DC0070003 41842DC0070004 41842DC0070005 41842DC0070006 41842DC0070007 41842DC0070008 41842DC0070009 41842DC0070010 41842DC0070011 41842DC0070012 41842DC0070013 41842DC0070014 41842DC0070015 41842DC0070016 41842DC0070017 41842DC0070018 41842DC0070020 41842DC0080041 41842DC0080042 41842DC0080001 41842DC0080003 41842DC0080006 41842DC0080007 41842DC0080008 41842DC0080009 41842DC0080011 41842DC0080013 41842DC0080014 41842DC0080015 41842DC0080017 41842DC0080018 41842DC0080019 41842DC0080020 41842DC0080021 41842DC0080022 41842DC0080023 41842DC0080025 41842DC0080026 41842DC0080031 41842DC0080032 41842DC0080034 41842DC0080035 41842DC0080036 41842DC0080037 41842DC0080039 41842DC0080040 41842DC0080004 41842DC0080005 41842DC0080010 41842DC0080012 41842DC0080016 41842DC0080024 41842DC0080027 41842DC0080028 41842DC0080029 41842DC0080030 41842DC0080033\\n $77 167 053 2\\n 2 Allowed Claims $77 167053 $2 082 971 $573 970 $813 $246 541 $489 569 $666520 $1227525 $808222 $834 709 $431 497 $542 670 $1737 055 $2 039 926 $768073 $248132 $358304 $426 $16016 $52129 $54 824 $0 $0 $5301 166 $1096060 $9397213 $2038761 $5227448 $3433 155 $2624 176 $1639439 $11 892 521 $11 143711 $623410 $889587 $1799512 $174 853 $1047 895 $405 240 $225 027 $90527 $929764 $32539 $218836 $125 613 $522 371 $0 $0 $0 $0 $113697 $158773 $943190 $366 487 $204670 $3903 $953 493 $17 298 $95 333 $7787 $3944\\n $0 2\\n 3 Reinsurance $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0\\n 2\\n 4 Member Cost Sharing $8 870396 $210 879 $422 547 $78 $47 605 $85 691 $144055 $163566 $182017 $99 629 $105 561 $89 922 $317 538 $133 493 $53630 $78902 $17158 $299 $11588 $27125 $16 179 $0 $0 $848 748 $240597 $451026 $131899 $863 466 $445 884 $324 728 $345 522 $802 099 $750 134 $218978 $58919 $264537 $65 535 $56 891 $61 979 $73 028 $33416 $182056 $14763 $84565 $24 301 $33 349 $0 $0 $0 $0 $27022 $25699 $166108 $72 903 $71647 $2458 $239 857 $7 849 $12 441 $3879 $307\\n 2\\n 5 Cost Sharing Reduction $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0\\n $68 296 656 2\\n 6 Incurred Claims $68 296656 $1 872 092 $151 423 $735 $198 936 $403 877 $522465 $1063959 $626205 $735 080 $325 936 $452 748 $1419 518 $1 906 432 $714443 $169230 $341146 $127 $4 427 $25004 $38 645 $0 $0 $4452 418 $855463 $8946187 $1906863 $4363982 $2987 271 $2299 448 $1293918 $11 090 422 $10 393577 $404432 $830668 $1534975 $109 318 $991 005 $343 261 $152 000 $57111 $747708 $17777 $134272 $101 312 $489 022 $0 $0 $0 $0 $86674 $133074 $777082 $293 584 $133023 $1445 $713 636 $9 449 $82 892 $3908 $3637\\n $1 030 482 2\\n 7 Risk Adjustment Transfer Amount $1 030482 $23 975 $0 799 $11 $3 657 $4 461 $13906 $23866 $12163 $10 539 $8 207 $9 520 $24 748 $23 984 $9309 $5488 $1119 $23 $221 $980 $380 $0 $0 $61 101 $12963 $118979 $20559 $70 280 $38 650 $26 986 $26 206 $145 734 $178 621 $14710 $11346 $28596 $3 771 $1 611 $3 044 $4 983 $2076 $13245 $895 $4297 $1 674 $5 545 $0 $0 $0 $0 $2210 $1494 $13191 $6 781 $3888 $210 $16 280 $146 $1 378 $259 $429\\n $86 196 566 2\\n 8 Premium $86 196566 $2 005 423 $0 981 $986 $305 896 $373 169 $1163173 $1996299 $1017434 $881 563 $686 466 $796 335 $2070 091 $2 006 178 $778644 $459046 $93618 $1903 $18456 $81961 $31 805 $0 $0 $5110 907 $1084347 $9952218 $1719724 $5878678 $3232 949 $2257 296 $2192029 $12 190 188 $14 941066 $1230414 $949022 $2392003 $315 395 $134 722 $254 652 $416 774 $173631 $1107925 $74837 $359453 $140 047 $463 825 $0 $0 $0 $0 $184899 $124977 $1103360 $567 246 $325243 $17533 $1361 809 $12 182 $115 249 $21658 $35869\\n 130 556 2\\n 9 Experience Period Member Months 130556 3\\n 151 0 1\\n 630 502 772 2\\n 064 3\\n 335 1\\n 720 1\\n 444 1\\n 268 1\\n 383 3\\n 349 2\\n 634 1\\n 151 892 204 4 33 177 50 0 0 7\\n 846 1\\n 694 12749 2\\n 493 9\\n 813 4\\n 878 3\\n 605 3\\n 776 16 711 19741 2\\n 373 1\\n 305 4\\n 241 581 361 616 633 357 1\\n 889 180 607 266 710 0 0 0 0 390 236 2\\n 062 1\\n 056 714 31 2\\n 508 33 225 41 72\\n 2\\n 10 Current Enrollment 10996 257 0 155 49 64 190 299 147 106 90 98 265 196 91 66 23 0 0 15 11 0 0 651 123 997 195 809 369 300 348 1\\n 377 1\\n 724 187 161 419 55 54 60 60 41 178 21 73 34 100 0 0 0 0 0 0 163 85 52 0 218 0 0 0 20\\n 2\\n 11 Current Premium PMPM $67550 $63531 $000 24 $623 $582 05 $49519 $56165 $616 70 $59723 $62594 $557 78 $601 68 $62174 $78611 $732 98 $553 76 $477 29 $0 00 $0 00 $45372 $551 76 $0 00 $000 $677 41 $660 25 $797 72 $722 11 $602 48 $702 68 $655 59 $597 80 $74852 $77162 $520 22 $72333 $580 85 $524 99 $404 69 $434 88 $651 22 $49630 $59440 $47942 $59289 $601 55 $72216 $0 00 $0 00 $000 $000 $000 $0 00 $54123 $546 01 $48134 $000 $55537 $000 $000 $0 00 $53683\\n 2\\n 12 Loss Ratio 7830% 92 25% #DIV/0! 63% 73 64 27% 10695% 4439% 5267% 6082% 8240% 46 92% 56 18% 6776% 93 91% 9067% 3643% 36010% 6\\n 59% 2371% 3015% 12007% #DIV/0! #DIV/0! 8609% 7796% 8883% 10957% 7336% 9131% 10066% 5833% 89 90% 6874% 3248% 8649% 6341% 3425% 72690% 13320% 3604% 3250% 6669% 2347% 3691% 7149% 10419% #DIV/0! #DIV/0! #DIV/0! #DIV/0! 4632% 10522% 6960% 51 14% 4042% 8\\n 15% 5178% 7665% 7107% 1783% 1002%\\n Per Member Per Month\\n 2\\n 13 Allowed Claims $59106 $66105 #DIV/0! 37 $499 $491 12 $63416 $32293 $368 07 $46990 $57805 $340 30 $392 39 $51868 $77446 $667 31 $278 17 $1756 39 $106 56 $485 32 $29452 $109648 #DIV/0! #DIV/0! $675 65 $647 02 $737 09 $817 79 $532 71 $703 80 $727 93 $434 17 $71166 $56450 $262 71 $68168 $424 31 $300 95 $2902 76 $657 86 $355 49 $25358 $49220 $18077 $36052 $472 23 $73573 #DIV/0! #DIV/0! #DIV/0! #DIV/0! $29153 $672 77 $45742 $347 05 $28665 $12591 $38018 $52418 $42370 $189 92 $54 77\\n 2\\n 14 Reinsurance $000 $000 #DIV/0! $000 $0 00 $000 $000 $0 00 $000 $0 00 $0 00 $0 00 $000 $000 $0 00 $0 00 $0 00 $0 00 $0 00 $000 $0 00 #DIV/0! #DIV/0! $0 00 $0 00 $0 00 $0 00 $0 00 $0 00 $0 00 $0 00 $000 $0 00 $0 00 $000 $0 00 $0 00 $0 00 $0 00 $0 00 $000 $000 $000 $000 $0 00 $000 #DIV/0! #DIV/0! #DIV/0! #DIV/0! $000 $0 00 $000 $0 00 $000 $000 $000 $000 $000 $0 00 $0 00\\n 2\\n 15 Member Cost Sharing $6794 $6692 #DIV/0! 19 $48 $94 83 $11100 $6979 $49 05 $10582 $69 00 $83 25 $65 02 $9482 $5068 $46 59 $88 46 $84 11 $74 82 $351 15 $15325 $323 58 #DIV/0! #DIV/0! $108 18 $142 03 $35 38 $52 91 $87 99 $91 41 $90 08 $91 50 $4800 $38 00 $92 28 $4515 $62 38 $112 80 $157 59 $100 61 $115 37 $9360 $9638 $8202 $13932 $91 36 $4697 #DIV/0! #DIV/0! #DIV/0! #DIV/0! $6929 $108 89 $8056 $69 04 $10035 $7929 $9564 $23785 $5529 $94 60 $4 26\\n 2\\n 16 Cost Sharing Reduction $000 $000 #DIV/0! $000 $0 00 $000 $000 $0 00 $000 $0 00 $0 00 $0 00 $000 $000 $0 00 $0 00 $0 00 $0 00 $0 00 $000 $0 00 #DIV/0! #DIV/0! $0 00 $0 00 $0 00 $0 00 $0 00 $0 00 $0 00 $0 00 $000 $0 00 $0 00 $000 $0 00 $0 00 $0 00 $0 00 $0 00 $000 $000 $000 $000 $0 00 $000 #DIV/0! #DIV/0! #DIV/0! #DIV/0! $000 $0 00 $000 $0 00 $000 $000 $000 $000 $000 $0 00 $0 00\\n 2\\n 17 Incurred Claims $52312 $59413 #DIV/0! 18 $451 $396 29 $52316 $25313 $319 03 $36407 $50906 $257 05 $327 37 $42386 $72378 $620 71 $189 72 $1672 29 $31 74 $134 17 $14127 $772 90 #DIV/0! #DIV/0! $567 48 $505 00 $701 72 $764 89 $444 71 $612 40 $637 85 $342 67 $66366 $52650 $170 43 $63653 $361 94 $188 15 $2745 16 $557 24 $240 13 $15997 $39582 $9876 $22121 $380 87 $68876 #DIV/0! #DIV/0! #DIV/0! #DIV/0! $22224 $563 87 $37686 $278 02 $18631 $4662 $28454 $28633 $36841 $95 32 $50 51\\n 2\\n 18 Risk Adjustment Transfer Amount $789 $761 #DIV/0! $724 $7 28 $578 $674 $7 16 $707 $7 30 $6 47 $6 88 $739 $911 $8 09 $6 15 $5 49 $5 69 $6 69 $554 $7 60 #DIV/0! #DIV/0! $7 79 $7 65 $9 33 $8 25 $7 16 $7 92 $7 49 $6 94 $872 $9 05 $6 20 $869 $6 74 $6 49 $4 46 $4 94 $7 87 $581 $701 $497 $708 $6 29 $781 #DIV/0! #DIV/0! #DIV/0! #DIV/0! $567 $6 33 $640 $6 42 $545 $676 $649 $441 $612 $6 32 $5 96\\n 2\\n 19 Premium $66023 $63644 #DIV/0! 51 $605 $609 35 $48338 $56355 $598 59 $59153 $61050 $541 38 $575 80 $61812 $76165 $676 49 $514 63 $458 91 $475 72 $559 28 $46306 $636 10 #DIV/0! #DIV/0! $651 40 $640 11 $780 63 $689 82 $599 07 $662 76 $626 16 $580 52 $72947 $75685 $518 51 $72722 $564 02 $542 85 $373 19 $413 40 $658 41 $48636 $58651 $41576 $59218 $526 49 $65328 #DIV/0! #DIV/0! #DIV/0! #DIV/0! $47410 $529 56 $53509 $537 16 $45552 $56557 $54299 $36916 $51222 $528 24 $49818\\n\\n Section III: Plan Adjustment Factors\\n 3\\n 1 Plan ID (Standard Component ID) 41842DC0010078 41842DC0010032 41842DC0040057 41842DC0070003 41842DC0070004 41842DC0070005 41842DC0070006 41842DC0070007 41842DC0070008 41842DC0070009 41842DC0070010 41842DC0070011 41842DC0070012 41842DC0070013 41842DC0070014 41842DC0070015 41842DC0070016 41842DC0070017 41842DC0070018 41842DC0070020 41842DC0080041 41842DC0080042 41842DC0080001 41842DC0080003 41842DC0080006 41842DC0080007 41842DC0080008 41842DC0080009 41842DC0080011 41842DC0080013 41842DC0080014 41842DC0080015 41842DC0080017 41842DC0080018 41842DC0080019 41842DC0080020 41842DC0080021 41842DC0080022 41842DC0080023 41842DC0080025 41842DC0080026 41842DC0080031 41842DC0080032 41842DC0080034 41842DC0080035 41842DC0080036 41842DC0080037 41842DC0080039 41842DC0080040 41842DC0080004 41842DC0080005 41842DC0080010 41842DC0080012 41842DC0080016 41842DC0080024 41842DC0080027 41842DC0080028 41842DC0080029 41842DC0080030 41842DC0080033\\n 3\\n 2 Market Adjusted Index Rate $677.31\\n 3\\n 3 AV and Cost Sharing Design of Plan 08776 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 08635 07258 08413 07499 10165 09555 08068 08368 07992 08049 09718 10060 07369 10507 08882 07246 06545 06647 08164 07160 07880 07240 07495 08793 09654 08877 06503 06981 08111 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000 00000\\n 3\\n 4 Provider Network Adjustment 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000\\n 3\\n 5 Benefits in Addition to EHB 1\\n 0010 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0010 1\\n 0010 1\\n 0010 1\\n 0010 1\\n 0010 1\\n 0010 1\\n 0010 1\\n 0010 1\\n 0010 1\\n 0010 1\\n 0010 1\\n 0010 1\\n 0010 1\\n 0010 1\\n 0010 1\\n 0010 1\\n 0010 1\\n 0010 1\\n 0010 1\\n 0010 1\\n 0010 1\\n 0010 1\\n 0010 1\\n 0010 1\\n 0010 1\\n 0010 1\\n 0010 1\\n 0010 1\\n 0010 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000\\n Administrative Costs\\n 3\\n 6 Administrative Expense 11 70% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 1187% 1368% 1212% 1332% 1034% 1089% 1254% 1218% 1265% 1258% 10 73% 1043% 1351% 1004% 1159% 1370% 1486% 1467% 1242% 1382% 1279% 1371% 1333% 1169% 1079% 1158% 1493% 1411% 1249% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00%\\n 3\\n 7 Taxes and Fees 4\\n 09% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 4\\n 11% 4\\n 44% 4\\n 16% 4\\n 38% 3\\n 84% 3\\n 94% 4\\n 24% 4\\n 17% 4\\n 25% 4\\n 24% 3\\n 92% 3\\n 86% 4\\n 41% 3\\n 79% 4\\n 07% 4\\n 44% 4\\n 65% 4\\n 62% 4\\n 22% 4\\n 47% 4\\n 28% 4\\n 44% 4\\n 38% 4\\n 08% 3\\n 93% 4\\n 07% 4\\n 66% 4\\n 52% 4\\n 23% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00%\\n 3\\n 8 Profit & Risk Load 2\\n 35% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 2\\n 38% 2\\n 74% 2\\n 43% 2\\n 67% 2\\n 07% 2\\n 19% 2\\n 52% 2\\n 44% 2\\n 54% 2\\n 52% 2\\n 16% 2\\n 09% 2\\n 71% 2\\n 02% 2\\n 32% 2\\n 75% 2\\n 98% 2\\n 95% 2\\n 49% 2\\n 78% 2\\n 57% 2\\n 75% 2\\n 67% 2\\n 34% 2\\n 17% 2\\n 33% 3\\n 00% 2\\n 83% 2\\n 51% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00% 0\\n 00%\\n 3\\n 9 Catastrophic Adjustment 10000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 10000 10000 10000 10000 10000 10000 10000 10000 10000 10000 10000 10000 10000 10000 10000 10000 10000 10000 10000 10000 10000 10000 10000 10000 10000 10000 10000 10000 10000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000 1\\n 0000\\n 3\\n 10 Plan Adjusted Index Rate $72685 $000 $000 $0 00 $000 $000 $0 00 $000 $0 00 $0 00 $0 00 $000 $000 $0 00 $0 00 $0 00 $0 00 $0 00 $000 $0 00 $717 10 $62179 $701 68 $638 48 $822 90 $780 69 $677 82 $698 61 $672 60 $676 56 $79201 $81566 $629 47 $84654 $734 20 $621 00 $572 50 $579 55 $684 44 $61503 $66483 $62056 $63822 $728 00 $78755 $733 79 $56956 $60263 $68084 $000 $0 00 $000 $0 00 $000 $000 $000 $000 $000 $0 00 $0 00\\n\\n 3\\n 11 Age Calibration Factor 09804 0.9804\\n 3\\n 12 Geographic Calibration Factor 1 1.0000\\n 3\\n 13 Tobacco Calibration Factor 1 1.0000\\n 3\\n 14 Calibrated Plan Adjusted Index Rate $71261 $000 $000 $0 00 $000 $000 $0 00 $000 $0 00 $0 00 $0 00 $000 $000 $0 00 $0 00 $0 00 $0 00 $0 00 $000 $0 00 $703 05 $60960 $687 92 $625 97 $806 77 $765 39 $664 54 $684 92 $659 42 $663 30 $77648 $79968 $617 13 $82995 $719 81 $608 83 $561 28 $568 19 $671 03 $60297 $65180 $60840 $62571 $713 73 $77211 $719 40 $55840 $59082 $66750 $000 $0 00 $000 $0 00 $000 $000 $000 $000 $000 $0 00 $0 00\\n\\n Section IV: Projected Plan Level Information\\n 41 Plan ID (Standard Component ID) Total 41842DC0010078 41842DC0010032 41842DC0040057 41842DC0070003 41842DC0070004 41842DC0070005 41842DC0070006 41842DC0070007 41842DC0070008 41842DC0070009 41842DC0070010 41842DC0070011 41842DC0070012 41842DC0070013 41842DC0070014 41842DC0070015 41842DC0070016 41842DC0070017 41842DC0070018 41842DC0070020 41842DC0080041 41842DC0080042 41842DC0080001 41842DC0080003 41842DC0080006 41842DC0080007 41842DC0080008 41842DC0080009 41842DC0080011 41842DC0080013 41842DC0080014 41842DC0080015 41842DC0080017 41842DC0080018 41842DC0080019 41842DC0080020 41842DC0080021 41842DC0080022 41842DC0080023 41842DC0080025 41842DC0080026 41842DC0080031 41842DC0080032 41842DC0080034 41842DC0080035 41842DC0080036 41842DC0080037 41842DC0080039 41842DC0080040 41842DC0080004 41842DC0080005 41842DC0080010 41842DC0080012 41842DC0080016 41842DC0080024 41842DC0080027 41842DC0080028 41842DC0080029 41842DC0080030 41842DC0080033\\n 4\\n 2 Allowed Claims $88 142943 $3 093 389 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $342 175 $83221 $7192 903 $1456048 $9683926 $2396770 $8909698 $4601 589 $3490 180 $3638894 $12 498 737 $14 651650 $2006340 $1552327 $4044898 $554 163 $412 235 $663 189 $894 918 $372237 $1991851 $229020 $574807 $574 458 $1129408 $624 972 $53 545 $83 221 $342175 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0\\n 4\\n 3 Reinsurance $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0\\n 4\\n 4 Member Cost Sharing $8 902437 $307 964 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $39 012 $20009 $984 093 $313429 $145858 $177701 $1534288 $650 780 $628 424 $633 888 $729 569 $368 974 $459171 $28138 $358840 $133 940 $129 869 $201 848 $145 299 $93328 $381477 $55499 $123952 $56 188 $72 837 $87 379 $17 107 $22 420 $57432 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0\\n 4\\n 5 Cost Sharing Reduction $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0\\n 4\\n 6 Incurred Claims $79 240505 $2 785 425 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $303 163 $63213 $6208 810 $1142619 $9538068 $2219069 $7375410 $3950 809 $2861 757 $3005006 $11 769 168 $14 282675 $1547169 $1580465 $3686057 $420 223 $282 366 $461 341 $749 619 $278909 $1610373 $173520 $450855 $518 270 $1056571 $537 593 $36 438 $60 801 $284743 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0\\n 4\\n 7 Risk Adjustment Transfer Amount $325 084 $11 705 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $1 295 $321 $27 218 $5620 $34609 $8566 $33 715 $17 413 $13 207 $13 770 $44 668 $52362 $7744 $5548 $15306 $2 139 $1 591 $2 560 $3 386 $1437 $7537 $884 $2219 $2 174 $4 036 $2 234 $207 $321 $1295 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0\\n 4\\n 8 Premium $96 824855 $3 416 943 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $372 894 $80211 $7670 017 $1441056 $11437438 $2685582 $9177696 $4885 380 $3567 485 $3741377 $14 207 794 $17 152565 $1957651 $1886090 $4513120 $533 437 $365 827 $595 779 $930 844 $354870 $2012433 $220299 $568656 $635 540 $1276614 $658 206 $47 273 $77 739 $354038 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0\\n 4\\n 9 Projected Member Months 130556 4\\n 701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 520 129 10 931 2\\n 257 13899 3\\n 440 13 540 6\\n 993 5\\n 304 5\\n 530 17 939 21029 3\\n 110 2\\n 228 6\\n 147 859 639 1\\n 028 1\\n 360 577 3\\n 027 355 891 873 1\\n 621 897 83 129 520 0 0 0 0 0 0 0 0 0 0 0\\n 4\\n 10 Loss Ratio 8157% 81 24% #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! 8102% 7849% 8066% 7898% 8314% 8237% 8007% 8058% 7992% 8002% 82 58% 8302% 7872% 8355% 8140% 7846% 7685% 7710% 8024% 7828% 7972% 7845% 7898% 8127% 8250% 8140% 7674% 7789% 8013% #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0!\\n Per Member Per Month\\n 4\\n 11 Allowed Claims $67514 $65803 #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! $658 03 $64513 $658 03 $645 13 $696 74 $696 74 $658 03 $658 03 $658 03 $658 03 $69674 $69674 $645 13 $69674 $658 03 $645 13 $645 13 $645 13 $658 03 $64513 $65803 $64513 $64513 $658 03 $69674 $696 74 $64513 $64513 $65803 #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0!\\n 4\\n 12 Reinsurance $000 $000 #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! $0 00 $000 $0 00 $0 00 $0 00 $0 00 $0 00 $0 00 $0 00 $0 00 $000 $0 00 $0 00 $000 $0 00 $0 00 $0 00 $0 00 $0 00 $000 $000 $000 $000 $0 00 $000 $0 00 $0 00 $000 $000 #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0!\\n 4\\n 13 Member Cost Sharing $6819 $6551 #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! $75 02 $15511 $90 03 $138 87 $10 49 $51 66 $113 32 $93 06 $118 48 $114 63 $4067 $17 55 $147 64 $1263 $58 38 $155 93 $203 24 $196 35 $106 84 $16175 $12602 $15634 $13912 $64 36 $4493 $97 41 $20611 $17380 $11045 #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0!\\n 4\\n 14 Cost Sharing Reduction $000 $000 #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! $0 00 $000 $0 00 $0 00 $0 00 $0 00 $0 00 $0 00 $0 00 $0 00 $000 $0 00 $0 00 $000 $0 00 $0 00 $0 00 $0 00 $0 00 $000 $000 $000 $000 $0 00 $000 $0 00 $0 00 $000 $000 #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0!\\n 4\\n 15 Incurred Claims $60695 $59252 #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! $583 01 $49002 $568 00 $506 26 $686 24 $645 08 $544 71 $564 97 $539 55 $543 40 $65607 $67919 $497 48 $70936 $599 65 $489 20 $441 89 $448 78 $551 19 $48338 $53200 $48879 $50601 $593 67 $65180 $599 32 $43902 $47132 $54758 #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0!\\n 4\\n 16 Risk Adjustment Transfer Amount $249 $249 #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! $2 49 $249 $2 49 $2 49 $2 49 $2 49 $2 49 $2 49 $2 49 $2 49 $249 $2 49 $2 49 $249 $2 49 $2 49 $2 49 $2 49 $2 49 $249 $249 $249 $249 $2 49 $249 $2 49 $2 49 $249 $249 #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0!\\n 417 Premium $74163 $72685 #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! $717 10 $62179 $701 68 $638 48 $822 90 $780 69 $677 82 $698 61 $672 60 $676 56 $79201 $81566 $629 47 $84654 $734 20 $621 00 $572 50 $579 55 $684 44 $61503 $66483 $62056 $63822 $728 00 $78755 $733 79 $56956 $60263 $68084 #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0!\", \"page_fill_runs\": [], \"page_lines\": 481}", "page": null, "expected_markdown": null, "tags": ["real", "kind:line"]} {"pdf": "docs/real/VNM351_심층분석보고서_p2.pdf", "category": "real", "id": "VNM351_심층분석보고서_p2", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"[ 목 차 ]\\n\\n\\n\\n\\n\\n\\n1. 규제 개요 ······························································1\\n\\n\\n2. 제정 세부내용 ······················································3\\n\\n\\n3. 관련 법령 및 표준 ············································10\", \"page_fill_runs\": [62, 54, 44], \"page_lines\": 4}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:middot"]} {"pdf": "docs/real/Village-of-Red-Hook-Town-of-Red-Hook-Assessment-Roll-2024_p211.pdf", "category": "real", "id": "Village-of-Red-Hook-Town-of-Red-Hook-Assessment-Roll-2024_p211", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"* IS USED. *\\n*COPYRIGHT * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *\", \"page_fill_runs\": [47], \"page_lines\": 2}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:star"]} {"pdf": "docs/real/Word-2016-Les-Nouveaute_s_p2.pdf", "category": "real", "id": "Word-2016-Les-Nouveaute_s_p2", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" SOMMAIRE\\n\\n\\n PRESENTATION GENERALE D'OFFICE 2010 _______________________________ ERREUR ! SIGNET NON DEFINI.\\n\\nLe Ribbon------------------------------------------------------------------------------------------------------------------------------------3\\n Réduire le ribbon------------------------------------------------------------------------------------ Erreur ! Signet non défini.\\n Les groupes de commandes---------------------------------------------------------------------- Erreur ! Signet non défini.\\n Affichage de nouveaux onglets ----------------------------------------------------------------- Erreur ! Signet non défini.\\n Affichage d'options supplémentaires---------------------------------------------------------- Erreur ! Signet non défini.\\n Personnaliser le Ribbon --------------------------------------------------------------------------- Erreur ! Signet non défini.\\n La Quick Access Toolbar--------------------------------------------------------------------------- Erreur ! Signet non défini.\\n Infobulles améliorées----------------------------------------------------------------------------------Erreur ! Signet non défini.\\n La status bar----------------------------------------------------------------------------------------------Erreur ! Signet non défini.\\n Personnaliser la status bar ----------------------------------------------------------------------- Erreur ! Signet non défini.\\n Le zoom amélioré ----------------------------------------------------------------------------------- Erreur ! Signet non défini.\\n La Mini Toolbar------------------------------------------------------------------------------------------Erreur ! Signet non défini.\\n La prévisualisation directe----------------------------------------------------------------------------Erreur ! Signet non défini.\\n L'apercu instantané du collage----------------------------------------------------------------------Erreur ! Signet non défini.\\n Le Raccourci clavier Alt--------------------------------------------------------------------------------Erreur ! Signet non défini.\\n Le Mode Backstage (Bouton File)-------------------------------------------------------------------Erreur ! Signet non défini.\\n La catégorie Info ------------------------------------------------------------------------------------ Erreur ! Signet non défini.\\n Ouvrir un document récent----------------------------------------------------------------------- Erreur ! Signet non défini.\\n Les types de fichiers------------------------------------------------------------------------------------Erreur ! Signet non défini.\\n Présentation des types de fichiers-------------------------------------------------------------- Erreur ! Signet non défini.\\n Conversion de fichiers ----------------------------------------------------------------------------- Erreur ! Signet non défini.\\n Conversion en .pdf---------------------------------------------------------------------------------- Erreur ! Signet non défini.\\n Les thèmes------------------------------------------------------------------------------------------------Erreur ! Signet non défini.\\n Les graphiques SmartArt------------------------------------------------------------------------------Erreur ! Signet non défini.\\n PRESENTATION DE MICROSOFT WORD 2010 (NOUVEAUTES)________________ ERREUR ! SIGNET NON DEFINI.\\n\\n Les styles rapides -------------------------------------------------------------------------------------------------------------------------4\\n Le volet de navigation (Navigation Pane) ------------------------------------------------------------------------------------------5\\n Parcourir les titres de votre document------------------------------------------------------------------------------------------5\\n Parcourir les pages de votre document-----------------------------------------------------------------------------------------6\\n Parcourir les résultats de la recherche ------------------------------------------------------------------------------------------6\\n Vérificateur orthographique contextuel--------------------------------------------------------------------------------------------8\\n Les outils d'image-------------------------------------------------------------------------------------------------------------------------8\\n Les nouveaux effets ------------------------------------------------------------------------------------------------------------------8\\n Suppression de l'arrière-plan ------------------------------------------------------------------------------------------------------9\\n Compression et retouches d'images améliorés-------------------------------------------------------------------------------9\\n Nouveaux WordArts ---------------------------------------------------------------------------------------------------------------------9\\n Les pages de garde --------------------------------------------------------------------------------------------------------------------- 11\\n Créer une page de garde---------------------------------------------------------------------------------------------------------- 11\\nQuick Parts-------------------------------------------------------------------------------------------------------------------------------- 13\\n Créer un Quick Parts --------------------------------------------------------------------------------------------------------------- 13\\n Utiliser un Quick Part -------------------------------------------------------------------------------------------------------------- 13\\n Modifier les buildings blocks----------------------------------------------------------------------------------------------------- 14\\n Gérer les buildings blocks--------------------------------------------------------------------------------------------------------- 15\\n Entête et pied de page ---------------------------------------------------------------------------------------------------------------- 16\\n Ajouter un en-tête ou pied de page -------------------------------------------------------------------------------------------- 16\\n Ajouter une numérotation de page -------------------------------------------------------------------------------------------- 16\\n Création de tableaux------------------------------------------------------------------------------------------------------------------- 17\\n Insérer un tableau ------------------------------------------------------------------------------------------------------------------ 17\\n Insérer un tableau prédéfini ----------------------------------------------------------------------------------------------------- 18\\n Styles de tableaux améliorés----------------------------------------------------------------------------------------------------- 18\\n Le mode d'affichage plein écran---------------------------------------------------------------------------------------------------- 19\\n Track changes : nouveautés---------------------------------------------------------------------------------------------------------- 19\\n Activer les Track Changes--------------------------------------------------------------------------------------------------------- 20\\n L'impression------------------------------------------------------------------------------------------------------------------------------ 21\", \"page_fill_runs\": [31, 132, 84, 70, 65, 58, 75, 75, 82, 94, 71, 83, 90, 76, 70, 80, 67, 84, 71, 84, 62, 77, 82, 96, 78, 16, 121, 90, 90, 89, 90, 92, 121, 114, 102, 79, 117, 117, 106, 128, 111, 110, 101, 105, 112, 92, 92, 115, 114, 101, 101, 100, 106, 105, 126], \"page_lines\": 56}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:dash"]} {"pdf": "docs/real/academic_writing_task_1_describing_data_and_making_approximations_p9.pdf", "category": "real", "id": "academic_writing_task_1_describing_data_and_making_approximations_p9", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"1 (DVD players)\\n\\n……………………………………………………………………………………………………\\n……………………………………………………………………………………………………\\n2 (CD players)\\n\\n……………………………………………………………………………………………………\\n……………………………………………………………………………………………………\\n3 (Televisions)\\n\\n……………………………………………………………………………………………………\\n……………………………………………………………………………………………………\\n4 (Radios)\\n\\n……………………………………………………………………………………………………\\n……………………………………………………………………………………………………\\n\\n5 (Video recorders)\\n\\n……………………………………………………………………………………………………\\n……………………………………………………………………………………………………\\n\\n\\n\\n British Council is a proud co-owner of IELTS 9 takeielts.org\", \"page_fill_runs\": [114, 114, 114, 114, 114, 114, 114, 114, 114, 114], \"page_lines\": 16}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:ellipsis"]} {"pdf": "docs/real/api.5l.2004_p109.pdf", "category": "real", "id": "api.5l.2004_p109", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" SPECIFICATION FOR liNE PIPE 99\\n\\n Table E-6C-Plain-end Line Pipe Dimensions, Weights per Unit Length, and Test Pressures for\\n Sizes 65/8 through 80 (SI Units) (Continued)\\n(I) (2) (3) (4) (5) (6) (7) (8) (9) (10) (II) (12) (13) (14) (15)\\n Specified Specified Plain-end Calculated\\n Outside Wall Weight per Inside Minimum Test Pressureb (kPa x 1(0)\\\"\\n Diameter Thickness Unit Length Diametera\\n f) t tVpe d ~~G~G~G~G~G~G~G~G~G~\\nSize (mm) (mm) (kg/m) (mm) A B X42 X46 X52 X56 X60 X65 X70 XRO\\n 219.1 22.2 107.79 174.7 Std. 193 193 207 207 207 207 207 207 207 207\\n Alt. 193 193 441 482 500 500 500 500 500 500\\n 219.1 25.4 121.33 168.3 Std. 193 193 207 207 207 207 207 207 207 207\\n Alt. 193 193 500 500 500 500 500 500 500 500\\n\\n 273.1 4.0 26.54 265.1 Std. 36 42 72 79 89 96 103 112 120 137\\n Alt. 45 53 72 79 89 96 103 112 120 137\\n 273.1 4.8 31.76 263.5 Std. 44 51 87 95 107 liS 124 134 144 165\\n Alt. 55 64 87 95 107 liS 124 134 144 165\\n 273.1 5.2 34.35 262.7 Std. 47 55 94 103 116 125 134 14S 156 179\\n Alt. 59 69 94 103 116 125 134 145 156 179\\n 273.1 5.6 36.94 261.9 Std. 51 59 101 III 125 135 144 156 168 192\\n Alt. 64 74 101 III 125 135 144 156 16X 192\\n 273.1 6.4 42.09 260.3 Std. 58 68 116 126 143 154 165 178 192 207\\n Alt. 73 85 116 126 143 154 165 17ll 192 220\\n 273.1 7.1 46.57 258.9 Std. 65 75 128 140 159 171 183 198 207 207\\n Alt. 81 94 128 140 159 171 183 198 213 244\\n 273.1 7.R 51.03 257.5 Std. 71 83 141 154 174 187 201 207 207 207\\n Alt. 89 103 141 154 174 187 201 218 235 268\\n 273.1 8.7 56.72 255.7 Std. 79 92 157 172 194 207 207 207 207 207\\n Alt. 99 liS 157 172 194 209 224 243 262 299\\n 273.1 9.3 60.50 254.5 Std. 85 98 168 184 207 207 207 207 207 207\\n Alt. 106 123 168 184 208 223 240 259 280 320\\n 273.1 11.1 71.72 250.9 Std. 101 118 200 207 207 207 207 207 207 207\\n Alt. 126 147 200 219 248 267 286 310 334 381\\n 273.1 127 81.55 247.7 Std. 116 134 207 207 207 207 207 207 207 207\\n Alt. 144 168 229 251 284 305 327 354 382 436\\n 273.1 14.3 91.26 244.5 Std. 130 lSI 207 207 207 207 207 207 207 207\\n Alt. 163 189 258 282 320 344 369 399 430 491\\n 273.1 15.9 100.85 241.3 Std. 145 168 207 207 207 207 207 207 207 207\\n Alt. 181 193 287 314 355 382 410 443 47ll 5(x)\\n 273.1 18.3 114.99 236.5 Std. 166 193 207 207 207 207 207 207 207 207\\n Alt. 193 193 330 361 409 440 472 500 500 5(X)\\n 273.1 20.6 128.27 231.9 Std. 187 193 207 207 207 207 207 207 207 207\\n Alt. 193 193 372 406 460 495 5(x) 5(X) 5m 500\\n 273.1 22.2 137.36 228.7 Std. 193 193 207 207 207 207 207 207 207 207\\n AIL 193 193 401 438 496 500 500 5(X) 500 5Cx)\\n 273.1 23.8 146.32 225.5 Std. 193 193 207 207 207 207 207 207 207 207\\n Alt. 193 193 430 470 500 500 5(X) 500 5m 500\\n 273.1 25.4 155.15 222.3 Std. 193 193 207 207 207 207 207 207 207 207\\n Alt. 193 193 459 500 500 5(x) 500 5(x) 5(x) 5(X)\\n 273.1 31.8 189.22 209.5 Std. 193 193 207 207 207 207 207 207 207 207\\n Alt. 193 193 500 500 500 5(X) 500 500 SeX) 5(x)\\n\\n 323.9 4.4 34.67 315.1 Std. 34 39 67 73 83 89 96 103 112 127\\n Alt. 42 49 67 73 83 89 96 103 112 127\\n 323.9 4.8 37.77 314.3 Std. 37 43 73 80 90 97 104 113 122 139\\n Alt. 46 54 73 80 90 97 104 113 122 139\\n 323.9 5.2 40.87 313.5 Std. 40 46 79 87 98 \\\\05 113 122 132 lSI\\n Alt. 50 58 79 87 98 105 113 122 132 151\\n 323.9 5.6 43.96 312.7 Std. 43 50 85 93 106 113 122 132 142 162\\n Alt. 54 63 85 93 106 113 122 132 142 162\", \"page_fill_runs\": [], \"page_lines\": 59}", "page": null, "expected_markdown": null, "tags": ["real", "kind:unit"]} {"pdf": "docs/real/arxiv-2208.03875_p6.pdf", "category": "real", "id": "arxiv-2208.03875_p6", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" 6 B.B. Zhu, L. Ji, A.Q. Zhu and Y.F. Tang\\n\\n\\n It can be verified that if the conditions P1(t) = P2(t) = · · · = Pd(t) hold, the above system (3.1)\\n is the d copies of the original system (2.1), thus we have P1(t) = P2(t) = · · · = Pd(t) = P(t) if\\n the same initial condition is imposed on P and each Pi, 1 ≤ i ≤ d.\\n The next step is to explicitly solve each subsystem with the Hamiltonian Hi for 1 ≤ i ≤ d.\\n Here we present the subsystem with H1 = H(pd1, p12, p23, · · · , pd-1,d)\\n  p˙1i = ki,2(P1) ∂H1, i = 1, 3, 4, · · · , d\\n  p˙ ∂p12\\n 12 = 0\\n p˙2i = ki,3(P2) ∂H1, i = 1, 2, 4, · · · , d\\n p˙23 = 0 ∂p23 (3.2)\\n  · · ·· · · · · ·\\n p˙d1 = 0\\n p˙d,i = ki,1(Pd) ∂H1, i = 2, 3, · · · , d.\\n ∂pd1\\n It can be seen that p12, p23, · · · , pd1 are all constants as their derivatives are zero. As the\\nHamiltonian H1 is just a function of constants p12, p23, · · · , pd1, therefore its partial derivatives\\nare all constants. Thus, whether the d subsystems can be solved explicitly or not depends on\\nkij , i, j = 1, · · · , d.\\n 2\\n For the constraint function ΩHc, we separate it into ΩHc = Pdi=d+1 ΩHi with Hd+i =\\n Pd (p1i-pji) 2 Pd (p2i-pji) 2 (pd-1,i-pdi)2\\n j=2 2 , H2d+i = j=3 2 , · · · , H(d-1)d+i = 2 , i = 1, 2, · · · , d. Here\\n we only present the subsystem with Hamiltonian ΩHd+1\\n  p˙11 = 0\\n  p˙\\n 1i = ki1(P1)Ω(p11 - p21 + p11 - p31 + · · · + p11 - pd1), i = 2, 3, · · · , d\\n p˙21 = 0\\n p˙2i = ki1(P2)Ω(p21 - p11), i = 2, 3, · · · , d (3.3)\\n · · · · · · · · ·\\n  p˙\\n d1 = 0\\n p˙d,i = ki1(Pd)Ω(pd1 - p11), i = 2, 3, · · · , d.\\nWe can find that p11, p21, · · · , pd1 are all constants.\\n Now we discuss how to identify the situation in which the above d2 subsystems can be solved\\nexplicitly. We make an explanation under the original variable P = (p1, p2, · · · , pd) and consider\\n the matrix K-1 (P) = (kij (P))d×d. From the subsystem (3.2) and (3.3), we observe that if we\\n want to solve each variable in a close form, the kij should only contain the i-th variable pi and the\\n j-th variable pj , i.e. kij = kij (pi, pj )[37], furthermore, the following conditions should also hold:\\n there exist continuous functions Fij (pi, pj ) and Gij (pi , pj ) such that dFij (pi,pj ) = 1\\n dpi kij (pi,pj ) and\\n dGij (pi,pj ) 1\\n dpj = kij (pi,pj ) and pi and pj can be solved in closed forms from the functions Fij (pi, pj )\\n and Gij (pi, pj ) for any 1 ≤ i, j ≤ d, i 6= j. If the above requirements are satisfied, then all the\\n subsystems can be solved explicitly.\\n Remark 3.1. By extending the d dimensional phase space to the d 2 dimensional phase space,\\nwhether the subsystems can be solved exactly or not depends totally on the elements of the skew-\\nsymmetric matrix K-1.\\n If all the d2 subsystems can be solved explicitly, then the first order explicit K-symplectic\\nmethod can be constructed by composing all the exact solutions. The higher order explicit\", \"page_fill_runs\": [], \"page_lines\": 50}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:middot"]} {"pdf": "docs/real/arxiv-2601.17103_p50.pdf", "category": "real", "id": "arxiv-2601.17103_p50", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" S8. Coverage and width: full results\\n\\n S8.1 Segmentation\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n DSC IOU BOUNDARY IOU NSD CLDICE HD HD PERC MASD ASSD\\n 100 100 100 100 100 100 100 100 100\\n\\n 95 95 95 95 95 95 95 95 95\\n\\n 90 90 90 90 90 90 90 90 90\\n Basic Basic\\n 85 Basic 85 Basic 85 Basic 85 Basic 85 Basic 85 Basic 85 BCa 85 BCa 85 Basic\\n BCa BCa BCa BCa BCa BCa Percentile Percentile BCa\\n Percentile Percentile Percentile Percentile Percentile Percentile Parametric t Parametric t Percentile\\n 80 Parametric t 80 Parametric t 80 Parametric t 80 Parametric t 80 Parametric t 80 Parametric t 80 Parametric z 80 Parametric z 80 Parametric t\\n Parametric z Parametric z Parametric z Parametric z Parametric z Parametric z Count below Count below\\n 50% coverage 50% coverage Parametric z\\n 75 75 75 75 75 75 75 75 75\\n\\n 70 70 70 70 70 70 70 70 70\\n\\n 65 65 65 65 65 65 65 65 65\\n\\n 60 60 60 60 60 60 60 60 60\\n\\n 55 55 55 55 55 55 55 55 55\\n\\n 50 50 50 50 50 50 50 50 50\\n10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250\\n Sample size Sample size Sample size Sample size Sample size Sample size Sample size Sample size Sample size\\n\\n DSC IOU BOUNDARY IOU NSD CLDICE HD HD PERC MASD ASSD\\n 100 100 100 100 100 100 100 100 100\\n\\n 95 95 95 95 95 95 95 95 95\\n\\n 90 90 90 90 90 90 90 90 90\\n Basic Basic Basic Basic Basic Basic\\n 85 BCa 85 BCa 85 BCa 85 BCa 85 85 BCa 85 BCa 85 85\\n Percentile Percentile Percentile Percentile Percentile Percentile\\n Count below Count below Count below Count below Basic Count below Count below Basic Basic\\n 80 50% coverage 80 50% coverage 80 50% coverage 80 50% coverage 80 BCa 80 50% coverage 80 50% coverage 80 BCa 80 BCa\\n Count above Count above Count above Count above Count above Count above\\n 99.5% coverage 99.5% coverage 99.5% coverage 99.5% coverage Percentile 99.5% coverage 99.5% coverage Percentile Percentile\\n 75 75 75 75 75 75 75 75 75\\n\\n 70 70 70 70 70 70 70 70 70\\n\\n 65 65 65 65 65 65 65 65 65\\n\\n 60 60 60 60 60 60 60 60 60\\n\\n 55 55 55 55 55 55 55 55 55\\n\\n 50 50 50 50 50 50 50 50 50\\n10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250\\n Sample size Sample size Sample size Sample size Sample size Sample size Sample size Sample size Sample size\\n\\n DSC IOU BOUNDARY IOU NSD CLDICE HD HD PERC MASD ASSD\\n 100 100 100 100 100 100 100 100 100\\n\\n 95 95 95 95 95 95 95 95 95\\n\\n 90 90 90 90 90 90 90 90 90\\n Basic Basic Basic\\n 85 BCa 85 BCa 85 BCa 85 85 85 85 85 85\\n Percentile Percentile Percentile\\n Count below Count below Count below Basic Basic Basic Basic Basic Basic\\n 80 50% coverage 80 50% coverage 80 50% coverage 80 BCa 80 BCa 80 BCa 80 BCa 80 BCa 80 BCa\\n Count above Count above Count above\\n 99.5% coverage 99.5% coverage 99.5% coverage Percentile Percentile Percentile Percentile Percentile Percentile\\n 75 75 75 75 75 75 75 75 75\\n\\n 70 70 70 70 70 70 70 70 70\\n\\n 65 65 65 65 65 65 65 65 65\\n\\n 60 60 60 60 60 60 60 60 60\\n\\n 55 55 55 55 55 55 55 55 55\\n\\n 50 50 50 50 50 50 50 50 50\\n10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250\\n Sample size Sample size Sample size Sample size Sample size Sample size Sample size Sample size Sample size\\n\\n DSC IOU BOUNDARY IOU NSD CLDICE HD HD PERC MASD ASSD\\n 100 100 100 100 100 100 100 100 100\\n\\n 95 95 95 95 95 95 95 95 95\\n\\n 90 90 90 90 90 90 90 90 90\\n\\n 85 Basic 85 Basic 85 Basic 85 Basic 85 85 Basic 85 Basic 85 Basic 85 Basic\\n BCa BCa BCa BCa Basic BCa BCa BCa BCa\\n 80 Percentile 80 Percentile 80 Percentile 80 Percentile 80 BCa 80 Percentile 80 Percentile 80 Percentile 80 Percentile\\n Count below Count below Count below Count below Count below Count below Count below Count below\\n 50% coverage 50% coverage 50% coverage 50% coverage Percentile 50% coverage 50% coverage 50% coverage 50% coverage\\n 75 75 75 75 75 75 75 75 75\\n\\n 70 70 70 70 70 70 70 70 70\\n\\n 65 65 65 65 65 65 65 65 65\\n\\n 60 60 60 60 60 60 60 60 60\\n\\n 55 55 55 55 55 55 55 55 55\\n\\n 50 50 50 50 50 50 50 50 50\\n10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250\\n Sample size Sample size Sample size Sample size Sample size Sample size Sample size Sample size Sample size\\n\\n DSC IOU BOUNDARY IOU NSD CLDICE HD HD PERC MASD ASSD\\n 100 100 100 100 100 100 100 100 100\\n\\n 95 95 95 95 95 95 95 95 95\\n\\n 90 90 90 90 90 90 90 90 90\\n Basic Basic Basic Basic Basic\\n 85 BCa 85 BCa 85 BCa 85 Basic 85 85 BCa 85 BCa 85 Basic 85\\n Percentile Percentile Percentile BCa Percentile Percentile BCa\\n Count below Count below Count below Basic Count below Count below Basic\\n 80 50% coverage 80 50% coverage 80 50% coverage 80 Percentile 80 BCa 80 50% coverage 80 50% coverage 80 Percentile 80 BCa\\n Count above Count above Count above Count below Count above Count above Count below\\n 99.5% coverage 99.5% coverage 99.5% coverage 50% coverage Percentile 99.5% coverage 99.5% coverage 50% coverage Percentile\\n 75 75 75 75 75 75 75 75 75\\n\\n 70 70 70 70 70 70 70 70 70\\n\\n 65 65 65 65 65 65 65 65 65\\n\\n 60 60 60 60 60 60 60 60 60\\n\\n 55 55 55 55 55 55 55 55 55\\n\\n 50 50 50 50 50 50 50 50 50\\n10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250 10 25 50 75 100 125 150 200 250\\n Sample size Sample size Sample size Sample size Sample size Sample size Sample size Sample size Sample size\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n Figure S4: Coverages for all metrics and all summary statistics for segmentation instances. To ease\\n zooming, this figure is also available as a separate PDF files at https://www.github.com/aramis-lab/\\n CIs_Medical_Imaging_Plots/blob/main/supplementary/all_cov_segm.pdf.\\nIf there are instances below 50% or above 99.5% coverage, their number is indicated above a triangle. This applies to other\\n coverage boxplots.\\n\\n\\n\\n\\n\\n\\n 1.0 DSC 1.0 IOU 1.0 BOUNDARY IOU 1.0 NSD 1.0 CLDICE 160 HD 140 HD PERC 99 MASD 100 ASSD\\n 0.9 0.9 0.9 0.9 0.9 144 126 90 90\\n 0.8 0.8 0.8 0.8 0.8 128 112 81 80\\n 0.7 Basic 0.7 Basic 0.7 Basic 0.7 Basic 0.7 Basic 112 Basic 98 Basic 72 Basic 70 Basic\\n BCa BCa BCa BCa BCa BCa BCa 63 BCa BCa\\n 0.6 Percentile 0.6 Percentile 0.6 Percentile 0.6 Percentile 0.6 Percentile 96 Percentile 84 Percentile Percentile 60 Percentile\\n Parametric t Parametric t Parametric t Parametric t Parametric t Parametric t Parametric t 54 Parametric t Parametric t\\n Parametric z Parametric z Parametric z Parametric z Parametric z Parametric z Parametric z Parametric z Parametric z\\n 0.5 0.5 0.5 0.5 0.5 80 70 45 50\\n 0.4 0.4 0.4 0.4 0.4 64 56 36 40\\n 0.3 0.3 0.3 0.3 0.3 48 42 27 30\\n 0.2 0.2 0.2 0.2 0.2 32 28 18 20\\n 0.1 0.1 0.1 0.1 0.1 16 14 9 10\\n 0.010 25 50 75 100 125 150 200 250 0.010 25 50 75 100 125 150 200 250 0.010 25 50 75 100 125 150 200 250 0.010 25 50 75 100 125 150 200 250 0.010 25 50 75 100 125 150 200 250 010 25 50 75 100 125 150 200 250 010 25 50 75 100 125 150 200 250 010 25 50 75 100 125 150 200 250 010 25 50 75 100 125 150 200 250\\n Sample size Sample size Sample size Sample size Sample size Sample size Sample size Sample size Sample size\\n\\n 1.0 DSC 1.0 IOU 1.0 BOUNDARY IOU 1.0 NSD 1.0 CLDICE 180 HD 140 HD PERC 110 MASD 110 ASSD\\n 0.9 0.9 0.9 0.9 0.9 162 126 99 99\\n 0.8 0.8 0.8 0.8 0.8 144 112 88 88\\n 0.7 0.7 0.7 0.7 0.7 126 98 77 77\\n 0.6 Basic 0.6 Basic 0.6 Basic 0.6 Basic 0.6 Basic 108 Basic 84 Basic 66 Basic 66 Basic\\n BCa BCa BCa BCa BCa BCa BCa BCa BCa\\n Percentile Percentile Percentile Percentile Percentile Percentile Percentile Percentile Percentile\\n 0.5 0.5 0.5 0.5 0.5 90 70 55 55\\n 0.4 0.4 0.4 0.4 0.4 72 56 44 44\\n 0.3 0.3 0.3 0.3 0.3 54 42 33 33\\n 0.2 0.2 0.2 0.2 0.2 36 28 22 22\\n 0.1 0.1 0.1 0.1 0.1 18 14 11 11\\n 0.010 25 50 75 100 125 150 200 250 0.010 25 50 75 100 125 150 200 250 0.010 25 50 75 100 125 150 200 250 0.010 25 50 75 100 125 150 200 250 0.010 25 50 75 100 125 150 200 250 010 25 50 75 100 125 150 200 250 010 25 50 75 100 125 150 200 250 010 25 50 75 100 125 150 200 250 010 25 50 75 100 125 150 200 250\\n Sample size Sample size Sample size Sample size Sample size Sample size Sample size Sample size Sample size\\n\\n 1.0 DSC 1.0 IOU 1.0 BOUNDARY IOU 1.0 NSD 1.0 CLDICE 160 HD 120 HD PERC 90 MASD 90 ASSD\\n 0.9 0.9 0.9 0.9 0.9 144 108 81 81\\n 0.8 0.8 0.8 0.8 0.8 128 96 72 72\\n 0.7 0.7 0.7 0.7 0.7 112 84 Basic 63 Basic 63 Basic\\n 0.6 Basic 0.6 Basic 0.6 Basic 0.6 Basic 0.6 Basic 96 Basic\\n BCa BCa BCa BCa BCa BCa 72 BCa 54 BCa 54 BCa\\n 0.5 Percentile 0.5 Percentile 0.5 Percentile 0.5 Percentile 0.5 Percentile 80 Percentile 60 Percentile 45 Percentile 45 Percentile\\n 0.4 0.4 0.4 0.4 0.4 64 48 36 36\\n 0.3 0.3 0.3 0.3 0.3 48 36 27 27\\n 0.2 0.2 0.2 0.2 0.2 32 24 18 18\\n 0.1 0.1 0.1 0.1 0.1 16 12 9 9\\n 0.010 25 50 75 100 125 150 200 250 0.010 25 50 75 100 125 150 200 250 0.010 25 50 75 100 125 150 200 250 0.010 25 50 75 100 125 150 200 250 0.010 25 50 75 100 125 150 200 250 010 25 50 75 100 125 150 200 250 010 25 50 75 100 125 150 200 250 010 25 50 75 100 125 150 200 250 010 25 50 75 100 125 150 200 250\\n Sample size Sample size Sample size Sample size Sample size Sample size Sample size Sample size Sample size\\n\\n 1.0 DSC 1.0 IOU 1.0 BOUNDARY IOU 1.0 NSD 1.0 CLDICE 120 HD 100 HD PERC 55 MASD 66 ASSD\\n 0.9 0.9 0.9 0.9 0.9 108 90 50 60\\n 0.8 0.8 0.8 0.8 0.8 96 80 45 54\\n 0.7 0.7 0.7 0.7 0.7 84 70 40 48\\n 0.6 Basic 0.6 Basic 0.6 Basic 0.6 Basic 0.6 Basic Basic Basic 35 Basic 42 Basic\\n BCa BCa BCa BCa BCa 72 BCa 60 BCa BCa 36 BCa\\n 0.5 Percentile 0.5 Percentile 0.5 Percentile 0.5 Percentile 0.5 Percentile 60 Percentile 50 Percentile 30 Percentile Percentile\\n 0.4 0.4 0.4 0.4 0.4 48 40 25 30\\n 0.3 0.3 0.3 0.3 0.3 36 30 20 24\\n 0.2 0.2 0.2 0.2 0.2 24 20 15 18\\n 10 12\\n 0.1 0.1 0.1 0.1 0.1 12 10 5 6\\n 0.010 25 50 75 100 125 150 200 250 0.010 25 50 75 100 125 150 200 250 0.010 25 50 75 100 125 150 200 250 0.010 25 50 75 100 125 150 200 250 0.010 25 50 75 100 125 150 200 250 010 25 50 75 100 125 150 200 250 010 25 50 75 100 125 150 200 250 010 25 50 75 100 125 150 200 250 010 25 50 75 100 125 150 200 250\\n Sample size Sample size Sample size Sample size Sample size Sample size Sample size Sample size Sample size\\n\\n 1.0 DSC 1.0 IOU 1.0 BOUNDARY IOU 1.0 NSD 1.0 CLDICE 280 HD 240 HD PERC 150 MASD 160 ASSD\\n 0.9 0.9 0.9 0.9 0.9 252 216 135 144\\n 0.8 0.8 0.8 0.8 0.8 224 192 120 128\\n 0.7 Basic 0.7 Basic 0.7 Basic 0.7 Basic 0.7 Basic 196 Basic 168 105 Basic 112 Basic\\n 0.6 BCa 0.6 BCa 0.6 BCa 0.6 BCa 0.6 BCa 168 BCa 144 Basic 90 96\\n BCa BCa BCa\\n Percentile Percentile Percentile Percentile Percentile Percentile Percentile Percentile Percentile\\n 0.5 0.5 0.5 0.5 0.5 140 120 75 80\\n 0.4 0.4 0.4 0.4 0.4 112 96 60 64\\n 0.3 0.3 0.3 0.3 0.3 84 72 45 48\\n 0.2 0.2 0.2 0.2 0.2 56 48 30 32\\n 0.1 0.1 0.1 0.1 0.1 28 24 15 16\\n 0.010 25 50 75 100 125 150 200 250 0.010 25 50 75 100 125 150 200 250 0.010 25 50 75 100 125 150 200 250 0.010 25 50 75 100 125 150 200 250 0.010 25 50 75 100 125 150 200 250 010 25 50 75 100 125 150 200 250 010 25 50 75 100 125 150 200 250 010 25 50 75 100 125 150 200 250 010 25 50 75 100 125 150 200 250\\n Sample size Sample size Sample size Sample size Sample size Sample size Sample size Sample size Sample size\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nFigure S5: CI widths for all metrics and all summary statistics for segmentation instances. To ease\\nzooming, this figure is also available as a separate PDF files at https://www.github.com/aramis-lab/\\nCIs_Medical_Imaging_Plots/blob/main/supplementary/all_width_segm.pdf.\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n 50\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nQR_LENGTH\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nQR_LENGTH\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nQR_LENGTH\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nQR_LENGTH\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nQR_LENGTH\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nQR_LENGTH\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nQR_LENGTH\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nQR_LENGTH\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nQR_LENGTH\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nQR_LENGTH\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nQR_LENGTH\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nQR_LENGTH\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nQR_LENGTH\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nQR_LENGTH\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nQR_LENGTH\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nQR_LENGTH\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nQR_LENGTH\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nQR_LENGTH\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nSTD TRMMED_MEAN MEDAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nSTD TRMMED_MEAN MEDAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nSTD TRMMED_MEAN MEDAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nSTD TRMMED_MEAN MEDAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nSTD TRMMED_MEAN MEDAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nSTD TRMMED_MEAN MEDAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nSTD TRMMED_MEAN MEDAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nSTD TRMMED_MEAN MEDAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nSTD TRMMED_MEAN MEDAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nSTD TRMMED_MEAN MEDAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nSTD TRMMED_MEAN MEDAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nSTD TRMMED_MEAN MEDAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nSTD TRMMED_MEAN MEDAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nSTD TRMMED_MEAN MEDAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nSTD TRMMED_MEAN MEDAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nSTD TRMMED_MEAN MEDAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nSTD TRMMED_MEAN MEDAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nSTD TRMMED_MEAN MEDAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nMEAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nMEAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nMEAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nMEAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nMEAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nMEAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nMEAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nMEAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nMEAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nMEAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nMEAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nMEAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nMEAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nMEAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nMEAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nMEAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nMEAN\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nMEAN\", \"page_fill_runs\": [], \"page_lines\": 228}", "page": null, "expected_markdown": null, "tags": ["real", "kind:line"]} {"pdf": "docs/real/corriges-exercices-php5-ed2_p160.pdf", "category": "real", "id": "corriges-exercices-php5-ed2_p160", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"{\\n//******************************************\\n//Récupération des valeurs\\n//******************************************\\n$nom= $_POST[\\\"nom\\\"];\\n$prenom= $_POST[\\\"prenom\\\"];\\n$siecle= $_POST[\\\"siecle\\\"];\\n$texte= $_POST[\\\"texte\\\"];\\n//***************************\\n//connexion au serveur MySQL\\n//***************************\\ninclude_once(\\\"connex.inc.php\\\");\\n$idcom=connex(\\\"dico\\\",\\\"myparam\\\");\\n//*************************************************************\\n//Recherche de l'idauteur et du siècle si l'auteur existe déjà\\n//dans la table auteurs\\n//*************************************************************\\n$queryaut = \\\"SELECT idauteur,siecle FROM auteurs WHERE\\nnom='$nom'\\\";\\n$result = mysql_query($queryaut,$idcom)or die(\\\"ERREUR RESULTAT\\\");\\n$tabid = mysql_fetch_row($result);\\n//Si l'auteur existe\\nif($tabid)\\n{\\n$idauteur= $tabid[0];\\n$siecle= $tabid[1];\\n$query = \\\"INSERT INTO citation (texte,idauteur) VALUES ('$texte','$idauteur')\\\";\\nmysql_query($query,$idcom)or die(\\\"ERREUR D'INSERTION\\\".$nom);\\n}\\n//si l'auteur n'existe pas encore\\nelse\\n{\\n$queryins=\\\"INSERT INTO auteurs (nom,prenom,siecle) VALUES ('$nom','$prenom',$siecle) \\\";\\nmysql_query($queryins,$idcom)or die(\\\"ERREUR D'INSERTION auteurs\\\");\\n$idauteur= mysql_insert_id();\\n$query = \\\"INSERT INTO citation (texte,idauteur) VALUES ('$texte',$idauteur) \\\";\\nmysql_query($query,$idcom)or die(\\\"ERREUR D'INSERTION citation\\\");\\n}\\n}\\ninclude_once('pied.htm');\\n?>\\n\\n\\n\\nLa base de données MySQL\\nNommée dico, la base de données doit répondre au modèle\\nconceptuel de données représenté à la figure 21-4. Les contraintes sont les suivantes :\", \"page_fill_runs\": [42, 42, 27, 27, 61, 61], \"page_lines\": 44}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:star"]} {"pdf": "docs/real/d23314dars_p61.pdf", "category": "real", "id": "d23314dars_p61", "type": "repetition_overshoot", "rule": "{\"reference_text\": \".78B; E< ThEDJ;DJI\\n\\n\\n\\n\\nG8@ \\u0015 Th;DI?L; #D9EC; - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \\u0014\\u0014\\nThEDIEB?:7J;: -J7J;C;DJI E< ?D7D9?7B *EI?J?ED - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \\u0014\\u0015\\nThEDIEB?:7J;: -J7J;C;DJI E< Th7I> BEMI - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \\u0014\\u0016\\nThEDIEB?:7J;: -J7J;C;DJI E< flGK?JO - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \\u0014\\u0017\\n-KCC7HO E< fiKI?D;II -;=C;DJ ffi7J7 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \\u0014\\u0018\\n(EJ; \\u0010 -KCC7HO E< -?=D?7H; - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \\u0016\\u0013\\n(EJ; \\u0015 #D9EC; .7N;I - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \\u0016\\u0015\\n(EJ; \\u0016 ft99EKDJI ,;9;?L78B; - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \\u0017\\u0010\\n(EJ; \\u0017 ftBBEM7D9; ThKIJEC;HI - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \\u0017\\u0012\\n(EJ; \\u0010\\u0010 ?D7D9?D= ,;9;?L78B;I 7D: )F;H7J?D= &;7I; flGK?FC;DJ - - - - - - - - - - - - - - - - - - - - - - - - \\u0017\\u0012\\n(EJ; \\u0010\\u0011 *HEF;HJO *B7DJ 7D: flGK?FC;DJ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \\u0017\\u0014\\n(EJ; \\u0010\\u0012 #DL;IJC;DJI - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \\u0017\\u0014\\n(EJ; \\u0010\\u0013 &;7I;I - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \\u0017\\u0015\\n(EJ; \\u0010\\u0014 &?78?B?J?;I ThECC?JC;DJI 7D: ThEDJ?D=;D9?;I - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \\u0017\\u0016\\n(EJ; \\u0010\\u0015 ftHH7D=;C;DJI M?J> )<< fi7B7D9; ->;;J ,?IA - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \\u0018\\u0012\\n(EJ; \\u0010\\u0016 ffi;8J - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \\u0018\\u0013\\n(EJ; \\u0010\\u0017 *EIJH;J?H;C;DJ *B7DI - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \\u0018\\u0014\\n(EJ; \\u0010\\u0018 ->7H; fi7I;: ThECF;DI7J?ED 7D: )J>;H ThECF;DI7J?ED ftHH7D=;C;DJI - - - - - - - - - - - - - \\u0010\\u000f\\u0013\\n(EJ; \\u0011\\u000f ->7H;>EB:;HIU flGK?JO - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \\u0010\\u000f\\u0017\\n(EJ; \\u0011\\u0010 ffi;H?L7J?L; ?D7D9?7B #DIJHKC;DJI - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \\u0010\\u0010\\u000f\\n(EJ; \\u0011\\u0011 7?H 07BK; ';7IKH;C;DJI - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \\u0010\\u0010\\u0011\\n(EJ; \\u0011\\u0012 &;=7B *HE9;;:?D=I - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \\u0010\\u0010\\u0013\\n(EJ; \\u0011\\u0013 -;=C;DJ 7D: ,;L;DK; #DC)Wft=/CÉO:Y=/; 793\\u0014FpC)W\\u0014:23kBft a\\bO :< ;\\nÇ?Ç?Ç?Ç?Ç?Ç?Ç?Ç?Ç'7Q5F?;):<:Y3$.Ž&:7L 3 f?:Y\\n Ç Ç?Ç?Ç?Ç?Ç?Ç?Ç?Ç?Ç F?;):<:Y 3 f?:Y\\n 3\\n 5N-%$©Ç\\n ä ä -Yä -?-Yä -?-Yä O6G9Bft : hÉ793\\u0014:Y\\n ç Ç?ä -Yä?ä -Yä?ä - F?;):<:Y 3 5N-%$©ä\\n hÉ793\\u0014:Y\\n 5N-%$©Ç\\n æ ä?ä -Yä?ä -Yä?ä - O6G9Bft : hÉ793\\u0014:Y\\n 5Thç&$©æ\\n ë -YÇ?ä -YÇ?ä -YÇ?ä ;):Y8 hÉ793\\u0014:Y\\n\\nÕT&-YÇ?ä -YÇ?ä -YÇ?ä–7Q5 ;):Y=?A W\\u0014:Y8ÂO_g–5)14a':E1?C)W\\u0014:<;\\b;)1k1?C<]ò;):Y8K A`14G914B\\u0014;-alBft5DCNO :'1?OftC)=?793ft:Y8\\n:7L 3 f?:Y\\n Ç -YÇ?ä -YÇ?ä -YÇ?ä O6G9Bft : 3 f?:Y\\n ä Ç?ä -Yä -?-Yä -?- F?;):<:Y 3 hÉ79 5N-%$©Ç\\n 3\\u0014:Y\\n 5N-%$©Ç\\n ç Ç -?-Yä?ä -Yä -?- F?;):<:Y hÉ793\\u0014:Y\\n 3\\n 5Thç&$©Ç\\n æ ä?ä?Ç?Ç -YÇ?Ç -YÇ ;):Y8 hÉ793\\u0014:Y\\n 5ffiä\\u0010$©æ\\n ë -?-Yä -Yä?ä -Yä?ä O6G9Bft : hÉ793\\u0014:Y\\n ÷ ä?ä -Yä?ä -Yä?ä - F?;):<:Y 3 5N-%$©Ç\\n hÉ793\\u0014:Y\\n :-ë\\u0010$©÷\\n é Ç?Ç?Ç?Ç?Ç?Ç?Ç?Ç?Ç ;):Y8 hÉ793\\u0014\\n\\n ¢XW_Bft5pC)W\\u0014:NA`14G914B\\u0014;X1?TÇ?Ç?Ç?Ç?Ç?Ç?Ç?Çn795p;):Y8“A`143kCD; =?8ft79A`C)7Q3\\u0014F'C)Wft=/Cffi7LCX7Q5ThF?;);):Y3$.\", \"page_fill_runs\": [], \"page_lines\": 41}", "page": null, "expected_markdown": null, "tags": ["real", "kind:unit"]} {"pdf": "docs/real/intinv325_p5.pdf", "category": "real", "id": "intinv325_p5", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" January 16, 2026\\nTable 2. Change in the U.S. Net International Investment Position\\n [Billions of dollars, not seasonally adjusted]\\n Change in position in 2025:Q3\\n End of Attributable to: End of\\n quarter quarter Other changes in postion\\n Line Type of investment position, Changes in position, Total\\n 2025:Q2 r Financial Price Exchange-rate volume and 2025:Q3 p\\n transactions changes 1 Total changes valuation n.i.e. 2\\n 1 U.S. net international investment position (line 4 less line 36) -26,158.0 -1,456.0 -386.1 -1,069.8 (4\\n ) (4\\n ) (4\\n ) -27,614.0\\n 2 Net international investment position excluding financial derivatives (line 5 less line 37) -26,156.9 -1,468.7 -370.1 -1,098.6 -1,059.2 -136.5 97.1 -27,625.6\\n 3 Financial derivatives other than reserves, net (line 6 less line 38) 3 -1.1 12.7 -16.1 28.8 (4\\n ) (4\\n ) (4\\n 3 ) 11.6\\n 3 3 3 3\\n 4 U.S. assets 39,558.0 1,713.5 ( ) ( ) ( ) ( ) ( ) 41,271.5\\n 5 Assets excluding financial derivatives (sum of lines 7, 10, 21, and 27) 37,400.9 2,009.8 427.73 1,582.1 1,625.9 -154.9 111.1 39,410.6\\n 3 3 3 3\\n 6 Financial derivatives other than reserves, gross positive fair value (line 15) 2,157.2 -296.3 ( ) ( ) ( ) ( ) ( ) 1,860.9\\n By functional category:\\n 7 Direct investment at market value 12,523.2 704.3 116.2 588.1 609.4 -43.7 22.5 13,227.5\\n 8 Equity 11,233.6 661.7 91.6 570.1 609.4 -43.7 4.5 11,895.4\\n 9 Debt instruments 1,289.5 42.6 24.6 18.0 ….. ….. 18.0 1,332.1\\n 10 Portfolio investment 17,611.9 950.9 86.2 864.7 875.9 -99.8 88.6 18,562.8\\n 11 Equity and investment fund shares 13,669.6 899.6 71.3 828.3 863.0 -89.5 54.8 14,569.2\\n 12 Debt securities 3,942.3 51.4 14.9 36.5 12.9 -10.2 33.8 3,993.6\\n 13 Short term 438.2 -19.1 -18.6 -0.5 ….. -0.5 0.0 419.0\\n 14 Long term 3,504.1 70.5 33.5 37.0 12.9 -9.7 33.8 3,574.6\\n ) (3\\n ) (3\\n ) (3\\n ) (3\\n 15 Financial derivatives other than reserves, gross positive fair value 2,157.2 -296.3 (3 ) 1,860.9\\n ) (3\\n ) (3\\n ) (3\\n ) (3\\n 16 Over-the-counter contracts 2,071.5 -301.4 (3 ) 1,770.1\\n (3\\n ) (3\\n ) (3\\n ) (3\\n ) (3\\n 17 Single-currency interest rate contracts 1,417.2 -204.6 ) (3 ) 1,212.6\\n ) (3\\n ) (3\\n 18 Foreign exchange contracts 431.6 -128.1 (3 ) (3\\n 3 ) 303.5\\n 3 3 3 3\\n 19 Other contracts 222.7 31.3 ( ) ( ) ( ) ( ) ( ) 254.0\\n ) (3\\n ) (3\\n ) (3\\n ) (3\\n 20 Exchange-traded contracts 85.7 5.1 (3 ) 90.8\\n 21 Other investment 6,161.7 213.9 224.4 -10.5 0.0 -10.5 0.0 6,375.6\\n 22 Other equity 79.1 0.2 0.2 (*) 0.0 (*) 0.0 79.3\\n 23 Currency and deposits 2,515.5 134.8 139.7 -4.9 ….. -4.9 0.0 2,650.3\\n 24 Loans 3,523.4 74.1 79.7 -5.6 ….. -5.6 0.0 3,597.5\\n 25 Insurance technical reserves n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a.\\n 26 Trade credit and advances 43.7 4.8 4.9 (*) ….. (*) 0.0 48.5\\n 27 Reserve assets 1,104.1 140.6 0.9 139.7 140.6 -0.9 0.0 1,244.7\\n 28 Monetary gold 859.7 140.6 0.0 140.6 140.6 ….. 0.0 1,000.3\\n 29 Special drawing rights 174.8 -0.1 0.3 -0.4 ….. -0.4 0.0 174.7\\n 30 Reserve position in the International Monetary Fund 30.3 0.2 0.2 -0.1 ….. -0.1 0.0 30.5\\n 31 Other reserve assets 39.3 -0.1 0.4 -0.5 0.0 -0.5 0.0 39.1\\n 32 Currency and deposits 22.1 6.3 0.2 6.1 ….. -0.1 6.2 28.4\\n 33 Securities 17.1 -6.4 0.1 -6.5 0.0 -0.4 -6.2 10.7\\n 34 Financial derivatives ..... ..... ..... ..... ..... ..... ..... .....\\n 35 Other claims 0.0 0.0 0.0 0.0 ….. 0.0 0.0 0.0\\n ) (3\\n ) (3\\n ) (3\\n ) (3\\n 36 U.S. liabilities 65,716.0 3,169.5 (3 ) 68,885.5\\n 37 Liabilities excluding financial derivatives (sum of lines 39, 42, and 57) 63,557.7 3,478.5 797.8 2,680.7 2,685.2 -18.5 14.0 67,036.2\\n ) (3\\n ) (3\\n ) (3\\n ) (3\\n 38 Financial derivatives other than reserves, gross negative fair value (line 51) 2,158.3 -309.0 (3 ) 1,849.3\\n By functional category:\\n 39 Direct investment at market value 18,596.5 1,306.7 115.1 1,191.6 1,201.1 ….. -9.5 19,903.2\\n 40 Equity 16,752.3 1,274.4 91.4 1,183.0 1,201.1 ….. -18.1 18,026.8\\n 41 Debt instruments 1,844.1 32.3 23.7 8.6 ….. ….. 8.6 1,876.4\\n 42 Portfolio investment 35,272.8 1,983.9 486.8 1,497.1 1,484.1 -10.5 23.5 37,256.7\\n 43 Equity and investment fund shares 19,855.3 1,599.7 206.1 1,393.5 1,388.5 ….. 5.0 21,455.0\\n 44 Debt securities 15,417.5 384.2 280.6 103.6 95.6 -10.5 18.5 15,801.7\\n 45 Short term 1,649.7 27.9 28.1 -0.2 ….. -0.2 0.0 1,677.6\\n 46 Treasury bills and certificates 1,415.3 0.4 0.4 0.0 ….. ….. 0.0 1,415.8\\n 47 Other short-term securities 234.4 27.4 27.6 -0.2 ….. -0.2 0.0 261.8\\n 48 Long term 13,767.8 356.3 252.5 103.8 95.6 -10.3 18.5 14,124.1\\n 49 Treasury bonds and notes 7,688.8 144.3 118.6 25.6 23.2 ….. 2.4 7,833.1\\n 50 Other long-term securities 6,079.0 212.0 133.9 78.1 72.3 -10.3 16.1 6,291.0\\n ) (3\\n ) (3\\n ) (3\\n ) (3\\n 51 Financial derivatives other than reserves, gross negative fair value 2,158.3 -309.0 (3 ) 1,849.3\\n (3\\n ) (3\\n ) (3\\n ) (3\\n ) (3\\n 52 Over-the-counter contracts 2,076.9 -313.2 ) (3 ) 1,763.7\\n ) (3\\n ) (3\\n 53 Single-currency interest rate contracts 1,391.0 -199.6 (3 ) (3\\n 3 ) 1,191.4\\n 3 3 3 3\\n 54 Foreign exchange contracts 453.1 -149.0 ( ) ( ) ( ) ( ) ( ) 304.1\\n ) (3\\n ) (3\\n ) (3\\n 55 Other contracts 232.9 35.4 (3 ) (3\\n 3 ) 268.2\\n 3 3 3 3\\n 56 Exchange-traded contracts 81.4 4.2 ( ) ( ) ( ) ( ) ( ) 85.6\\n 57 Other investment 9,688.5 187.9 195.9 -8.0 ….. -8.0 0.0 9,876.4\\n 58 Other equity n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a.\\n 59 Currency and deposits 4,811.0 37.9 39.5 -1.7 ….. -1.7 0.0 4,848.9\\n 60 Loans 4,393.3 142.9 148.8 -5.9 ….. -5.9 0.0 4,536.2\\n 61 Insurance technical reserves n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a.\\n 62 Trade credit and advances 326.3 7.5 7.5 (*) ….. (*) 0.0 333.8\\n 63 Special drawing rights allocations 157.8 -0.3 0.0 -0.3 ….. -0.3 0.0 157.5\\n p Preliminary r Revised .....Not applicable n.a. Not available (*) Value between zero and +/- $50 million 0.0 T ransactions or other changes are possible but are zero for a given period.\\n 1. Represents gains or losses on foreign-currency-denominated assets and liabilities due to their revaluation at current exchange rates.\\n 2. Changes in volume and valuation n.i.e. (not included elsewhere) includes changes due to shifts in the composition of reporting panels and to the incorporation of more comprehensive survey results. Also includes\\n capital gains and losses of direct investment affiliates and changes in positions that cannot be allocated to financial transactions, price changes, or exchange-rate changes.\\n 3. Financial transactions and other changes in financial derivatives positions are available only on a net basis, which is shown on line 3; they are not separately available for gross positive fair values and gross negative fair\\n values of financial derivatives.\\n 4. Data are not separately available for price changes, exchange-rate changes, and changes in volume and valuation n.i.e. (not included elsewhere).\\n Note. Details may not add to totals because of rounding.\\n U.S. Bureau of Economic Analysis\\n Page 5 of 5\", \"page_fill_runs\": [10, 40, 10, 10], \"page_lines\": 139}", "page": null, "expected_markdown": null, "tags": ["real", "kind:line"]} {"pdf": "docs/real/j02119751305_p2.pdf", "category": "real", "id": "j02119751305_p2", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" < 목 차 >\\n\\n\\n\\n 1. 머리말 (연구의 동기) ·······························································································1\\n\\n 2. 조사 장소와 연구 날짜 ···························································································1\\n\\n 3. 조사 방법 ·································································································································2\\n\\n 4. 조사 결과 ·································································································································3\\n\\n5. 고 찰 ···········································································································································12\\n (1) 위장의 길이와 체장과의 관계 ···············································································12\\n (2) 충만도의 변화 ···················································································································13\\n (3) 물고기의 위 내용물 ······································································································14\\n\\n6. 결 론 ···········································································································································14\\n\\n7. 문 헌 ···········································································································································16\", \"page_fill_runs\": [95, 91, 129, 129, 139, 79, 115, 102, 139, 139], \"page_lines\": 11}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:middot"]} {"pdf": "docs/real/jresv39n5p385_A1b_p1.pdf", "category": "real", "id": "jresv39n5p385_A1b_p1", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"I\\n\\n U. S. Department of Commerce Research Paper RP1835\\n National Bureau of Standards Volume 39, November 1947\\n Part of the Journal of Research of the National Bureau of Standards (\\n Deposition of Nickel and Cobalt by Chemical Reduction\\n By Abner Brenner and Grace Riddell\\n\\n A process has been developed for dep ositing nickel an d cobalt from hot solut ions of\\n hypophosphite wi th out t h e use of curren t . T he r edu ction of metal occurs only on certain\\n ca talytic metal surfaces . By specific a dhesion of t he can be pretreatments, t he deposits\\n imp roved and by other pretr eatments, t he reduction can be induced on noncatalytic surfaces.\\n The r ed uction can be i nhi bited completely by the presence of certain ions in t he plating\\n solu tion or by th e ca talytic metal surface becomin g in active. TIle possible mechanism of\\n the reaction and t he factors affecting t he rate of deposit ion a rc discussed . T he deposit\\n p rodu ced by t his proces are sound , hard , a nd of good quali ty .\\n I. Introduction solu tion, and that deposits arc not usually ob tained\\n on the glass vessels. No electric curren t is in-\\n Since the publication of a report by the au thors 1 volved in the depo ition . It is suggested that this\\n of a process for depositing nickel by chemical re- process be designated as \\\" clecLroless nickel\\n duction, additional information has been obtained plating\\\" and \\\"electroless cobalt plating\\\".\\n tha t broadens the operating condi tions and the\\n applications of this process. The first paper de- II. ·Composition and Operating Charac-\\n scribed the deposi tion of nickel from an ammoniacal teristics of Solutions\\n solution containing hypophosphite. The process\\n has been extended to include the deposition of 1. Nickel\\n nickel from acid solutions and of cobalt and cobalt- (a)\\n nickel alloys from ammoniacal solutions . Alkaline Solutions\\n The process involve the reducing ac tion of This subject, treated in the previous paper, will\\n hypophosphites in a solution of nickel or cobalt at be reviewed briefly for completeness. The most\\n 90 0 C or above in the presence of certain catalytic satisfactory alkaline solutions are ammoniacal,\\n metals. The reactions can be expressed by the and contain citrates, ammonium salts, hypo-\\n following equations: phosphites, and nickel salts. A typical bath is\\n NiCI2+ N aH2P02+ H 20 --? composed of: gjiiter\\n Ni+ 2I-ICl+ NaH2P03 (1) Nickel chloride_ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 30\\n Sodium hypophosphite _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 10\\n or (2) Ammonium chlori de _______________________ 50\\n Sodiu m citrate ____ ____ __ _______ ___________ 100\\n The hypophosphite undergoes oxidation, and the Ammonium h ydrox ide to a pH of 8 to 10\\n nickel is reduced. Both of these componen ts must Such a solution deposits ni ckel a t the rate of\\n be added at intervals to make th e deposition 0.0002 to 0.0003 in . (0.005 to 0.008 mm) pC'!' hour.\\n con tinuous. As previously indicated, the rate of deposition\\n An interesting feature of the process is that the depends upon the composition of the solution and\\n deposition of nickel or cobalt OCCLlrs only on certain is approximately proportional to the concentration\\n metallic surfaces that are immersed in the hot of the hypophosphite, as shown in table l. Vary-\\n 1 Abner 13ren llcr an d Grace E. R idocll, J. Research NBS 3 7 ,31 (1946) ing the concen tration of nic.kel salts within the\\n RP1725: AES Annual P roceedings, p . 20 (1946). limits shown produces no appreciable change in\\n i Deposition of Nickel and Cobalt 385\", \"page_fill_runs\": [28, 21, 23, 28], \"page_lines\": 46}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:underscore"]} {"pdf": "docs/real/lakeo_trail_waterway_p3.pdf", "category": "real", "id": "lakeo_trail_waterway_p3", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" general info\\n ______________________________________________________________________________________________________________________________________________________________________________________L S\\n R M BIC BF BT L P GS I T P G/P CwE Cwo/E C L S F DW RR PA HT SB G EA SDS VI T\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n 1 W.P. Franklin Campground ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n 2 W.P. Franklin Lock Recreation Area ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n W.P. Franklin Visitor Center ■ ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n 3 Alva Access Area ■ ■ ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n 4 LaBelle Access Area ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n 5 Barron Park ■ ■ ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n 6 Belle Hatchee Marina ■ ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n 7 Port LaBelle Marina ■ ■ ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n 8 Ortona Lock Recreation Area ■ ■ ■ ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n 9 Ortona Lock Campground ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n10 Moore Haven Lock Recreation Area ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n11 Marina R.V. Resort ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n12 Sportman's Village ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n13 Fisheating Creek ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n14 Harney Pond Canal ■ ■ ■ ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n15 Bare Beach ■ ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n16 Indian Prairie Canal ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n17 Okee-Tantie ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n18 C. Scott Driver Jr. ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n19 Okeechobee ■ ■ ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n20 Nubbin Slough ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n21 Henry Creek ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n22 Chancy Bay ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n23 Port Mayaca Lock Recreation Area ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n24 Canal Point ■ ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n25 Pahokee ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n26 Paul Rardin Park ■ ■ ■ ■ ■ ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n27 Belle Glade ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n28 South Bay ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n29 John Stretch Park ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n30 USACE Operations Office, Clewiston ■ ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n31 Clewiston Park ■ ■ ■ ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n32 Liberty Point ■ ■ ■ ■ ■ ■ ■ ■ • ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n33 Alvin Ward Sr. ■ ■ ■ ■ ■ ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n34 Port Mayaca Wayside Park ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n35 Indiantown Marina ■ ■ ■ ■ ■ ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n36 St. Lucie Lock Recreation Area ■ ■ ■ ■ ■ ■ ■ ❂ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n St. Lucie Visitor Center ■ ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n St. Lucie Campground ■ ■ ■ ■ ■ ■ ■ ■ ■ ■\\n ______________________________________________________________________________________________________________________________________________________________________________________\\n37 Phipps Martin County Park ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■\\n ■ Boat: L = Launch; S = Storage; R = Rentals; M = Marina; BIC = Boat in Camping\\n ■ Fish: BF = Bank Fishing; BT = Bait & Tackle; L = License; P = Pier; GS = Guide Service; I = Ice\\n ■ Picnic: T = Tables; P = Pavilion; G/P = Grilles & Pits\\n ■ Camp: Cw/E = Camping w/Electric; Cwo/E = Camping without Electric; C = Cabins; L = (•\\n Laundry; S = Showers; F = Fee\\n ■ General: DW = Drinking Water; RR = Restrooms; PA = Play Area; HT = Hiking Trail Lake Okeechobee Scenic Trail (LOST), Part of the Florida National Scenic Trail: SB = Snack Bar; G = Groceries;\\n EA = Equestrian Access; SDS = Sanitary Dump Station; VI = Visitor Information; T = Telephone)\\n ❂ Nature Trail\", \"page_fill_runs\": [182], \"page_lines\": 91}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:underscore"]} {"pdf": "docs/real/math-deep_p258.pdf", "category": "real", "id": "math-deep_p258", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"258 CHAPTER 8. GAUSSIAN ELIMINATION, LU, CHOLESKY, ECHELON FORM\\non the left, i > j, and on the right, i < j. The index i is the index of the row that is changed\\nby the multiplication. For example, if m = 3 and we want to add twice row 1 to row 3, since\\nβ = 2, j = 1 and i = 3, we form\\n E3,1;2 = I + 2e31 = 1 0 0  0 0 0  1 0 0 \\n 0 1 0  +  0 0 0  =  0 1 0\\n 0 0 1 2 0 0 2 0 1  ,\\nand calculate\\n 1 0 0  b11 b12 · · · · · · · · · b1n\\n E3,1;2B = 0 1 0 b21 b22 · · · · · · · · · b2n\\n  2 0 1   b31 b32 · · · · · · · · · b3n\\n  b11 b12 · · · · · · · · · b1n \\n =  b21 b22 · · · · · · · · · b2n  .\\n 2b11 + b31 2b12 + b32 · · · · · · · · · 2b1n + b3n\\nTherefore, during Step 3 (the elimination step), the matrix A is multiplied on the left by a\\nproduct Ek of matrices of the form Ei,k;βi,k , with i > k.\\nConsequently, we see that\\n Ak+1 = EkPkAk,\\nand then\\n Ak = Ek-1Pk-1 · · · E1P1A.\\nThis justifies the claim made earlier that Ak = MkA for some invertible matrix Mk; we can\\npick\\na product of invertible matrices. Mk = Ek-1Pk-1 · · · E1P1,\\n The fact that det(P(i, k)) = -1 and that det(Ei,j;β) = 1 implies immediately the fact\\nclaimed above: We always have\\n det(Ak) = ± det(A).\\nFurthermore, since\\n Ak = Ek-1Pk-1 · · · E1P1A\\nand since Gaussian elimination stops for k = n, the matrix\\n An = En-1Pn-1 · · · E2P2E1P1A\\nis upper-triangular. Also note that if we let M = En-1Pn-1 · · · E2P2E1P1, then det(M) = ±1,\\nand\\n det(A) = ± det(An).\\n The matrices P(i, k) and Ei,j;β are called elementary matrices. We can summarize the\\nabove discussion in the following theorem:\", \"page_fill_runs\": [], \"page_lines\": 35}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:middot"]} {"pdf": "docs/real/new-product-specification-approval-form_p1.pdf", "category": "real", "id": "new-product-specification-approval-form_p1", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" Indiana University Licensed Product and Property Request Form\\n\\n*SUBMIT ONE FORM FOR EACH NEW PRODUCT. IF USING A SHADE OF RED, PLEASE PROVIDE A PHYSICAL SAMPLE IN PMS 201C.\\n\\nLICENSEE'S NAME:\\n\\nCONTACT NAME:\\n\\nEMAIL:\\n\\nPRODUCT:\\n\\nCOMPLETE DESCRIPTION (e.g., V neck, lg sl T shirt)\\n\\nSIZE(S) and MINIMUMS:\\n\\nCOLOR(S) (list PMS color(s), method of imprint, and imprint PMS color(s)):\\n\\n\\nIP (Intellectual Property) with campus name and logo used:\\n\\n\\nMANUFACTURER NAME and ADDRESS:\\n\\n\\nTERRITORIES (where the product will be sold):\\n\\nPROPOSED SALES CHANNELS:\\n\\nWHO APPLIES LOGO? (COMPANY NAME)\\n\\nAPPROXIMATE WHOLESALE and MSRP PRICE:\\n\\nSAMPLE ATTACHED: YES NO___\\nPlease send sample(s) and form(s) to: IU Licensing & Trademarks, 711 E. State Rd. 45/46 Bypass,\\nBloomington, IN 47408\\n***********************************************************************************************************************************************\\nL&T OFFICE USE\\nRECEIVED BY____________________________________________________________________DATE______________________\\nPRODUCT APPROVED BY _________________________________________________________ DATE _______________ ______\\nADDENDUM SPECS: ADV - YES NO___ $_______ INS - YES NO____ $_______ PRM RATE - YES NO___ %_____\\nADDENDUM COMPLETED BY _______________________________________________________DATE______________________\", \"page_fill_runs\": [66, 20, 57, 21, 53, 20], \"page_lines\": 24}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:star"]} {"pdf": "docs/real/nyse-c-2002-10K-02573628_p39.pdf", "category": "real", "id": "nyse-c-2002-10K-02573628_p39", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" COMMITMENTS PLEDGED ASSETS At December 31, 2001 and 2000 the approximate market values of securities sold under agreements to repurchase and other assets\\n pledged, excluding the impact of FIN 39 and FIN 41 were as follows:\\n IN MILLIONS OF DOLLARS 2001 2000 ------------------------------------------------------------------------------------------------ For securities\\n sold under agreements to repurchase $ 183,814 $ 161,909 As collateral for securities borrowed of approximately equivalent\\n value 44,340 41,149 As collateral on bank loans 154 225 To clearing organizations or segregated under securities laws and\\n regulations 12,834 10,427 For securities loaned 17,562 21,226 Other 43,054 41,520 ------------------------------------------------------------\\n------------------------------------ $ 301,758 $ 276,456\\n ================================================================================================\\n In addition, included in cash and due from banks at December 31, 2001 and 2000 is $5.3 billion and $2.7 billion, respectively, of cash segregated under Federal and other\\n brokerage regulations or deposited with clearing organizations. At December 31, 2001 the Company had $975 million of outstanding letters of credit from banks to satisfy various\\n collateral and margin requirements. COLLATERAL At December 31, 2001 and 2000, the approximate market value of collateral received by the Company that may be sold or\\n repledged by the Company, excluding amounts netted in accordance with FIN 39 and FIN 41, was $245.0 billion and $236.6, respectively. This collateral was received in\\n connection with resale agreements, securities borrowings and loans, derivative transactions, and margined broker loans. At December 31, 2001 and 2000, a substantial portion of\\n the collateral received by the Company had been sold or repledged in connection with repurchase agreements, securities sold, not yet purchased, securities borrowings and loans,\\n pledges to clearing organizations, segregation requirements under securities laws and regulations, derivative transactions, and bank loans. In addition, at December 31, 2001 and\\n 2000, the Company had pledged $47.5 billion and $47.5 billion, respectively, of collateral that may not be sold or repledged by the secured parties. LEASE COMMITMENTS\\n Rental expense (principally for offices and computer equipment) was $1.7 billion, $1.5 billion and $1.4 billion for the years ended December 31, 2001, 2000 and 1999, respectively.\\n Future minimum annual rentals under noncancelable leases, net of sublease income, are as follows:\\n IN MILLIONS OF DOLLARS AT YEAR-END ----------------------------------------------\\n ------------- 2002 $ 1,079 2003 927 2004 761 2005 759 2006 488 Thereafter\\n2,654 ----------------------------------------------------------- $ 6,668\\n ===========================================================\\n The Company and certain of Salomon Smith Barney's subsidiaries together have an option to purchase the buildings presently leased for Salomon Smith Barney's executive\\n offices and New York City operations at the expiration of the lease term. LOAN COMMITMENTS\\n IN MILLIONS OF DOLLARS AT YEAR-END 2001 2000 ----------------------------------------------------------------------------------------------------- One\\n to four family residential mortgages $ 5,470 $ 2,456 Revolving open-end loans secured by 1-4 family residential properties 7,107\\n 6,164 Commercial real estate, construction and land development 1,882 1,130 Credit card lines 387,396 347,383 Commercial and\\n other consumer loan commitments(1) 210,909 197,415 ----------------------------------------------------------------------------------------------------- Total\\n $ 612,764 $ 554,728\\n =====================================================================================================\\n (1) Includes commercial commitments to make or purchase loans, to purchase third-party receivables, and to provide note issuance or revolving underwriting facilities. The\\n majority of unused commitments are contingent upon customers maintaining specific credit standards. Commercial commitments generally have floating interest rates and fixed\\n expiration dates and may require payment of fees. Such fees (net of certain direct costs) are deferred and, upon exercise of the commitment, amortized over the life of the loan or,\\n if exercise is deemed remote, amortized over the commitment period. The table does not include commercial letters of credit issued on behalf of customers and collateralized by\\n the underlying shipment of goods which totaled $5.7 billion and $6.8 billion at December 31, 2001 and 2000. LOANS SOLD WITH CREDIT ENHANCEMENTS\\n AMOUNTS -------------------- IN BILLIONS OF DOLLARS AT YEAR-END 2001 2000 FORM OF CREDIT ENHANCEMENT ------------------\\n ----------------------------------------------------------------------------------- Residential mortgages and other loans sold with recourse(1) $ 7.7 $ 10.4\\n 2001: Recourse obligation of $3.5, and put options as described below 2000; Recourse obligation of $5.1, and put options as\\n described below. ----------------------------------------------------------------------------------------------------- GNMA sales/servicing agreements(2) 13.4\\n 16.1 Secondary recourse obligation ----------------------------------------------------------------------------------------------------- Securitized credit card\\n receivables 66.8 57.0 Includes net revenue over the life of the transaction. Also includes other recourse obligations of $1.0 in 2001\\n\\n and 2000.\\n =====================================================================================================\\n (1) Residential mortgages represent 57% of amounts in 2001 and 71% in 2000. (2) Government National Mortgage Association sales/servicing agreements covering securitized\\n residential mortgages. 83 Citigroup and its subsidiaries are obligated under various credit enhancements related to certain sales of loans or sales of participations in pools of\\n loans, as summarized above. Net revenue on securitized credit card receivables is collected over the life of each sale transaction. The net revenue is based upon the sum of\\n finance charges and fees received from cardholders and interchange revenue earned on cardholder transactions, less the sum of the yield paid to investors, credit losses,\\n transaction costs, and a contractual servicing fee, which is also retained by certain Citigroup subsidiaries as servicers. As specified in certain of the sale agreements, the net\\n revenue collected each month is accumulated up to a predetermined maximum amount, and is available over the remaining term of that transaction to make payments of yield,\\n fees, and transaction costs in the event that net cash flows from the receivables are not sufficient. When the predetermined amount is reached, net revenue is passed directly to\\n the Citigroup subsidiary that sold the receivables. The amount contained in these accounts is included in other assets and was $139 million at December 31, 2001 and $66 million\\n at December 31, 2000. Net revenue from securitized credit card receivables included in other revenue was $2.1 billion, $2.4 billion, and $2.1 billion for the years ended December\\n 31, 2001, 2000, and 1999, respectively. Various put options were written during 2000 and 1999 which require Citigroup to purchase, upon request of the holders, securities issued\\n in certain securitization transactions in order to broaden the investor base and improve execution in connection with the securitizations. The put option at year-end 2001 is\\n exercisable in October of each year beginning in October 2000, with respect to an aggregate of up to approximately $2 billion principal amount of certificates backed by\\n manufactured housing contract receivables, of which approximately $133 million was exercised in 2000. If exercised, the Company will be obligated to purchase the certificates or\\n notes at par plus accrued interest. Two option contracts from 2000 that were exercised in 2001 were the following: a put option, exercisable at any time after June 15, 2000, with\\n respect to an aggregate of up to approximately $1 billion principal amount of notes secured by home equity loan receivables only to the extent the securitization trust cannot meet\\n its obligation under a separate put option by the trust which is exercisable at any time after March 15, 2000; and a put option, originally exercisable at any time after September 15,\\n 2000, the exercise of which had been extended to April 12, 2001, with respect to an aggregate of up to approximately $1.25 billion of notes secured by home equity loan\\n receivables only to the extent the notes are not purchased by the securitization trust pursuant to a separate put option issued by the trust and exercisable at any time after June\\n 15, 2000. The aggregate amortized amount of these options was approximately $1.4 billion at December 31, 2001 and $3.4 billion at December 31, 2000. The Company has\\n recorded liabilities totaling approximately $6 million at December 31, 2001 and $17 million at December 31, 2000 in connection with these options. Subsequent to their initial\\n issuance, such options are marked to market with the fluctuation being reflected in the Consolidated Statement of Income. FINANCIAL GUARANTEES Financial guarantees are\\n used in various transactions to enhance the credit standing of Citigroup customers. They represent irrevocable assurances, subject to the satisfaction of certain conditions, that\\n Citigroup will make payment in the event that the customer fails to fulfill its obligations to third parties. Citicorp issues financial standby letters of credit which are obligations to pay\\n a third-party beneficiary when a customer fails to repay an outstanding loan or debt instrument, such as assuring payments by a foreign reinsurer to a U.S. insurer, to act as a\\n substitute for an escrow account, to provide a payment mechanism for a customer's third-party obligations, and to assure payment of specified financial obligations of a customer.\\n Fees are recognized ratably over the term of the standby letter of credit. The following table summarizes financial standby letters of credit issued by Citicorp. The table does not\\n include securities lending indemnifications issued to customers, which are fully collateralized and totaled $19.9 billion at December 31, 2001 and $15.5 billion at December 31,\\n 2000, and performance standby letters of credit.\\n2001 2000 -------------------------------------------- ------------ IN BILLIONS OF DOLLARS AT YEAR-END Expire within Expire after TOTAL\\n AMOUNT Total amount 1 year 1 year OUTSTANDING outstanding -----------------------------------------------------------------------------------------------\\n ------- Insurance, surety $ 2.8 $ 6.7 $ 9.5 $ 8.0 Options, purchased securities, and escrow 0.3 0.1 0.4 0.3 Clean letters of credit 3.3 1.0\\n 4.3 4.5 Backstop state, country, and municipal securities -- -- -- 0.1 Other debt related 7.4 2.7 10.1 10.2 ---------------------------------------------\\n --------------------------------------------------------- TOTAL(1) $ 13.8 $ 10.5 $ 24.3 $ 23.1\\n ======================================================================================================\\n (1) Total is net of cash collateral of $2.2 billion in 2001 and $2.0 billion in 2000. Collateral other than cash covered 30% of the total in 2001 and 24% in 2000. OTHER\\n COMMITMENTS Salomon Smith Barney and a principal broker-dealer subsidiary have each provided a portion of a residual value guarantee in the amount of $77 million in\\n connection with the lease of the buildings occupied by Salomon Smith Barney's executive offices and New York operations. 27. CONTINGENCIES In the ordinary course of\\n business, Citigroup and/or its subsidiaries are defendants or co-defendants in various litigation matters, other than environmental and asbestos property and casualty insurance\\n claims as discussed in Note 13 to the Consolidated Financial Statements. Although there can be no assurances, the Company believes, based on information currently available,\\n that the ultimate resolution of these legal proceedings would not be likely to have a material adverse effect on its results of operations, financial condition, or liquidity. 84 28.\\n CITIGROUP (PARENT COMPANY ONLY) CONDENSED STATEMENT OF INCOME\\n YEAR ENDED DECEMBER 31, --------------------------------- IN MILLIONS OF DOLLARS 2001 2000 1999 --\\n ----------------------------------------------------------------------------- REVENUES $ 54 $ 133 $ 80 ----------------------------\\n --------------------------------------------------- Expenses: Interest 651 346 389 Other 267 255 133 ----------------------\\n --------------------------------------------------------- Total 918 601 522 ---------------------------------------------------------------\\n ---------------- PRE-TAX LOSS (864) (468) (442) Income tax benefit 348 167 156 ------------------------------------\\n ------------------------------------------- LOSS BEFORE EQUITY IN NET INCOME OF SUBSIDIARIES (516)\\n (301) (286) Equity in net income of subsidiaries 14,642 13,820 11,529 ------------------------------------------------\\n------------------------------- INCOME $ 14,126 $ 13,519 $ 11,243\\n ===============================================================================\\n CONDENSED STATEMENT OF FINANCIAL POSITION\", \"page_fill_runs\": [96, 60, 36, 46, 13, 59, 101, 101, 20, 18, 83, 102, 101, 56, 95, 45, 57, 33, 77, 28, 51, 22, 57, 63, 16, 36, 43, 48, 31], \"page_lines\": 94}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:equals"]} {"pdf": "docs/real/nyse-cbu-2002-10K-02581525_p26.pdf", "category": "real", "id": "nyse-cbu-2002-10K-02581525_p26", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" Weighted Average Exercise Price Options Range of Option Shares Shares Outstanding Price Per Share Exercisable\\n Outstanding ------------------------------------------------------------------------------------------------ Outstanding at December 31, 1998 533,753\\n $ 6.75 - $35.31 360,246 $24.70 Granted 130,379 $25.38 - $29.31 Exercised / (cancelled), net (34,117) $12.13 - $19.13\\nForfeited (1,085) ------------------------------------------------------------------------------------------------ Outstanding at December 31, 1999\\n 628,930 $ 6.75 - $35.31 424,692 $25.08 Granted 150,491 $23.13 Exercised / (cancelled), net (2,777) $13.13 - $35.31\\nForfeited (2,218) ------------------------------------------------------------------------------------------------ Outstanding at December 31, 2000\\n 774,426 $ 6.75 - $34.81 542,703 $24.57 Granted 272,979 $24.90 Exercised / (cancelled), net (65,851) $ 7.50 - $26.50\\nForfeited (5,488) ------------------------------------------------------------------------------------------------ Outstanding at December 31, 2001\\n 976,066 $ 6.75 - $34.81 652,114 $25.37\\n ================================================================================================\\n Statement of Financial Accounting Standards (SFAS) No. 123, \\\"Accounting for Stock-Based Compensation,\\\" provides for a fair-value-based method of accounting for stock\\n compensation plans with employees and others. Alternatively, the statement allows that entities may continue to account for stock-based compensation plans in accordance with\\n Accounting Principles Board (APB) Opinion No. 25, \\\"Accounting for Stock Issued to Employees,\\\" with disclosure of pro forma amounts reflecting the difference between cost\\n charged to operations pursuant to APB No. 25 and compensation cost that would have been charged to operations had SFAS No. 123 been applied. The Company has elected to\\n continue following APB No. 25 in accounting for its stock-based compensation plans. Application of the fair-value based accounting provision of SFAS No. 123 results in the\\n following pro forma amounts of net income and earnings per share: ------------------------------------------------------------ 2001 2000 1999 ------------------------------------------------------------ Net\\n Income: As reported $ 19,129 $ 24,899 $ 23,662 Pro forma 18,307 24,240 23,111 Earnings per share: As reported: Basic $ 1.64 $ 2.34 $ 2.20 Diluted $ 1.62 $ 2.32 $ 2.18 Pro\\n forma: Basic $ 1.57 $ 2.28 $ 2.15 Diluted $ 1.55 $ 2.26 $ 2.13 ============================================================ The fair value of these options was\\n estimated at the date of grant using a Black-Scholes options pricing model with the following weighted average assumptions for 2001, 2000 and 1999: risk-free interest rates by\\n grant of 5.11% during 2001, 4.65% to 6.93% during 2000, and 4.65% to 5.78% during 1999; dividend yields of 3.00% during 2001, 2000 and 1999; volatility factors of the expected\\n market price of the Company's common stock of 28.14% for 2001, 29.15% for 2000 and 30.78% for 1999; and a weighted-average expected life of the option of 7.02 years in\\n 2001, 7.11 in 2000 and 6.70 for 1999. 58 For the purposes of pro forma disclosures, the estimated fair value of the options is amortized to expense over the options' vesting\\n period. Therefore, the preceding results are not likely to be representative of the effects on reported net income for future years due to additional years of vesting. At December\\n 31, 2001 the weighted average information for outstanding and exercisable shares is as follows: Options Outstanding ----------------------------------------------------------------------------\\n Weighted Average Options Exercisable ---------------------------------------------------------------------------- Weighted Average Range of Exercise Remaining Exercise Exercise Price Shares\\n Price Life (years) Shares Price ---------------------------------------------------------------------------- $ 6.75 - $ 7.06 2,000 $ 6.75 0.0 2,000 $ 6.75 $10.59 - $14.13 33,870 $ 12.78 3.4 33,870 $\\n 12.78 $14.13 - $17.66 97,039 $ 15.37 3.5 97,039 $ 15.37 $17.66 - $21.19 75,570 $ 19.13 5.0 75,570 $ 19.13 $21.19 - $24.72 142,306 $ 23.13 8.0 68,673 $ 23.13 $24.72 - $28.25\\n 274,022 $ 24.91 8.9 90,017 $ 24.77 $28.25 - $31.78 205,013 $ 30.11 6.6 138,699 $ 30.19 $31.78 - $34.81 146,246 $ 34.81 10.5 146,246 $ 34.81 ---------------------------------------------\\n ----------------------------- Total / Average 976,066 $ 25.37 7.5 652,114 $ 25.27 ============================================================================\\n Directors may elect to defer all or a portion of their director fees until a certain distribution date pursuant to a Deferred Compensation Plan. The administrator has established an\\n account for each participating director and credits to such account the number of shares of Company common stock which would have been purchased with the director fees and\\n shares equal to the amount of dividends which would have been received. On the distribution date, the director shall be entitled to receive either shares of the Company common\\n stock equal to the number of shares accumulated or at the Company's election, cash equal to the fair value of the number of shares accumulated. As of December 31, 2001 and\\n 2000 there were 31,473 and 25,239 shares credited to participant accounts, for which a liability of $933 and $769 was accrued, respectively. The expense recognized under this\\n plan for the years ended December 31, 2001, 2000 and 1999 was $164, $130, and $146, respectively. NOTE M: EARNINGS PER SHARE Basic earnings per share is computed\\n based on the weighted average shares outstanding. Diluted earnings per share is computed based on the weighted average shares outstanding adjusted for the dilutive effect of\\n the assumed exercise of stock options during the year. The following is a reconciliation of basic to diluted earnings per share for the years ended December 31: Per share Income\\n Shares amount -------------------------------------------------------------------------- 2001 Net Income $ 19,129 Basic EPS 19,129 11,681 $ 1.64 Effect of dilutive securities: Stock options 144 --\\n -------------- Diluted EPS $ 19,129 11,825 $ 1.62 ========================================================================== 2000 Net Income $ 24,899 Basic\\n EPS 24,899 10,629 $ 2.34 Effect of dilutive securities: Stock options 108 ------------------ Diluted EPS $ 24,899 10,737 $ 2.32\\n ========================================================================== 1999 Net Income $ 23,662 Basic EPS 23,662 10,755 $ 2.20 Effect of dilutive\\n securities: Stock options 106 ------------------ Diluted EPS $ 23,662 10,861 $ 2.18 ==========================================================================\\n For the year ended December 31, 2001 basic and diluted earnings per share before extraordinary item was $1.77 and $1.75, respectively. 59 NOTE N: COMMITMENTS,\\n CONTINGENT LIABILITIES AND RESTRICTIONS The Company is a party to financial instruments with off-balance-sheet risk in the normal course of business to meet the\\n financing needs of its customers. These financial instruments consist primarily of commitments to extend credit, which involve, to varying degrees, elements of credit risk in excess\\n of the amount recognized in the statement of condition. The contract amount of those commitments to extend credit reflects the extent of involvement the Company has in this\\n particular class of financial instrument. The Company's exposure to credit loss in the event of nonperformance by the other party to the financial instrument for commitments to\\n extend credit is represented by the contractual amount of the instrument. The Company uses the same credit policies in making commitments as it does for on-balance-sheet\\n instruments. Financial instruments whose contract amounts represent credit risk are as follows at December 31: -------------------------------------------------------------------------------- 2001\\n 2000 -------------------------------------------------------------------------------- Financial instruments whose contract amounts represent credit risk at December 31: Letters of credit $ 18,059 $\\n 18,682 Commitments to make or purchase loans or to extend credit on lines of credit 336,218 226,285 -------------------------------------------------------------------------------- Total $354,277\\n $244,967 ================================================================================ The fair value of these financial instruments is not significant.\\n Commitments to extend credit are agreements to lend to a customer as long as there is no violation of any condition established in the contract. Commitments generally have fixed\\n expiration dates or other termination clauses and may require payment of a fee. Since some of the commitments are expected to expire without being drawn upon, the total\\n commitment amounts do not necessarily represent future cash requirements. The Company evaluated each customer's credit worthiness on a case-by-case basis. The amount of\\n collateral obtained, if deemed necessary by the Company upon extension of credit, is based on management's credit evaluation of the customer. Collateral held varies but may\\n include residential real estate, income-producing commercial properties, and personal property. The Company has unused lines of credit totaling $3,900 at December 31, 2001\\n and 2000. The Company has additional unused borrowing capacity of approximately $260,000 through collateralized transactions with the Federal Home Loan Bank. The\\n Company is required to maintain a reserve balance, as established by the Federal Reserve Bank of New York. The required average total reserve for the 14-day maintenance\\n period ended December 31, 2001 was $34,063, of which $2,000 was required to be on deposit with the Federal Reserve Bank of New York. The remaining $32,063 was\\n represented by cash on hand. NOTE O: LEASES The Company leases buildings and office space under agreements that expire in various years. Rental expense included in\\n operating expenses amounted to $1,620, $1,014 and $991 in 2001, 2000 and 1999, respectively. The future minimum rental commitments as of December 31, 2001 for all\\n noncancelleable operating leases are as follows: 2002 $ 1,483 2003 1,341 2004 1,127 2005 750 2006 627 Thereafter 2,555 ------------------------ $ 7,883\\n ======================== 60 NOTE P: REGULATORY MATTERS The Bank is subject to various regulatory capital requirements administered by the federal banking\\n agencies. Failure to meet minimum capital requirements can initiate certain mandatory and possibly additional discretionary actions by regulators that, if undertaken, could have a\\n direct material effect on the Bank's financial statements. Under capital adequacy guidelines and the regulatory framework for prompt corrective action, the Bank must meet specific\\n capital guidelines that involve quantitative measures of the Bank's assets, liabilities, and certain off-balance sheet items as calculated under regulatory accounting practices. The\\n Bank's capital amounts and classification are also subject to qualitative judgments by the regulators about components, risk weightings, and other factors. Quantitative measures\\n established by regulation to ensure capital adequacy require the Bank to maintain minimum amounts and ratios (set forth in the table below) of total and Tier I capital (as defined in\\n the regulations) to risk-weighted assets (as defined), and of Tier I capital (as defined) to average assets (as defined). Management believes, as of December 31, 2001 and\\n December 31, 2000, that the Bank meets all capital adequacy requirements to which it is subject and is \\\"well capitalized\\\" under the regulatory framework of prompt corrective\\n action. To be categorized as \\\"well capitalized,\\\" the Bank must maintain minimum total risk-based, Tier I risk-based, and Tier I leverage ratios as set forth in the following table.\\n To Be Well Capitalized Under For Capital Prompt Corrective Actual Adequacy Purposes Action Provisions -------------------------------------------------------------\\n ---------------------------------------------------- Amount Ratio Amount Ratio Amount Ratio --------------------------------------------------------------------------------------------------\\n--------------- As of December 31, 2001: Total Core Capital (to Risk Weighted Assets) $212,391 12.57% $135,154 8.00% $168,943 10.00% Tier I\\nCapital (to Risk Weighted Assets) $189,493 11.22% $ 67,577 4.00% $101,366 6.00% Tier I Capital (to Average Assets) $189,493 6.69% $113,268\\n 4.00% $141,585 5.00% As of December 31, 2000: Total Core Capital (to Risk Weighted Assets) $189,903 12.08% $125,790 8.00% $157,237 10.00%\\n Tier I Capital (to Risk Weighted Assets) $170,415 10.84% $ 62,867 4.00% $ 94,300 6.00% Tier I Capital (to Average Assets) $170,415 6.75%\\n $100,963 4.00% $126,204 5.00%\\n =================================================================================================================\\n 61 NOTE Q: PARENT COMPANY STATEMENTS Condensed financial statement information of the parent company is as follows: CONDENSED BALANCE SHEETS December\\n 31 December 31 2001 2000 -------------------------------------------------------------------------------- Assets: Cash and cash equivalents $ 12,921 $ 323 Investment securities 605 895\\n Investment in and advances to subsidiaries 346,980 239,683 Other assets 311 1,295 -------------------------------------------------------------------------------- Total assets $360,735 $242,196\\n ================================================================================ Liabilities: Accrued interest and other liabilities $ 6,377 $ 3,553\\n Borrowings 86,378 36,852 Shareholders' equity 267,980 201,791 -------------------------------------------------------------------------------- Total liabilities and shareholders' equity $360,735\\n $242,196 ================================================================================ CONDENSED STATEMENTS OF INCOME\\n Years Ended December 31 ------------------------------------------------------------------------------------ 2001 2000 1999 --------\\n ---------------------------------------------------------------------------- Revenues: Dividends from subsidiaries $18,373 $14,046\\n $23,139 Interest on investments and deposits 57 40 40 ------------------------------------------------------------------------------\\n------ Total revenues 18,430 14,086 23,179 ------------------------------------------------------------------------------------\\n Expenses: Interest on long term notes and debentures 5,041 3,450 3,025 Other expenses 48 25 19 ----------------\\n -------------------------------------------------------------------- Total expenses 5,089 3,475 3,044 ---------------------------------------\\n --------------------------------------------- Income before tax benefit and equity in undistributed net income of\\n subsidiaries 13,341 10,611 20,135 Income tax benefit 1,419 1,000 900 --------------------------------------------------------\\n ---------------------------- Income before equity in undistributed net income of subsidiaries 14,760 11,611 21,035\\n Equity in undistributed net income of subsidiary banks 4,369 13,288 2,627 ---------------------------------------------------\\n --------------------------------- Net income $19,129 $24,899 $23,662\\n ====================================================================================\", \"page_fill_runs\": [96, 96, 96, 96, 60, 60, 60, 76, 76, 76, 45, 29, 76, 74, 14, 74, 18, 74, 18, 74, 80, 80, 80, 80, 24, 24, 61, 52, 98, 15, 80, 80, 80, 80, 80, 84, 76, 78, 84, 16, 68, 39, 45, 56, 28, 51, 33], \"page_lines\": 98}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:equals"]} {"pdf": "docs/real/oregon_moda_indy_prelim_p99.pdf", "category": "real", "id": "oregon_moda_indy_prelim_p99", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"Press TAB and directional arro Product-Plan Data Collection [assistive technology users, please reference cell A1 for instructions] To add a product to Worksheet 2 - Plan Product Info, select the Add Product button or Ctrl + Shift + P.\\n Company Legal Name: Moda Health Plan, Inc To add a plan to Worksheet 2 - Plan Product Info, select the Add Plan button or Ctrl + Shift + L.\\n HIOS Issuer ID: 39424 State: OR To validate, select the Validate button or Ctrl + Shift + I.\\n To finalize, select the Finalize button or Ctrl + Shift + F.\\n Effective Date of Rate Change(s): 1/1/2026 Market: Individual To remove a product, navigate to the corresponding Product Name/Product ID field and select the Remove Product button or Ctrl + Shift + Q.\\n Product/Plan Level Calculations To remove a plan, navigate to the corresponding Plan Name/Plan ID field and select the Remove Plan button or Ctrl + Shift + A.\\n Field # Section I: General Product and Plan Information\\n 1.1 Product Name EPO Prepared/Protected EPO Standard Plans Individual EPO Individual EPO 1 Individual EPO 2 Individual EPO 3 Individual EPO 4 EPO Gold/Silver/Bronze\\n 1.2 Product ID 39424OR160 39424OR161 39424OR166 39424OR167 39424OR168 39424OR169 39424OR170 39424OR162\\n 1.3 Plan Name Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health Moda Health\\n 1.4 Plan ID (Standard Component ID) 39424OR1600001 39424OR1600002 39424OR1610001 39424OR1610002 39424OR1610003 39424OR1620001 39424OR1620002 39424OR1620003 39424OR1620004 39424OR1620050 39424OR1620062 39424OR1620063 39424OR1620064 39424OR1620065 39424OR1620066 39424OR1620075 39424OR1620076 39424OR1660001 39424OR1660002 39424OR1670001 39424OR1670002 39424OR1670003 39424OR1670004 39424OR1680001 39424OR1680002 39424OR1680003 39424OR1680004 39424OR1680005 39424OR1680007 39424OR1680008 39424OR1690001 39424OR1690002 39424OR1690003 39424OR1700001\\n 1.5 Metal Gold Silver Gold Silver Bronze Gold Silver Bronze Bronze Gold Silver Silver Silver Silver Silver Bronze Silver Silver Bronze Gold Silver Bronze Silver Silver Silver Silver Silver Bronze Bronze Gold Gold Silver Silver Gold\\n 1.6 AV Metal Value 0.791 0.702 0.816 0.717 0.642 0.785 0.701 0.640 0.649 0.799 0.719 0.700 0.699 0.698 0.703 0.647 0.703 0.708 0.647 0.820 0.719 0.647 0.712 0.707 0.716 0.707 0.709 0.649 0.641 0.789 0.808 0.712 0.719 0.799\\n 1.7 Plan Category Terminated Terminated Terminated Terminated Terminated Terminated Terminated Terminated Terminated Terminated Terminated Terminated Terminated Terminated Terminated Terminated Terminated Renewing Renewing Renewing Renewing Renewing Renewing Renewing Renewing Renewing Renewing Renewing Renewing New Renewing New New Renewing\\n 1.8 Plan Type EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO EPO\\n 1.9 Exchange Plan? Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes No Yes No No No Yes Yes Yes Yes Yes Yes Yes No No Yes No Yes Yes Yes Yes Yes No Yes Yes\\n 1.10 Effective Date of Proposed Rates 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026 1/1/2026\\n 1.11 Cumulative Rate Change % (over 12 mos prior) 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 6.68% 10.28% 8.62% 6.59% 11.36% 10.79% 10.86% 8.00% 10.86% 7.06% 8.95% 10.58% 0.00% 9.66% 0.00% 0.00% 9.77%\\n 1.12 Product Rate Increase % 0.00% 0.00% 7.06% 10.30% 0.00% 9.22% 9.66% 9.77%\\n 1.13 Submission Level Rate Increase % 9.13%\\nWorksheet 1 Totals Section II: Experience Period and Current Plan Level Information\\n 2.1 Plan ID (Standard Component ID) Total 39424OR1600001 39424OR1600002 39424OR1610001 39424OR1610002 39424OR1610003 39424OR1620001 39424OR1620002 39424OR1620003 39424OR1620004 39424OR1620050 39424OR1620062 39424OR1620063 39424OR1620064 39424OR1620065 39424OR1620066 39424OR1620075 39424OR1620076 39424OR1660001 39424OR1660002 39424OR1670001 39424OR1670002 39424OR1670003 39424OR1670004 39424OR1680001 39424OR1680002 39424OR1680003 39424OR1680004 39424OR1680005 39424OR1680007 39424OR1680008 39424OR1690001 39424OR1690002 39424OR1690003 39424OR1700001\\n $289,714,528 2.2 Allowed Claims $290,741,211 $25,794,581 $8,665,503 $12,464,661 $15,786,607 $26,214,987 $18,257,092 $14,096,341 $15,002,878 $8,888,440 $15,340,194 $2,239,408 $13,437,989 $984,451 $1,325,389 $4,098,903 $2,664,600 $27,688,209 $12,236,295 $1,067,000 $5,949,112 $7,174,775 $12,841,521 $1,546,953 $1,035,280 $5,466,654 $488,262 $5,184,329 $1,174,477 $8,229,276 $0 $7,266,775 $0 $0 $8,130,267\\n $28,028,836 2.3 Reinsurance $28,041,939 $1,704,855 $727,625 $398,349 $1,105,349 $4,548,625 $1,235,005 $1,303,674 $2,152,543 $971,568 $1,262,262 $187,811 $1,295,182 $157,237 $165,487 $392,849 $470,740 $2,988,551 $1,124,356 $157,479 $319,893 $531,726 $1,723,700 $99,163 $114,935 $536,174 $43,515 $420,997 $220,649 $688,235 $0 $574,594 $0 $0 $418,813\\n 2.4 Member Cost Sharing $56,252,013 $3,542,433 $1,799,755 $1,372,032 $2,383,338 $7,996,383 $3,017,551 $2,728,861 $4,380,025 $2,474,792 $2,477,619 $472,634 $2,153,626 $232,347 $352,020 $805,478 $932,952 $4,438,455 $2,048,128 $307,186 $802,872 $1,171,258 $3,575,176 $327,460 $264,814 $1,102,997 $86,429 $740,357 $340,033 $1,572,128 $0 $1,213,771 $0 $0 $1,139,103\\n 2.5 Cost Sharing Reduction $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0\\n $206,371,627 2.6 Incurred Claims $206,447,260 $20,547,294 $6,138,124 $10,694,280 $12,297,920 $13,669,980 $14,004,537 $10,063,806 $8,470,311 $5,442,080 $11,600,314 $1,578,963 $9,989,181 $594,867 $807,882 $2,900,575 $1,260,908 $20,261,204 $9,063,811 $602,335 $4,826,347 $5,471,792 $7,542,645 $1,120,330 $655,531 $3,827,483 $358,318 $4,022,975 $613,795 $5,968,913 $0 $5,478,410 $0 $0 $6,572,351\\n $8,427,216 2.7 Risk Adjustment Transfer Amount $8,431,156 $512,586 $218,769 $119,769 $332,337 $1,367,600 $371,319 $391,966 $647,189 $292,114 $379,515 $56,468 $389,412 $47,275 $49,756 $118,115 $141,534 $898,545 $338,052 $47,348 $96,180 $159,870 $518,252 $29,815 $34,557 $161,207 $13,083 $126,578 $66,341 $206,926 $0 $172,759 $0 $0 $125,921\\n $234,011,073 2.8 Premium $234,112,723 $12,956,506 $6,964,760 $3,735,663 $10,745,922 $31,612,340 $10,861,921 $12,987,872 $14,915,413 $7,252,290 $9,712,437 $1,254,608 $12,145,027 $926,079 $1,125,941 $2,335,449 $3,453,678 $27,760,153 $11,282,778 $1,294,139 $3,340,582 $5,807,736 $13,051,433 $776,247 $804,526 $5,759,417 $271,057 $4,510,874 $1,884,216 $5,382,803 $0 $5,349,207 $0 $0 $3,851,649\\n 346,697 2.9 Experience Period Member Months 346,697 21,078 8,996 4,925 13,666 56,237 15,269 16,118 26,613 12,012 15,606 2,322 16,013 1,944 2,046 4,857 5,820 36,949 13,901 1,947 3,955 6,574 21,311 1,226 1,421 6,629 538 5,205 2,728 8,509 0 7,104 0 0 5,178\\n 2.10 Current Enrollment 33,027 0 576 0 0 0 1,491 0 0 0 0 0 0 0 0 380 0 0 5,876 851 842 1,436 8,594 260 265 1,555 322 1,380 1,336 4,420 0 1,604 0 0 1,839\\n 2.11 Current Premium PMPM $721.35 $0.00 $765.08 $0.00 $0.00 $0.00 $809.28 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $531.30 $0.00 $0.00 $813.53 $655.64 $874.45 $876.61 $640.60 $649.58 $626.97 $858.54 $530.79 $833.33 $681.79 $632.49 $0.00 $718.13 $0.00 $0.00 $699.76\\n 2.12 Loss Ratio 85.12% 152.55% 85.45% 277.38% 111.01% 41.45% 124.67% 75.22% 54.43% 72.13% 114.95% 120.43% 79.69% 61.12% 68.72% 118.22% 35.07% 70.70% 78.00% 44.90% 140.43% 91.69% 55.58% 138.99% 78.12% 64.65% 126.11% 86.75% 31.47% 106.78% #DIV/0! 99.21% #DIV/0! #DIV/0! 165.24%\\n Per Member Per Month\\n 2.13 Allowed Claims $838.60 $1,223.77 $963.26 $2,530.90 $1,155.17 $466.15 $1,195.70 $874.57 $563.74 $739.96 $982.97 $964.43 $839.19 $506.40 $647.80 $843.92 $457.84 $749.36 $880.25 $548.02 $1,504.20 $1,091.39 $602.58 $1,261.79 $728.56 $824.66 $907.55 $996.03 $430.53 $967.13 #DIV/0! $1,022.91 #DIV/0! #DIV/0! $1,570.16\\n 2.14 Reinsurance $80.88 $80.88 $80.88 $80.88 $80.88 $80.88 $80.88 $80.88 $80.88 $80.88 $80.88 $80.88 $80.88 $80.88 $80.88 $80.88 $80.88 $80.88 $80.88 $80.88 $80.88 $80.88 $80.88 $80.88 $80.88 $80.88 $80.88 $80.88 $80.88 $80.88 #DIV/0! $80.88 #DIV/0! #DIV/0! $80.88\\n 2.15 Member Cost Sharing $162.25 $168.06 $200.06 $278.59 $174.40 $142.19 $197.63 $169.31 $164.58 $206.03 $158.76 $203.55 $134.49 $119.52 $172.05 $165.84 $160.30 $120.12 $147.34 $157.77 $203.00 $178.17 $167.76 $267.10 $186.36 $166.39 $160.65 $142.24 $124.65 $184.76 #DIV/0! $170.86 #DIV/0! #DIV/0! $219.99\\n 2.16 Cost Sharing Reduction $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 #DIV/0! $0.00 #DIV/0! #DIV/0! $0.00\\n 2.17 Incurred Claims $595.47 $974.82 $682.32 $2,171.43 $899.89 $243.08 $917.19 $624.38 $318.28 $453.05 $743.32 $680.00 $623.82 $306.00 $394.86 $597.19 $216.65 $548.36 $652.03 $309.37 $1,220.32 $832.34 $353.93 $913.81 $461.32 $577.38 $666.02 $772.91 $225.00 $701.48 #DIV/0! $771.17 #DIV/0! #DIV/0! $1,269.28\\n 2.18 Risk Adjustment Transfer Amount $24.32 $24.32 $24.32 $24.32 $24.32 $24.32 $24.32 $24.32 $24.32 $24.32 $24.32 $24.32 $24.32 $24.32 $24.32 $24.32 $24.32 $24.32 $24.32 $24.32 $24.32 $24.32 $24.32 $24.32 $24.32 $24.32 $24.32 $24.32 $24.32 $24.32 #DIV/0! $24.32 #DIV/0! #DIV/0! $24.32\\n 2.19 Premium $675.27 $614.69 $774.21 $758.51 $786.33 $562.13 $711.37 $805.80 $560.46 $603.75 $622.35 $540.31 $758.45 $476.38 $550.31 $480.84 $593.42 $751.31 $811.65 $664.68 $844.65 $883.44 $612.43 $633.15 $566.17 $868.82 $503.82 $866.64 $690.70 $632.60 #DIV/0! $752.99 #DIV/0! #DIV/0! $743.85\\n Section III: Plan Adjustment Factors\\n 3.1 Plan ID (Standard Component ID) 39424OR1600001 39424OR1600002 39424OR1610001 39424OR1610002 39424OR1610003 39424OR1620001 39424OR1620002 39424OR1620003 39424OR1620004 39424OR1620050 39424OR1620062 39424OR1620063 39424OR1620064 39424OR1620065 39424OR1620066 39424OR1620075 39424OR1620076 39424OR1660001 39424OR1660002 39424OR1670001 39424OR1670002 39424OR1670003 39424OR1670004 39424OR1680001 39424OR1680002 39424OR1680003 39424OR1680004 39424OR1680005 39424OR1680007 39424OR1680008 39424OR1690001 39424OR1690002 39424OR1690003 39424OR1700001\\n 3.2 Market Adjusted Index Rate $918.06\\n 3.3 AV and Cost Sharing Design of Plan 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.7685 0.6503 0.9460 0.7910 0.6519 0.7499 0.7658 0.8137 0.7354 0.7896 0.6503 0.6394 0.9230 0.9822 0.7877 0.8367 0.9649\\n 3.4 Provider Network Adjustment 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\\n 3.5 Benefits in Addition to EHB 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 1.0014 1.0014 1.0014 1.0014 1.0014 1.0014 1.0014 1.0014 1.0014 1.0014 1.0014 1.0014 1.0014 1.0014 1.0014 1.0014 1.0014\\n 3.6 Administrative Costs\\n 3.7 Administrative Expense 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 7.11% 7.11% 7.11% 7.11% 7.11% 7.11% 7.11% 7.11% 7.11% 7.11% 7.11% 7.11% 7.11% 7.11% 7.11% 7.11% 7.11%\\n 3.8 Taxes and Fees 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.06% 2.06% 2.06% 2.06% 2.06% 2.06% 2.06% 2.06% 2.06% 2.06% 2.06% 2.06% 2.06% 2.06% 2.06% 2.06% 2.06%\\n Profit & Risk Load 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 3.00% 3.00% 3.00% 3.00% 3.00% 3.00% 3.00% 3.00% 3.00% 3.00% 3.00% 3.00% 3.00% 3.00% 3.00% 3.00% 3.00%\\n 3.9 Catastrophic Adjustment 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000\\n 3.10 Plan Adjusted Index Rate $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $804.41 $680.69 $990.21 $827.97 $682.36 $784.94 $801.59 $851.73 $769.77 $826.50 $680.69 $669.28 $966.13 $1,028.10 $824.51 $875.80 $1,009.99\\n 3.11 Age Calibration Factor 0.5724 0.5724\\n 3.12 Geographic Calibration Factor 1 1.0000\\n 3.13 Tobacco Calibration Factor 0.994 0.9940\\n 3.14 Calibrated Plan Adjusted Index Rate $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $457.68 $387.29 $563.39 $471.08 $388.24 $446.61 $456.08 $484.60 $437.97 $470.25 $387.29 $380.80 $549.70 $584.95 $469.12 $498.30 $574.65\\n Section IV: Projected Plan Level Information\\n 4.1 Plan ID (Standard Component ID) Total 39424OR1600001 39424OR1600002 39424OR1610001 39424OR1610002 39424OR1610003 39424OR1620001 39424OR1620002 39424OR1620003 39424OR1620004 39424OR1620050 39424OR1620062 39424OR1620063 39424OR1620064 39424OR1620065 39424OR1620066 39424OR1620075 39424OR1620076 39424OR1660001 39424OR1660002 39424OR1670001 39424OR1670002 39424OR1670003 39424OR1670004 39424OR1680001 39424OR1680002 39424OR1680003 39424OR1680004 39424OR1680005 39424OR1680007 39424OR1680008 39424OR1690001 39424OR1690002 39424OR1690003 39424OR1700001\\n 4.2 Allowed Claims $409,967,251 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $72,863,369 $10,595,157 $10,391,778 $17,793,354 $107,013,269 $3,225,985 $3,286,405 $19,258,013 $3,992,988 $17,102,129 $16,634,707 $55,066,409 $18,415,484 $19,792,327 $4,709,538 $7,127,160 $22,699,179\\n 4.3 Reinsurance $36,222,734 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $6,444,614 $933,194 $923,140 $1,574,822 $9,426,082 $285,168 $290,652 $1,705,524 $352,804 $1,513,584 $1,465,142 $4,847,856 $1,635,146 $1,759,450 $416,784 $631,574 $2,017,198\\n 4.4 Member Cost Sharing $92,908,040 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $15,304,482 $3,369,992 $498,766 $3,371,713 $33,881,036 $732,411 $698,394 $3,250,033 $959,445 $3,262,598 $5,290,986 $18,063,857 $1,270,402 $296,189 $906,618 $1,053,120 $697,999\\n 4.5 Cost Sharing Reduction $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0\\n 4.6 Incurred Claims $280,836,477 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $51,114,273 $6,291,971 $8,969,872 $12,846,819 $63,706,151 $2,208,406 $2,297,359 $14,302,456 $2,680,739 $12,325,948 $9,878,579 $32,154,697 $15,509,935 $17,736,688 $3,386,136 $5,442,466 $19,983,982\\n 4.7 Risk Adjustment Transfer Amount $8,305,001 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $1,477,595 $213,959 $211,654 $361,069 $2,161,174 $65,382 $66,640 $391,036 $80,889 $347,028 $335,922 $1,111,497 $374,900 $403,400 $95,559 $144,805 $462,495\\n 4.8 Premium $311,445,058 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $56,719,232 $6,949,847 $10,001,111 $14,265,845 $70,372,301 $2,449,028 $2,549,049 $15,893,213 $2,971,301 $13,686,841 $10,911,464 $35,498,655 $17,284,141 $19,790,940 $3,759,771 $6,051,786 $22,290,530\\n 4.9 Projected Member Months 396,310 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 70,510 10,210 10,100 17,230 103,130 3,120 3,180 18,660 3,860 16,560 16,030 53,040 17,890 19,250 4,560 6,910 22,070\\n 4.10 Loss Ratio 87.83% #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! 87.83% 87.83% 87.83% 87.83% 87.83% 87.83% 87.83% 87.83% 87.83% 87.83% 87.83% 87.83% 87.83% 87.83% 87.83% 87.83% 87.83%\\n Per Member Per Month\\n 4.11 Allowed Claims $1,034.46 #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! $1,033.38 $1,037.72 $1,028.89 $1,032.70 $1,037.65 $1,033.97 $1,033.46 $1,032.05 $1,034.45 $1,032.74 $1,037.72 $1,038.21 $1,029.37 $1,028.17 $1,032.79 $1,031.43 $1,028.51\\n 4.12 Reinsurance $91.40 #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! $91.40 $91.40 $91.40 $91.40 $91.40 $91.40 $91.40 $91.40 $91.40 $91.40 $91.40 $91.40 $91.40 $91.40 $91.40 $91.40 $91.40\\n 4.13 Member Cost Sharing $234.43 #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! $217.05 $330.07 $49.38 $195.69 $328.53 $234.75 $219.62 $174.17 $248.56 $197.02 $330.07 $340.57 $71.01 $15.39 $198.82 $152.41 $31.63\\n 4.14 Cost Sharing Reduction $0.00 #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00\\n 4.15 Incurred Claims $708.63 #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! $724.92 $616.26 $888.11 $745.61 $617.73 $707.82 $722.44 $766.48 $694.49 $744.32 $616.26 $606.23 $866.96 $921.39 $742.57 $787.62 $905.48\\n 4.16 Risk Adjustment Transfer Amount $20.96 #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! $20.96 $20.96 $20.96 $20.96 $20.96 $20.96 $20.96 $20.96 $20.96 $20.96 $20.96 $20.96 $20.96 $20.96 $20.96 $20.96 $20.96\\n 4.17 Premium $785.86 #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! $804.41 $680.69 $990.21 $827.97 $682.36 $784.94 $801.59 $851.73 $769.77 $826.50 $680.69 $669.28 $966.13 $1,028.10 $824.51 $875.80 $1,009.99\", \"page_fill_runs\": [], \"page_lines\": 76}", "page": null, "expected_markdown": null, "tags": ["real", "kind:word"]} {"pdf": "docs/real/publication-asb-life_p154.pdf", "category": "real", "id": "publication-asb-life_p154", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" SUPPLEMENT FOR THE YEAR OF THE\\n\\n PART 5 - OTHER CREDIT INSURANCE\\n\\n 1 2 3\\nCredit Family Leave Personal GAP All Other (a)\\n 1. Earned Premiums:\\n\\n 1.1 Gross written premiums .................................................................................................. ............................................................. ............................................................. .............................................................\\n 1.2 Refunds on terminations ................................................................................................. ............................................................. ............................................................. .............................................................\\n 1.3 Net written premiums (Lines 1.1 - 1.2)............................................................................ ............................................................. ............................................................. .............................................................\\n 1.4 Premium reserves, start of period ................................................................................... ............................................................. ............................................................. .............................................................\\n 1.5 Premium reserves, end of period..................................................................................... ............................................................. ............................................................. .............................................................\\n 1.6 Actual earned premiums (Lines 1.3 + 1.4 - 1.5) ............................................................... ............................................................. ............................................................. .............................................................\\n 1.7 Earned premiums at prima facie rates ............................................................................. ............................................................. ............................................................. .............................................................\\n\\n 2. Incurred Claims:\\n\\n 2.1 Claims paid ...................................................................................................................... ............................................................. ............................................................. .............................................................\\n 2.2 Total claim reserve, start of period.................................................................................. ............................................................. ............................................................. .............................................................\\n 2.3 Total claim reserve, end of period ................................................................................... ............................................................. ............................................................. .............................................................\\n 2.4 Incurred claims (Lines 2.1 - 2.2 + 2.3).............................................................................. ............................................................. ............................................................. .............................................................\\n\\n 3. Incurred Compensation:\\n\\n 3.1 Commissions and service fees incurred ........................................................................... ............................................................. ............................................................. .............................................................\\n 3.2 Other incurred compensation.......................................................................................... ............................................................. ............................................................. .............................................................\\n 3.3 Total incurred compensation (Lines 3.1 + 3.2) ................................................................. ............................................................. ............................................................. .............................................................\\n 3.4 Commissions/service fee percentage (Lines 3.1/1.3) ....................................................... .......................................................... % ..........................................................% ..........................................................%\\n 3.5 Other incurred compensation percentage (Lines 3.2/1.6) ............................................... .......................................................... % ..........................................................% ..........................................................%\\n\\n 4. Loss Percentage:\\n\\n 4.1 Actual loss percentage (Lines 2.4/1.6) ............................................................................. ..........................................................% ..........................................................% ..........................................................%\\n 4.2 Loss percentage at prima facie rates (Lines 2.4/1.7) ........................................................ .......................................................... % ..........................................................% ..........................................................%\\n\\n (a) Provide a description of \\\"other\\\" coverages (including their percent of Line 1.6, Column 3):............................................................................................................................................................................\\n\\n ..........................................................................................................................................................................................................................................................................................................................\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n © 2019-2025 National Association of Insurance Commissioners Supp230.8 LAH/Fraternal\", \"page_fill_runs\": [281, 280, 259, 266, 268, 246, 260, 301, 265, 266, 261, 258, 273, 248, 113, 58, 58, 105, 58, 58, 135, 58, 58, 114, 58, 58, 172, 314], \"page_lines\": 29}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:dot"]} {"pdf": "docs/real/q3-2006_p2.pdf", "category": "real", "id": "q3-2006_p2", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" CONTENTS\\n\\n\\n\\n\\n Introduction … … … … … … … … …\\n\\n A. The External Environment … … … … … … …\\n\\n B. Real Sector Developments … … … … … … …\\n\\nC. Fiscal Developments … … … … … … … …\\n\\n D. Monetary Developments … … … … … … …\\n E. Price Developments … … … … … … … …\\n\\n F. The Stock Market … … … … … … … …\\n\\nG. Developments In The Foreign Exchange Market… … … …\\n H. External Debt … … … … … … … … …\\n\\nI. External Sector Developments … … … … … …\\n\\nJ. Developments In The Rural Banking Sector … … … …\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n 2\", \"page_fill_runs\": [27, 21, 21, 24, 21, 24, 24, 12, 27, 18, 12], \"page_lines\": 13}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:ellipsis"]} {"pdf": "docs/real/r13-2018-financials-nfs_p2.pdf", "category": "real", "id": "r13-2018-financials-nfs_p2", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" TABLE OF CONTENTS\\n\\n DOCUMENT HISTORY ··················································································································································6\\n UPDATE 18C ··································································································································································6\\n Revision History ····························································································································································6\\nOverview ·········································································································································································6\\n Common Technology and User Experience ·············································································································7\\n Common Financials Features ·································································································································7\\n Approval Groups Report ·····································································································································7\\n Audit History Enablement ··································································································································7\\n Automatic Data Provisioning ······························································································································7\\n Simplified Workflow Rules Configuration ··········································································································7\\n Workflow Rules Report ·······································································································································7\\n REST APIs for Financials ········································································································································7\\n Advanced Collections ·············································································································································7\\n REST APIs for Collections Strategy ···················································································································7\\n Cash Management ·················································································································································8\\n REST APIs for Banks ·········································································································································8\\n REST APIs for Bank Accounts ···························································································································8\\n REST APIs for Bank Branches ··························································································································8\\n REST APIs for External Cash Transactions ·····································································································8\\n Expenses ································································································································································8\\n REST APIs for Expenses ···································································································································8\\n Payables ·································································································································································8\\n REST APIs for Payments ···································································································································8\\n REST APIs for Supplier Invoices ·······················································································································8\\n Receivables ····························································································································································9\\n REST APIs for Receivables Invoices ················································································································9\\n REST APIs for Standard Receipts ·····················································································································9\\nFinancials ·······································································································································································9\\n Advanced Collections ··············································································································································9\\n Assignment of Collections Activities to Collector Groups ················································································9\\n Automatically Initiate or Fulfill Collections Tasks in Third Party Systems ·······················································9\\n Send Invoices with Collections Dunning Letters ·······························································································9\\n Assets ·········································································································································································9\\n Search by Project Asset Name While Preparing Source Lines in Fixed Assets ············································9\\n Asset Cost and Depreciation Report ·················································································································\\n 10\\n Budgetary Control ····················································································································································\\n 10\\n Audit Budgetary Control Setup Changes ··········································································································\\n 10\\n Cash Management ····················································································································································\\n 10\\n Cash to General Ledger Reconciliation Report ································································································\\n 10\\n Create External Transaction for Foreign Exchange Gain or Loss ···································································\\n 10\\n Overdue Invoices in Cash Forecast ···················································································································\\n 10\\n Expenses ····································································································································································\\n 11\\n Spend Authorization ············································································································································\\n 11\\n General Ledger ··························································································································································\\n 11\\n Import and Update Account Combinations ········································································································\\n 11\\n Payables ·····································································································································································\\n 11\\n Match in Full ························································································································································\\n 11\\n New Predefined Job Roles ·································································································································\\n 11\\n\\n\\n 2\", \"page_fill_runs\": [146, 162, 156, 169, 109, 129, 133, 130, 126, 106, 135, 136, 141, 115, 145, 137, 123, 122, 101, 160, 131, 161, 131, 119, 156, 112, 117, 167, 142, 80, 55, 95, 169, 44, 113, 148, 106, 148, 96, 67, 115, 164, 140, 154, 104, 165, 152, 129], \"page_lines\": 64}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:middot"]} {"pdf": "docs/real/rapport_sara_qoc_2018_vf_signe_p4.pdf", "category": "real", "id": "rapport_sara_qoc_2018_vf_signe_p4", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"SOMMAIRE\\n AVANT-PROPOS ........................................................................................................................................................................................................................................I\\n REMERCIEMENTS ......................................................................................................................................................................................................................................I\\n SOMMAIRE.............................................................................................................................................................................................................................................III\\n LISTE DES TABLEAUX ............................................................................................................................................................................................................................IVIII\\n LISTE DES GRAPHIQUES ........................................................................................................................................................................................................................ VIII\\n SIGLES ET ABRÉVIATIONS.........................................................................................................................................................................................................................IX\\nRÉSUMÉ..................................................................................................................................................................................................................................................IX\\n INTRODUCTION........................................................................................................................................................................................................................................1\\n CHAPITRE : PLAN DE SONDAGE ..........................................................................................................................................................................................................3\\n I.OBJECTIFS DE L'ETUDE.......................................................................................................................................................................................................................3\\n1.1 BUT ............................................................................................................................................................................................................ 3\\n1.2 OBJECTIFS DE L'ENQUÊTE.................................................................................................................................................................................. 3\\n1.3 RÉSULTATS ATTENDUS ..................................................................................................................................................................................... 3\\n1.4. TYPE D'ENQUÊTE ............................................................................................................................................................................................ 4\\n1.5. POPULATIONS CIBLES ...................................................................................................................................................................................... 4\\n1.6. ECHANTILLONNAGE......................................................................................................................................................................................... 4\\n1.7. CRITÈRES D'INCLUSION .................................................................................................................................................................................... 5\\n1.8. BASE DE SONDAGE.......................................................................................................................................................................................... 5\\n1.9. DÉTERMINATION DE LA TAILLE DE L'ÉCHANTILLON................................................................................................................................................... 6\\n1.10. MÉTHODOLOGIE DE COLLECTE DES DONNÉES......................................................................................................................................................... 7\\n1.11. L'ÉQUIPE TECHNIQUE ...................................................................................................................................................................................... 8\\n1.12. SAISIE ET TRAITEMENT ....................................................................................................................................................................................10\\n1.13. DÉFINITION OPÉRATIONNELLE DES CONCEPTS .......................................................................................................................................................10\\n CHAPITRE SARA ..................................................................................................................................................................................................................................12\\n II.RESULTATS SARA.............................................................................................................................................................................................................................12\\n2.1. DISPONIBILITE ET UTILISATION DES SERVICES DE SANTE ...........................................................................................................................................12\\n2.2. CAPACITE OPERATIONNELLE GENERALE DES SERVICES..............................................................................................................................................21\\n2.3. DISPONIBILITE ET CAPACITE OPERATIONNELLE DES SERVICES SPECIFIQUES ....................................................................................................................36\\n2.9. PALUDISME..................................................................................................................................................................................................82\\n2.10. SERVICE DE CONSEIL ET DEPISTAGE EN MATIERE DE VIH ..........................................................................................................................................88\\n2.11. SERVICES DE SOINS ET APPUI EN MATIERE DE VIH..................................................................................................................................................91\\n2.12. PRESCRIPTION D'ANTIRETROVIRAUX (ARV) ET PRISE EN CHARGE DES PATIENTS ............................................................................................................97\\n2.13. TUBERCULOSE (TB) .....................................................................................................................................................................................102\\n2.14. SERVICE DE PRÉVENTION DE LA TRANSMISSION DU VIH/SIDA DE LA MÈRE À L'ENFANT (PTME) ....................................................................................107\\n2.15. INFECTIONS SEXUELLEMENT TRANSMISSIBLES (IST)..............................................................................................................................................114\\n2.16. CAPACITÉ OPÉRATIONNELLE DE L'ENSEMBLE VIH-TB-PALUDISME-IST .....................................................................................................................119\\n2.17. LES MALADIES NON TRANSMISSIBLES......................................................................................................................................................119\\n2.18. DIAGNOSTIC ET PRISE EN CHARGE DES MALADIES CARDIO-VASCULAIRES (MCV)..........................................................................................................125\\n2.19. DIAGNOSTIC ET PRISE EN CHARGE DES MALADIES RESPIRATOIRES CHRONIQUES (MRC).................................................................................................130\\n2.20. DIAGNOSTIC ET PRISE EN CHARGE DU CANCER DU COL DE L'UTÉRUS..........................................................................................................................135\\n2.21. SERVICES DE CHIRURGIE DE BASE .....................................................................................................................................................................140\\n2.22. TRANSFUSION SANGUINE ..............................................................................................................................................................................149\\n2.23. GRANDS ÉTABLISSEMENTS OU HÔPITAUX ..........................................................................................................................................................154\\n2.24. EQUIPEMENT D'IMAGERIE .............................................................................................................................................................................159\\n2.25. CHAINE D'APPROVISIONNEMENT.....................................................................................................................................................................162\\n2.26. SERVICE DE PRISE EN CHARGE DE LA MALNUTRITION.............................................................................................................................................168\\n2.27. SERVICE DE LA RÉADAPTATION........................................................................................................................................................................174\\n2.26. SERVICE DE PRISE EN CHARGE DE LA MALNUTRITION.............................................................................................................................................182\\n CHAPITRE QUALITE DES SOINS (QOC)............................................................................................................................................................................................ 186\\n III.PALUDISME................................................................................................................................................................................................................................... 186\\n3.1. OBJECTIFS DU PROGRAMME...........................................................................................................................................................................186\\n3.2. INDICATEURS DE PRISE EN CHARGE DU PALUDISME...............................................................................................................................................186\\n3.3. COMMENTAIRE GÉNÉRAL ..............................................................................................................................................................................193\\n3.4. SYNTHÈSE DES RÉSULTATS ET RECOMMANDATIONS..............................................................................................................................................193\\n IV.PREVENTION DE LA TRANSMISSION MERE ENFANT (PTME) DU VIH..................................................................................................................................... 195\\n4.1. INDICATEURS DE LA PRESTATION DES SOINS EN MATIÈRE DE PTME..........................................................................................................................195\\n4.2. COMMENTAIRE...........................................................................................................................................................................................201\\n4.3. SYNTHÈSE ET RECOMMANDATION....................................................................................................................................................................202\\n V.TRAITEMENT ANTIRETROVIRAL (TARV) .....................................................................................................................................................................................203\\n5.1. INDICATEURS GÉNÉRAUX DU VIH/SIDA ...........................................................................................................................................................203\\n5.2. INDICATEURS SUR LES SOINS EN MATIÈRE DU VIH/SIDA.......................................................................................................................................203\\n VI.TUBERCULOSE.............................................................................................................................................................................................................................. 212\\n6.1. INDICATEURS GÉNÉRAUX DE LA TUBERCULOSE ....................................................................................................................................................212\\n6.2. TRAITEMENT DE LA TUBERCULOSE....................................................................................................................................................................213\\n6.3. SCORE DE QUALITE DES SOINS.........................................................................................................................................................................216\\n CONCLUSION..................................................................................................................................................................................................................................... 219\\n\\n\\n\\n\\n\\n\\n II\", \"page_fill_runs\": [232, 230, 237, 220, 216, 217, 242, 232, 202, 215, 204, 178, 181, 188, 182, 185, 180, 186, 147, 153, 182, 180, 151, 226, 221, 139, 142, 116, 194, 138, 146, 108, 181, 84, 142, 117, 150, 106, 97, 122, 165, 174, 154, 173, 165, 141, 168, 141, 188, 227, 171, 143, 174, 142, 133, 122, 187, 164, 181, 155, 135, 222, 148, 164, 169, 229], \"page_lines\": 68}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:dot"]} {"pdf": "docs/real/spfQ325_p18.pdf", "category": "real", "id": "spfQ325_p18", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" LONG-TERM (5-YEAR TABLE EIGHT\\n AND 10-YEAR) INFLATION FORECASTS\\n\\n ANNUAL AVERAGE OVER THE NEXT 5 YEARS: 2025-2029\\n ===============================================\\n CPI INFLATION RATE PCE INFLATION RATE\\n ------------------------- -------------------------\\n MINIMUM 1.90 MINIMUM 1.87\\n LOWER QUARTILE 2.40 LOWER QUARTILE 2.24\\n MEDIAN 2.43 MEDIAN 2.30\\n UPPER QUARTILE 2.74 UPPER QUARTILE 2.45\\n MAXIMUM 3.50 MAXIMUM 3.30\\n MEAN 2.54 MEAN 2.37\\n STDN . DEVIATION 0.33 STD. DEVIATION 0.28\\n MISSING 288 NMISSING 288\\n\\n ANNUAL AVERAGE OVER THE FOLLOWING 5 YEARS: 2030-2034\\n ==========================================================\\n CPI INFLATION RATE PCE INFLATION RATE\\n ------------------------- -------------------------\\n MINIMUM 1.86 MINIMUM 1.67\\n LOWER QUARTILE 2.00 LOWER QUARTILE 1.90\\n MEDIAN 2.20 MEDIAN 2.00\\n UPPER QUARTILE 2.42 UPPER QUARTILE 2.28\\n MAXIMUM 3.70 MAXIMUM 3.50\\n MEAN 2.27 MEAN 2.10\\n STDN . DEVIATION 0.37 STD. DEVIATION 0.35\\n MISSING 288 NMISSING 288\\n\\n ANNUAL AVERAGE OVER THE NEXT 10 YEARS: 2025-2034\\n ================================================\\n CPI INFLATION RATE PCE INFLATION RATE\\n ------------------------- -------------------------\\n MINIMUM 2.08 MINIMUM 1.84\\n LOWER QUARTILE 2.20 LOWER QUARTILE 2.10\\n MEDIAN 2.31 MEDIAN 2.20\\n UPPER QUARTILE 2.59 UPPER QUARTILE 2.28\\n MAXIMUM 3.60 MAXIMUM 3.40\\n MEAN 2.41 MEAN 2.24\\n STDN . DEVIATION 0.32 STD. DEVIATION 0.29\\n MISSING 288 NMISSING 288\\n\\n\\n\\nNote: The summary statistics for each forecast horizon are computed on a sample of panelists\\n that may differ from one horizon to the next. The usual identity linking the 10-year\\n horizon to the two underlying five-year horizons may not hold in the results.\\nSource: Research Department, Federal Reserve Bank of Philadelphia.\\n Survey of Professional Forecasters, Third Quarter 2025.\\n\\n\\n 18\", \"page_fill_runs\": [], \"page_lines\": 44}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:equals"]} {"pdf": "docs/real/st-jude-financials-990-irs-form-2023_p99.pdf", "category": "real", "id": "st-jude-financials-990-irs-form-2023_p99", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" ST. JUDE CHILDREN'S RESEARCH HOSPITAL,\\n Schedule R (Form 990) 2022 INC. 62-0646012 Page 3\\n\\n Part V Transactions With Related Organizations. Complete if the organization answered \\\"Yes\\\" on Form 990, Part IV, line 34, 35b, or 36.\\n\\n Note: Complete line 1 if any entity is listed in Parts II, III, or IV of this schedule. Yes No\\n 1 During the tax year, did the organization engage in any of the following transactions with one or more related organizations listed in Parts II-IV?\\n a Receipt of (i) interest, (ii) annuities, (iii) royalties, or (iv) rent from a controlled entity ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1a X\\n b Gift, grant, or capital contribution to related organization(s) ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1b X\\n c Gift, grant, or capital contribution from related organization(s) ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1c X\\n d Loans or loan guarantees to or for related organization(s) ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1d X\\n e Loans or loan guarantees by related organization(s) ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1e X\\n f Dividends from related organization(s) ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1f X\\n g Sale of assets to related organization(s) ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1g X\\n h Purchase of assets from related organization(s) ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1h X\\n i Exchange of assets with related organization(s) ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1i X\\n j Lease of facilities, equipment, or other assets to related organization(s) ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1j X\\n k Lease of facilities, equipment, or other assets from related organization(s) ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1k X\\n l Performance of services or membership or fundraising solicitations for related organization(s) ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1l X\\n m Performance of services or membership or fundraising solicitations by related organization(s) ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1m X\\n n Sharing of facilities, equipment, mailing lists, or other assets with related organization(s) ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1n X\\n o Sharing of paid employees with related organization(s) ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1o X\\n p Reimbursement paid to related organization(s) for expenses ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1p X\\n q Reimbursement paid by related organization(s) for expenses ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1q X\\n r Other transfer of cash or property to related organization(s) ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1r X\\n s Other transfer of cash or property from related organization(s)  1s X\\n 2 If the answer to any of the above is \\\"Yes,\\\" see the instructions for information on who must complete this line, including covered relationships and transaction thresholds.\\n (a) (b) (c) (d)\\nName of related organization Transaction Amount involved Method of determining amount involved\\n type (a-s)\\n\\n (1)\\n\\n (2)\\n\\n (3)\\n\\n (4)\\n\\n (5)\\n\\n (6)\\n 232163 09-14-22 Schedule R (Form 990) 2022\", \"page_fill_runs\": [45, 57, 56, 58, 61, 68, 67, 63, 63, 51, 50, 40, 40, 43, 59, 57, 57, 57], \"page_lines\": 35}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:symbol"]} {"pdf": "docs/real/statistical-report-2003_p43.pdf", "category": "real", "id": "statistical-report-2003_p43", "type": "repetition_overshoot", "rule": "{\"reference_text\": \" Office of the Revenue Commissioners Statistical Report 2003\\n\\n\\n\\n TABLE CAT2\\n\\nDistribution of Net Receipt for Capital Acquisitions Tax classified under - Inheritance Tax, Gift Tax,\\n Discretionary Trust Tax and Probate Tax.\\n\\n Capital\\n Acquisitions 1998 1999 2000 2001 2002 2003\\n Tax € € € € € €\\n Inheritance Tax 98,455,375 133,731,623 154,723,513 121,504,568 128,062,522 130,653,240\\n\\n Gift Tax 7,657,731 13,345,483 15,417,767 13,752,087 13,147,217 26,540,077\\n\\n Discretionary Trust Tax 10,671,215 13,460,187 15,271,597 11,028,235 4,306,573 53,501,778\\n\\n Probate Tax 25,027,002 31,722,729 37,514,394 21,405,405 5,375,506 2,551,072\\n\\n Total 141,811,323 192,260,022 222,927,271 167,690,295 150,891,818 213,246,166\\n\\n\\n\\n\\n Distribution of Net Receipt for 2003\\nProbate Tax\\n\\n 1%\\n\\nDiscretionary Trust Tax\\n\\n 25%\\n\\n\\n\\n\\n\\n\\n\\n\\n Inheritance Tax\\n\\nGift Tax 62%\\n\\n 12%\\n\\n\\n\\n TABLE CAT3\\n\\n Gifts and Inheritances taken on or after 1 December 1999 - Rate of Tax\\n\\nThe following Table is applicable to taxable gifts and taxable inheritances taken on or after 1 December 1999\\n\\n\\n\\n Portion of Value Rate of Tax\\n\\n %\\n The threshold amount… … … … … … Nil\\n The balance … … … … … … … … … 20\\n\\n\\n\\n\\n 43\", \"page_fill_runs\": [18, 27], \"page_lines\": 28}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:ellipsis"]} {"pdf": "docs/real/student_departure_form_p1.pdf", "category": "real", "id": "student_departure_form_p1", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"DEPARTURE FORM\\n\\n Please fill this form completely and return to the Education Attache\\n\\n Name: Mr./Ms/Mrs. ------------------------------------------------------------\\n Last Name First Name\\n\\n Residential Address: ------------------------------------------------------------\\n\\n ------------------------------------------------------------\\n City State Zip\\n Telephone: ------------------------------------------------------------\\n\\n Name of Institution: ------------------------------------------------------------\\n Degree: ---------------- Program Title: ----------------------------------------\\n\\n Date of Last Final Examination: ---------------------------------------------\\n Date of Graduation Ceremony: ---------------------------------------------\\n Preferred Dates of Departure: ------------------and/or------------------\\n (Reminder: You are allowed to stay for two weeks after graduation/completion of studies)\\n\\n Comments/Special Instructions: ----------------------------------------------\\n ------------------------------------------------------------------------------------------\\n ------------------------------------------------------------------------------------------\\n ------------------------------------------------------------------------------------------\\n Contact Address in Botswana: ---------------------------------------------\\n ---------------------------------------------\\n ---------------------------------------------\\n ---------------------------------------------\\n ---------------------------------------------\\n Email Address : ------------------------------------------------------------\\n Telephone: Home: ---------------------------- Cell: -----------------------\", \"page_fill_runs\": [61, 60, 60, 60, 16, 40, 45, 45, 18, 18, 46, 45, 60, 28, 23], \"page_lines\": 25}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:dash"]} {"pdf": "docs/real/tr364_p85.pdf", "category": "real", "id": "tr364_p85", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"WEEKS ON 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1\\nSTUDY 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0\\nCARCASS 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 TOTAL:\\nID 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 2~ TISSUES\\n2 2 2 3 3 3 4 4 4 5 5 6 6 7 7 7 7 8 8 9 9 9 0 0 0 TUMORS\\n3 4 5 3 4 5 3 4 5 4 5 4 5 2 3 4 5 4 5 3 4 5 3 4 5\\nEsophagus I- 50\\nIntestine large 50\\nIntestine small 50\\nLiver 50\\nHepatocellular carcinoma h 1\\nLeukemia mononuclear x x x x x x x x 19\\nNeoplastic nodule X X 4\\nNeoplastic nodule, multiple + X X 2\\nMesentery + 4\\nMesothelioma malignant X 1\\nSarcoma 1\\nPancreas 50\\nLeukemia mononuclear 2\\nSaliva glands 50\\nStoma3 50\\nSemsa,sarcoma X 1\\nTongue + 2\\nPa illoma squamous 1\\nToot% 1\\nNeoplasm. NOS 1\\nBlood vessel M I\\nHeart\\nLeukemia mononuclear X l- 5:\\nAdrenal gland I\\nLeukernma mononuclear\\nMedulla pheochromocytoma malignant\\nMedulla' pheochromocytoma benign 19\\nMedulla' pheochromocytoma benign. x x\\nmu~tipie X\\nIslets pancreatic\\nAdenoma x X X\\nCarnnoma\\nParathyroid gland ++++++++M++++++++++++++t t 1\\n48\\nPituitary gland 49\\nLeukemia mononuclear 4\\nPara distalis adenoma x x x x x x X X 12\\nThymid gland 50\\nC cell. adenoma X 1\\nC-call, carnnoma X 1\\nCEFTERALBODPSYSFF~\\nNone\\nEpididymis I- 50\\nPre utlalgland + + + + + + + + + M + + + + M + + + + + + + + + + 43\\n*&noma 2\\nCarnnoma X X 4\\nProstate + 50\\nSeminal vesicle 2\\nTestes\\nLeukemia mononuclear\\nSeminoma malignant, poor\\nInterstitial cell, adenoma X X X\\nInterstitial cell, adenoma, multiple I x x x x x x x x x x x x x x x x 1-1\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n 83 Rhodamine 6G,NTP TR 364\", \"page_fill_runs\": [14], \"page_lines\": 60}", "page": null, "expected_markdown": null, "tags": ["real", "kind:spaced:digit"]} {"pdf": "docs/real/vhdl-style-guide-readthedocs-io-en-3.0.0_p17.pdf", "category": "real", "id": "vhdl-style-guide-readthedocs-io-en-3.0.0_p17", "type": "repetition_overshoot", "rule": "{\"reference_text\": \"vhdl-style-guide Documentation, Release 3.0.0\\n\\n\\nHere is an example output running against a test file:\\n\\n$ vsg -f example/architecture-empty.vhd\\n================================================================================\\nFile: example/architecture-empty.vhd\\n================================================================================\\nPhase 1 of 7... Reporting\\nTotal Rules Checked: 83\\nTotal Violations: 3\\nError : 3\\nWarning : 0\\n----------------------------+------------+------------+-------------------------------\\n˓→-------\\nRule | severity | line(s) | Solution\\n----------------------------+------------+------------+-------------------------------\\n˓→-------\\nport_021 | Error | 45 | Move the ( to the same line\\n˓→as the \\\"port\\\" keyword.\\ninstantiation_034 | Error | 169 | Change to component\\n˓→instantiation\\ngeneric_map_003 | Error | 170 | Move the ( to the same line\\n˓→as the \\\"generic map\\\" keyword.\\n----------------------------+------------+--------------------------------------\\nNOTE: Refer to online documentation at https://vhdl-style-guide.readthedocs.io/en/\\n˓→latest/index.html for more information.\\n\\nVSG will report the rule which is violated and the line number or group of lines where the violation occured. It also\\ngives a suggestion on how to fix the violation. The rules VSG uses are grouped together into Phases. These phases\\nfollow the order in which the user would take to address the violations. Each rule is detailed in the Rules section. The\\nviolation and the appropriate fix for each rule is shown.\\nThe violations can be fixed manually, or use the -fix option to have VSG update the file.\\n\\n$ vsg -f example/architecture-empty.vhd\\n================================================================================\\nFile: example/architecture-empty.vhd\\n================================================================================\\nPhase 7 of 7... Reporting\\nTotal Rules Checked: 378\\nTotal Violations: 0\\n\\nIf rule violations can not be fixed, they will be reported after fixing everything else:\\n\\n$ vsg -f example/architecture-empty.vhd\\n================================================================================\\nFile: example/architecture-empty.vhd\\n================================================================================\\nPhase 1 of 7... Reporting\\nTotal Rules Checked: 83\\nTotal Violations: 1\\nError : 1\\nWarning : 0\\n----------------------------+------------+------------+-------------------------------\\n˓→-------\\nRule | severity | line(s) | Solution\\n----------------------------+------------+------------+-------------------------------\\n˓→-------\\ninstantiation_034 | Error | 169 | Change to component\\n˓→instantiation (continues on next page)\\n\\n\\n 11\", \"page_fill_runs\": [], \"page_lines\": 55}", "page": null, "expected_markdown": null, "tags": ["real", "kind:run:equals"]}